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CHAPTER 1 – INTRODUCTION  1 
 
 
1 Stress 
In 1865 the French physiologist Claude Bernard (1813 – 1878) was the first one 
describing the importance of a stable internal equilibrium of an organism 
compared to the fluctuating external environment. This idea was rendered more 
precisely over half a century later by Walter Cannon (1871 – 1945) defining the 
internal equilibrium and its maintenance within an adequate range as 
“homeostasis” (Cannon, 1929). Disruption of this homeostasis, e.g. through 
exposure to cold, traumatic pain or emotional distress, activates the adrenal 
medulla and the sympathetic nervous system (SNS), coined together the 
“sympathoadrenal” system. This promotes the “fight or flight” response which 
restores the internal milieu. It was in 1936 when Hans Selye, with his 
groundbreaking paper “A syndrome produced by diverse nocuous agents”, 
defined “stress” as “the non-specific response of the body to any physical 
demand” (Selye, 1936a). He also established the term “stressor”. Stressors, 
which can be physical or chemical in nature, cause the physiological stress 
response (Selye, 1975).  
The modern concept of stress research entitles stressors as consciously or 
unconsciously sensed threat to homeostasis (McEwen and Stellar, 1993; 
Goldstein and Kopin, 2007). The specificity of the stress response is dependent 
on the particular type of stressor, the way in which the organism perceives the 
stressor, and the personal ability to cope with it (Goldstein and Kopin, 2007).  
 
1.1 The Stress System 
Following stressor exposure the two main stress response systems, the SNS and 
the hypothalamic-pituitary-adrenal (HPA) axis, get activated. Both systems, 
differing in their time course and in their effector hormones, coordinate the 
restoration of the homeostasis of the organism following stressor exposure, a 
processed called allostasis (Sterling et al., 1988). Moreover, also behavioural 
responses to a stressful experience take place, like increased arousal, alertness, 
heightened attention, anxiety or aggression, while feeding or sexual behaviour 
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are suppressed (Stratakis and Chrousos, 1995; Herman and Cullinan, 1997; 
McEwen and Wingfield, 2003). In the following sections the SNS and the HPA 
axis are discussed in detail, with the main focus directed on the latter one. 
 
1.1.2 Sympathetic nervous system (SNS) 
In response to stressful stimuli, the SNS, together with the parasympathetic and 
enteric nervous system forming the autonomic nervous system, gets rapidly 
activated and controls cardiovascular, gastrointestinal, respiratory and other 
somatic systems (Chrousos, 1998). The control station of the SNS is the locus 
coeruleus (LC), located in the brain stem and containing a cluster of 
norepinephrine (NE)-containing neurons. The LC-NE system innervates nearly 
the entire central nervous system (CNS) (Berridge and Waterhouse, 2003) and 
gets activated by diverse stressors, e.g. shock, hypotension, swim and social 
stressors (Valentino and Van Bockstaele, 2008), probably mediated by the 
afferents of the paraventricular nucleus (PVN) which innervate dendrites in the 
LC (Reyes et al., 2005). The LC also projects to sympathetic preganglionic 
neurons, emphasizing its role in regulating the SNS (Valentino and Van 
Bockstaele, 2008).  
The cell bodies of the preganglionic neurons originate in the intermediolateral 
column (lateral horn) at the thoracic and lumbar region (“thoracolumbar system”) 
of the spinal cord. These sympathetic preganglionic neurons synapse with 
postganglionic neurons located in ganglia which lie on each side of the spinal 
cord, the sympathetic trunk. The postganglionic neurons innervate the peripheral 
organs, like e.g. heart and blood vessels leading amongst others to 
vasoconstriction and increase in the heart rate (Abboud, 2010) (see Fig. 1). 
Sympathetic preganglionic neurons also can directly innervate the adrenal 
medulla, for stimulating the release of catecholamines from chromaffin cells 
which are embryologically and anatomically homologous to the sympathetic 
ganglia. As the adrenal medulla consists of postganglionic neurons which 
originate from the SNS and release their neurotransmitters directly into the blood 
stream, the adrenal functions as an endocrine gland (Elenkov et al., 2000). While 
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the transmitter of the preganglionic neurons is acetylcholine, the end organs get 
stimulated by catecholamines secreted by the postsynaptic sympathetic fibers, 
thereby, NE/noradrenaline represents the major neurotransmitter (Holgert et al., 
1998). In contrast, the adrenal gland secretes mainly epinephrine/adrenaline and 
only to a lesser extent NE following sympathetic stimulation (Holgert et al., 1998). 
The catecholamines bind to α- and β-adrenoreceptors (α1, α2, β1, β2, β3) which 
belong to the family of seven-transmembrane domain receptors, also known as 
G-protein coupled receptors (GPCR) (Minneman et al., 1981). The 
catecholamines released in response to activation of the SNS prepare the 
organism for the “fight or flight” response. The major effects are increase in heart 
and breathing rate, blood pressure, attention and mobilization of energy while 
e.g. digestion is reduced. 
 
 
Figure 1: Schematic representation of the sympathetic nervous system (SNS). The 
preganglionic neurons of the SNS start from the first thoracic segment (T1) and extend to 
the second lumbar segment (L2) of the spinal cord. Their synapses with the postsynaptic 
neurons lie in small sympathetic ganglia, forming a chain near the spinal cord, called the 
sympathetic trunk. The postganglionic neurons run from the ganglia to the target organs. 
[taken and adapted from: wps.aw.com/bc_martini_ fap_9_oa/185/47590/12183 208.cw/-
/12183 232/ index.html] 
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1.2.2 Hypothalamic-Pituitary-Adrenal (HPA) axis 
Along with the SNS, the HPA axis gets, albeit in a delayed manner, activated in 
response to stressor exposure. In the following section the components of the 
HPA axis, i.e. hypothalamus, pituitary, and adrenal, are discussed in detail (see 
Fig. 2). 
 
Figure 2: Schematic illustration of the HPA axis. Corticotropin-releasing hormone 
(CRH) and arginine vasopressin (AVP) are released from parvocellular neurons of the 
paraventricular nucleus (PVN) of the hypothalamus. Neurons of the PVN reach the 
median eminence and release CRH and AVP into the portal blood system. They trigger 
the release of adrenocorticotropic hormone (ACTH) from corticotroph cells of the anterior 
pituitary into the blood stream. ACTH in turn binds to its receptor in the adrenal cortex, 
stimulating the synthesis and release of glucocorticoids (GC, cortisol in humans, 
corticosterone in rats and mice) which negatively signal back to pituitary and PVN. [taken 
and adapted from (Lightman and Conway-Campbell, 2010)] 
 
 
  
Glucocorticoids
(GC)
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The Paraventricular nucleus of the Hypothalamus 
The activation of the HPA axis starts in a distinct set of neurons located in the 
parvocellular PVN, one nucleus of the hypothalamus (Whitnall, 1993). These 
neurons produce the main adrenocorticotropic hormone (ACTH) secretagogues, 
corticotropin releasing hormone (CRH) and arginine vasopressin (AVP) 
(Sawchenko et al., 1984; Whitnall et al., 1985; Aguilera, 1994; Herman and 
Cullinan, 1997). The PVN gets excitatory input from ascending brainstem 
systems, circumventricular organs and hypothalamic-basal forebrain pathways. In 
detail, catecholaminergic neurons from the lower brainstem, mainly activated in 
response to systemic stress, activate the PVN (Sawchenko and Swanson, 1982; 
Ziegler and Herman, 2002). Innervation from the circumventricular organs, 
activated during osmotic stress, is angiotensinergic and stimulates release and 
synthesis of CRH (Kovacs and Sawchenko, 1993; Ziegler and Herman, 2002).  
The majority of projections to the PVN originates from the dorsomedial nucleus of 
the hypothalamus, medial preoptic area, anterioventral third ventricular region 
and ventral medial, posterior medial and intermediate divisions of the bed 
nucleus of the stria terminalis (BNST) (Ziegler and Herman, 2002). These local 
projections can be either excitatory or inhibitory in nature whereby most of them 
are gamma-aminobutyric acid (GABA)ergic and, therefore, inhibit the PVN and in 
turn HPA axis activity (see also Sec. 3.5). Limbic activation of the HPA axis is 
associated with the amygdala, from where the information is relayed via 
catecholaminergic pathways in the brainsteam or via the lateral BNST to the PVN 
(Herman and Cullinan, 1997; Ziegler and Herman, 2002).  
The PVN is comprised of magnocellular and parvocellular neurons, whereupon 
HPA axis activation is supposed to be mainly regulated by the latter one (see Fig. 
3). Both cell types can be differentiated according to their localization, their cell 
size, and their synthesized peptides (Swanson and Kuypers, 1980; van den Pol, 
1982; Ma et al., 1999). The CRH-containing axons of the parvocellular neurons, 
whereby about 50% of the neurosecretory cells coexpress AVP (Sawchenko et 
al., 1984; Whitnall et al., 1985; Aguilera, 1994) project to the external zone of the 
median eminence, located at the bottom of the brain and release CRH and AVP 
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in the pituitary portal circulation from where they can directly target the anterior 
pituitary (Gillies et al., 1982; Rivier and Vale, 1983). While AVP alone is a weak 
ACTH secretagogue (Vale et al., 1983) it plays a role in regulating the HPA axis 
during acute and chronic stress (see also Sec. 4).  
Magnocellular neurons of the PVN and also of the supraoptic nucleus (SON) 
express the neuropeptides Oxytocin (OXT) and AVP (Brownstein et al., 1980) 
and either project to the posterior pituitary from where the neurohormones are 
directly released into the blood stream or they can also project to limbic regions 
via their axon collaterals (Neumann and Landgraf, 2012). OXT is mainly 
associated with parturition and lactation, but it also exhibits anxiolytic properties 
and is implicated in the stress response (Cook, 1997; Hashiguchi et al., 1997; 
Neumann et al., 2000; Landgraf and Neumann, 2004; Waldherr and Neumann, 
2007; Neumann and Landgraf, 2012). OXT release was demonstrated in 
response to various acute stressors, like shaker stress (Nishioka et al., 1998), 
forced swim (FS) (Wotjak et al., 1998) or Morris water maze testing (Engelmann 
et al., 2006). However social defeat (SD) elicited no increased OXT release in the 
PVN and SON (Wotjak et al., 1996), indicating stressor-dependend differences in 
the OXT release. HPA axis activation in response to an acute stressor was 
shown to be suppressed by OXT (Neumann et al., 2000; Windle et al., 2004). 
Magnocellular AVP, also known as antidiuretic hormone, controls water 
conservation in the kidney and is released upon osmotic stimulation (Leng et al., 
1999; Stricker and Sved, 2002) and also regulates vasoconstriction (Altura and 
Altura, 1984).  
Autonomic parvocellular neurons which express CRH and to a lesser extent other 
neuropeptides project to the brainstem and spinal cord (Swanson and Kuypers, 
1980) and are involved in the regulation of the sympathoadrenal system (Aguilera 
and Liu, 2012). CRH is also present in other brain regions, mainly in limbic 
structures, like the BNST, the central amygdala (CeA), LC, cerebral cortex, 
cerebellum and the dorsal root neurons of the spinal cord (Sawchenko and 
Swanson, 1985). CRH in these brain regions acts as a neurotransmitter and is 
implicated in the behavioural response to stress. 
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Figure 3: Schematic illustration of the different subregions of the PVN. The 
parvocellular division (pc) contains neurons expressing corticotrophin releasing hormone 
(CRH) and arginine vasopressin (AVP). Both are released in the pituitary portal 
circulation, stimulating the release and synthesis of adrenocorticotropic hormone (ACTH) 
in the anterior pituitary. The magnocellular division (mc) of the PVN and of the supraoptic 
nucleus (SON) contain AVP and oxytocin (OXT) expressing neurons which project to the 
posterior pituitary and mediate the release of AVP and OXT in the peripheral circulation. 
The autonomic parvocellular neurons (ap) contain mainly CRH and to a lesser extent 
other neuropeptides and project to the brainstem and spinal cord. [taken and adapted 
from (Aguilera and Liu, 2012)] 
 
 
The Pituitary  
The pituitary gland, situated at the basis of the brain, is comprised of the anterior 
pituitary, consisting of the anterior and intermediate lobes and the neuropituitary 
also known as posterior lobe or posterior pituitary. While anterior and 
intermediate lobes consist of oral ectoderm, the posterior pituitary originates from 
neural tissue, i.e. from the infundibulum (Kelberman et al., 2009) (see Fig. 4).  
pc mc
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Figure 4: Rat pituitary section stained with 
antibody against γ-melanocyte stimulating 
hormone. The staining reveals the three regions 
of the pituitary; the anterior lobe/anterior 
pituitary, the intermediate lobe and the posterior 
lobe/posterior pituitary or neuropituitary. PL, 
posterior lobe, AL, anterior lobe; IL, intermediate 
lobe [taken and adapted from (Bicknell, 2008)] 
 
The anterior pituitary contains five major cell types: the corticotrophs, thyrotropes, 
gonadotropes, somatotropes and lactotropes, producing different types of 
hormones which regulate adrenal function, thyroid function, reproduction, growth, 
and lactation, respectively. Corticotroph cells, comprising about 10 – 20 % of the 
total cell population of the anterior pituitary, produce ACTH and constitute the 
prinicipal site for HPA axis regulation (Yeung et al., 2006). The posterior lobe 
receives input from the axon terminals of the magnocelluar neurons of the PVN 
and also of the SON (Kelberman et al., 2009). In contrast, the anterior pituitary 
receives the endocrine information from parvocellular neurons via the portal 
blood (see also Fig. 3).  
CRH released from these parvocellular neurons binds to the membrane-bound 
CRH receptor 1 (CRH-R1), the main subtype in pituitary corticotroph cells 
(Chalmers et al., 1996). CRH receptors, the CRH-R1 and the CRH receptor 2 
(CRH-R2), are members of the GPCR and are coupled to adenylatcyclase which 
stimulates cyclic adenosine monophosphate (cAMP) synthesis and proteinkinase 
A (PKA) activity. CRH can bind to both receptor types but shows a higher affinity 
for the CRH-R1. The CRH-R1 is not only expressed in the pituitary but also 
widely distributed in the brain, especially in the cerebral cortex, cerebellum, 
amygdala, hippocampus, LC, and in the olfactory bulb (Grigoriadis et al., 1996). 
In the periphery it is amongst others localized in the adrenal, heart, spleen, colon, 
skin, testis, and placenta (Hillhouse and Grammatopoulos, 2006). In contrast, the 
CRH-R2 is widely expressed in the peripheral blood vessels, skeletal, smooth, 
and cardiac muscles but only in distinct areas of the brain, like lateral septal 
IL
AL
AL
PL
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nuclei, ventromedial nucleus of the hypothalamus, PVN, and BNST (Grigoriadis 
et al., 1996; Hillhouse and Grammatopoulos, 2006).  
A binding protein for CRH (CRH-BP), located at different sites of the CNS, 
modulates CRH actions and probably acts as a negative regulator of CRH 
signalling (Thomson, 1998; Seasholtz et al., 2001). Moreover, some CRH-like 
peptides, the urocortins (urocortin 1, urocortin 2, urocortin 3), are distributed 
throughout stress-sensitive central and peripheral structures like the pituitary, 
gastrointestinal tract, testis, immune tissue, kidney, heart, adrenal, peripheral 
blood cells, muscle, and skin (Aguilera et al., 2004). While urocortin 1 binds to 
CRH-R1 and CRH-R2, Urocortin 2 and 3 selectively activate CRH-R2 
(Dautzenberg and Hauger, 2002). The distribution pattern of the urocortins 
suggests a role in coordinating the stress response (Aguilera et al., 2004; 
Jamieson et al., 2006).  
CRH administration was shown to increase gene transcription of pro-
opiomelanocortin (POMC), the precursor of ACTH, in the anterior and 
intermediate lobe in in vivo as well as in in vitro studies (Affolter and Reisine, 
1985; Lundblad and Roberts, 1988; Autelitano et al., 1990). After CRH binding to 
its receptor, cAMP and PKA activate via both calcium (Ca2+)- dependent and 
independent transduction signals the mitogen-activated protein kinase (MAPK) 
pathway which in turn activates Nur77 and Nurr1, two transcription factors (TF) 
involved in regulation of POMC expression (Murphy and Conneely, 1997; 
Kovalovsky et al., 2002).  
As already mentioned before, POMC is only a precursor protein, from which 
different end products can be generated by endoproteolytic cleavage through 
proproteins and prohormone converting enzymes in a tissue specific manner 
(Marcinkiewicz et al., 1993). POMC is produced in corticotroph cells of the 
anterior pituitary and in melanotroph cells of the intermediate lobe (Bicknell, 
2008). In the anterior pituitary, POMC, in a first step, is processed to pro-µ-
melanocyte stimulating hormone, ACTH, and β-Lipotrophin. A main proportion of 
β-Lipotrophin is then further cleaved to β-endorphin. In the intermediate lobe 
POMC is cleaved to corticotrophin-like intermediate peptide, α- melanocyte 
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stimulating hormone, µ-Lipotrophin, and β–Endorphin whereby these products 
can be further processed (Bicknell, 2008).  
In addition to its role in regulating POMC expression, CRH binding to CRH-R1 
leads, as described above, to the activation of the PKA, which in turn - via a so 
far unknown pathway - opens voltage-dependent Ca2+ channels (VDCC), leading 
to increased influx of extracellular Ca2+ and eliciting the release of ACTH vesicles 
into the blood stream (Won et al., 1990; Kuryshev et al., 1996). Moreover, 
extracellular Ca2+ influx, via binding to a ryanodine receptor, enhances 
intracellular Ca2+ release which further promotes ACTH release (Yamamori et al., 
2004) (see Fig. 5). 
AVP receptors also belong to the family of GPCR and are divided into three 
major subtypes: AVP receptor 1a (AVPR-1a), AVP receptor 1b (AVPR-1b or V3), 
and V2. While the V2 receptor, which regulates the water resorption in the 
kidney, is coupled to Gs signalling via adenylate cyclase, the AVPR-1a, localized 
in smooth muscle cells and in the liver, and the AVPR-1b, localized in 
corticotroph cells, are coupled to Gq and signal via phospholipase C (PLC) 
(Aguilera and Rabadan-Diehl, 2000a).  
While AVP alone is a weak stimulus for ACTH secretion, together with CRH it 
acts in a synergistic way on the corticotroph cells (Gillies et al., 1982; Antoni, 
1993; Aguilera, 1994; Lightman, 2008). Activated PLC cleaves 
phosphatidylinositol 4,5-bisphosphate (PIP2) into diacylglycerol (DAG) and 
inositol 1,4,5-trisphosphate (IP3). IP3 promotes the release of Ca
2+ from IP3 – 
sensitive intracellular stores (Tse and Lee, 1998) while DAG, in addition, 
activates proteinkinase C (PKC) which stimulates influx of extracellular Ca2+ via 
L-type Ca2+ channels (Won et al., 1990) (see Fig. 5). The synergistic effect of 
AVP and CRH on ACTH release seems to be mediated by the activation of PKC 
which contributes to the CRH-stimulated cAMP production by inhibiting the 
activity of phosphodiesterases leading in turn to a reduced degradation of cAMP 
(Abou-Samra et al., 1987). Interestingly, there are also studies describing 
heterodimers of CRH-R1 and AVPR-1b, probably contributing to the synergistic 
effect of CRH and AVP (Young et al., 2007) (see Fig. 5).  
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Figure 5: Schematic illustration of the intracellular pathways involved in 
corticotropin releasing hormone (CRH)- and arginine vasopressin (AVP)-mediated 
ACTH release in pituitary corticotroph cells. CRH binds to the CRH receptor 1 (CRH-
R1), activates proteinkinase A (PKA) via cyclic AMP (cAMP) and stimulates pro-
opiomelanocortin (POMC) gene transcription or triggers the influx of Ca2+ via voltage-
gated channels (VDCC). Ca2+ that entered the cell via the VDCC can in turn stimulate the 
release of intracellular Ca2+ via binding to the ryanodine receptor. AVP, by binding to the 
AVP receptor 1b (AVPR-1b) activates phospholipase C (PLC) and via inositol 1,4,5-
trisphosphate (IP3) promotes intracellular Ca2+ release. Diacylglycerol (DAG) can activate 
proteinkinase C (PKC) which can act synergistically with CRH to increase intracellular 
Ca2+. Ca2+ is of importance for the fusion of the ACTH vesicles with the plasma 
membrane of the cell. [adapted from (Yamamori et al., 2004)] 
 
 
Adrenal gland 
ACTH released from the pituitary into the blood stream can bind to the 
melanocortin-2-receptor (Mc2r) at the adrenal cortex and triggers the synthesis 
and release of glucocorticoids (GC, cortisol in humans, corticosterone (CORT) in 
rats and mice) (Elias and Clark, 2000). The adrenal is composed of the adrenal 
cortex, producing primarily steroid hormones, and the adrenal medulla, 
CRH-R1
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composed of mainly chromaffin cells, modified postganglionic sympathetic 
neurons, secreting primarily the catecholamines ephinephrine/adrenaline and 
NE/noradrenaline upon stimulation by the sympathetic preganglionic neurons 
(Diaz-Flores et al., 2008) (see also Sec. 2.1.2). In detail, the adrenal cortex 
consists of three layers. The innermost layer, the zona reticularis produces GC 
and in some species like in humans also androgens, estrogens and progestins. 
The outermost layer, the zona glomerulosa, synthesizes and secretes 
mineralocorticoids (aldosterone) for controlling the salt and water balance in the 
kidney. The medial layer, the zona fasciculata, synthesizes the main amount of 
GC (Rosol et al., 2001). GC secretion is mainly stimulated by ACTH, but also 
other hormones produced by the medulla, like adrenaline, have a stimulating 
effect (Bremner et al., 1996). 
The Mc2r belongs to the family of melanocortin receptors (Mc1r to Mc5r), 
members of the GPCR, and stimulates the activation of adenylatcyclase and the 
production of cAMP. Within minutes, the protein expression of the steroid acute 
regulatory protein - expressed in all steroid hormone-producing cells (adrenal, 
gonads) - is increased which stimulates steroidogenesis (Cherradi and Capponi, 
1998; Miller, 2008). Mc2r mRNA expression was also shown to be increased 
following stimulation with ACTH in human as well as in mouse adrenocortical 
cells in vitro (Mountjoy et al., 1994).  
GC, mainly released from the zona fasciculata and zona reticularis, belong to the 
family of steroid hormones. Because of their common origin and their similar 
effectiveness with the mineralocorticoids they are denotet corticosteroids. While 
in humans the cortisol is the main corticosteroid (Nishida et al., 1977), in mice 
and rats it is CORT. GC can exert diverse effects on the whole body. For 
instance they play a major role in energy mobilization by increasing the blood 
glucose levels, they are implicated in modulation of the immune systems as well 
as in the regulation of cardiovascular functions (Sapolsky et al., 2000). Moreover, 
GC play a central role in the basal HPA axis activity as well as in the termination 
of the stress response by exerting a negative feedback at different levels of the 
HPA axis (see also Sec. 3.5). 
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1.2 Acute vs. chronic/repeated stress 
The term “stress“ is mostly used in a negative sense, whereby it is often buried in 
oblivion, that the acute stress response constitutes one of the major survival 
mechanisms of an organism. The synchronal interplay between all physiological 
systems, resulting in coordinated activation of cardiovascular, locomotor, 
neuroendocrine and also immune system facilitates the “fight or flight” reaction 
(Dhabhar, 2009). Sterling and Eyer (1988), therefore, coined the term “allostasis”, 
meaning that the body returns to homeostasis by active processes. To achieve 
this allostasis, the stress hormones, mainly catecholamines and GC from the 
adrenal medulla and the adrenal cortex, respectively, are released (McEwen, 
1998b).  
Stress is composed of a series of events, starting with a stimulus (stressor) that is 
perceived by the brain (stress perception), disrupts the homeostasis and in turn 
activates physiological systems in the body (stress response) to restore the 
physiological balance (Dhabhar, 2009). The acute stress response is beneficial 
and adaptive for the body, contributes to the well-being of an organism, promotes 
survival, and increases its biological fitness. In contrast, repeated or chronic 
stressor exposure can have deleterious effects, promoting the development of 
somatic as well as affective disorders (McEwen, 1998a; Chrousos, 2009). 
McEwen and Stellar in 1993 introduced the term “allostatic load“ describing the 
long lasting burden and negative consequences of prolonged activation of the 
stress system (McEwen and Stellar, 1993).  
Important criteria for distinguishing between acute and chronic stress are 
duration and intensity of the stressor. While acute stress lasts from minutes to 
hours, chronic stress occurs from days to month (Dhabhar, 2000). The intensity 
may be estimated by measurement of stress hormone levels, GC and 
catecholamines, and of heart rate and blood pressure (Dhabhar, 2000).  
An acute stressor elicits a peak in blood GC levels within 15 – 30 min and a 
decline to basal levels 60 – 120 min later (Paskitti et al., 2000; de Kloet et al., 
2005). In contrast, mice exposed to chronic SD over a period of 3 weeks (Keeney 
et al., 2006; Hartmann et al., 2012a) or exposed to chronic subordination in the 
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visible burrow system for 14 days (Albeck et al., 1997) showed sustained 
elevated plasma CORT levels compared with control mice. This prolonged 
release of GC can have deleterious effects on the organism, e.g. the damage of 
the hippocampus (McEwen, 1998a) and inhibition of the immune function 
(Dhabhar, 2000). Nevertheless, there are also chronic stress paradigms resulting 
in unchanged or even decreased plasma GC levels. For instance, in rats, 
repeated exposure to noise (4 h/day for 3 weeks) did not affect basal plasma 
CORT levels (Armario et al., 1986), whereby chronic social isolation for 3 weeks 
resulted in reduced basal plasma CORT levels compared with controls (Adzic et 
al., 2009; Djordjevic et al., 2012). 
Chronic stress paradigms can be further divided in homotypic (same stimulus) or 
heterotypic (different stimuli) stressors whereby homotypic stressor exposure 
commonly results in adaptation of the stress response (Bartolomucci, 2007; 
Wood et al., 2010). As the homeostasis of an organism is important to guarantee 
survival, such adaptational mechanisms are indispensable to cope with repeated 
internal as well as external stimuli or stressors which are not life threatening. 
However, despite adapting to repeated innocuous stimuli, it is important for an 
organism to respond to a novel and perhaps dangerous challenge, in an 
adequate manner. Nevertheless the mechanisms underlying this adaptation and 
sensitization process are only poorly understood (Aguilera, 1994). The adaptation 
of the ACTH response, in-depth described in a review of Aguilera (1994), during 
chronic stress involves a bulk of mechanisms, with the regulation of the ACTH 
secretagogues CRH and AVP as well as their receptors on the pituitary, and the 
GC feedback playing a major role (Aguilera, 1994).  
Three different patterns, characterized by the degree of adaptation to the 
persistent stressor and the magnitude of response to a novel, heterotypic 
superimposed stressor, are described. The first one is characterized by a 
desensitization of the ACTH response to a repeated/chronic stressor (physical or 
psychological stressor like repeated immobilization) and a hyperresponsiveness 
to the novel stressor (see Fig. 6 top). In the second pattern, no desensitization of 
the ACTH release (repeated painful stimuli like ip hypertonic saline injection) but 
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a hyperresponsiveness to the novel stimulus is observed (see Fig. 6 bottom). The 
third pattern is characterized of a small and transient increase in plasma ACTH 
(e.g. prolonged osmotic stimulation during water deprivation) and a 
hyporesponsivenss to the novel stressor (Aguilera, 1994).  
 
Figure 6: Plasma adrenocorticotropic hormone (ACTH) release during adaptation 
to repeated/chronic stressor exposure. Shown are plasma ACTH levels in controls 
and rats subjected to repeated immobilization (2 h/day, upper panel) or ip injection of 
hypertonic saline (5 ml, lower panel) for 14 days under basal conditions and following 
exposure to an acute novel stressor (ip hypertonic saline injection in the upper group 
and 30 min immobilization in the lower group). [Taken and adapted from (Aguilera, 
1994)] 
 
According to Aguilera and colleagues, AVP, under basal conditions only a weak 
stimulator of the ACTH release, becomes more and more attention as an 
important factor in the process of adaptation to repeated/chronic stressors and in 
the hyperresponsiveness to a novel heterotypic stressor, mediated by its 
synergistic effect on CRH-mediated ACTH secretion (Aguilera, 1994; Aguilera 
and Rabadan-Diehl, 2000a). Interestingly, following repeated immobilization, a 
significant increase in CRH neurons coexpressing AVP (from 50 % in controls to 
90 % in chronically stressed animals) (Bartanusz et al., 1993) and also an 
increase in AVP mRNA (Ma and Lightman, 1998; Ma and Aguilera, 1999) has 
been described. This indicates that stress paradigms associated with a 
hyperresponsiveness to a novel heterotypic stressor (repeated immobilization, 
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repeated hypertonic saline injection) increase AVP expression while prolonged 
osmotic stress elicited no enhanced AVP activation in parvocellular neurons 
(Aguilera, 1994). 
Also regulation of CRH mRNA expression depends on the type and duration of 
the homotypic stressor (Aguilera, 1998; Aguilera and Rabadan-Diehl, 2000a). In 
stress paradigms associated with sustained ACTH responses, like foot shock 
(Imaki et al., 1991; Sawchenko et al., 1993) or ip hypertonic saline injection (Ma 
and Aguilera, 1999), CRH mRNA levels are elevated. In contrast, following 
repeated restraint stress (Ma and Lightman, 1998; Ma et al., 1999) or colony-
housing (De Goeij et al., 1992), associated with desensitization of the ACTH 
response, CRH levels are unchanged.  
As indicated above, the expression of AVP increases in chronic stress paradigms 
associated with hyperresponsiveness to a novel heterotypic stressor but not 
during osmotic stimulation (Aguilera, 1994; Aguilera and Rabadan-Diehl, 2000a). 
Besides changes in PVN AVP expression, thereby, regulation of pituitary AVPR-
1b expression seems to play a major role, as there is a good correlation between 
receptor content in the pituitary and corticotroph ACTH secretion in response to a 
superimposed heterotypic stressor (Aguilera, 1994; Aguilera et al., 1994; Aguilera 
and Rabadan-Diehl, 2000b). Under chronic stress conditions associated with 
reduced ACTH release in response to a novel stressor (chronic osmotic 
stimulation), AVP receptors decrease, while stress paradigms with enhanced 
ACTH response to a novel stressor (repeated immobilization, repeated 
hypertonic saline injection) result in receptor up-regulation (Aguilera and 
Rabadan-Diehl, 2000b), whereby mRNA not always correlates with AVP binding 
(Rabadan-Diehl et al., 1995; Rabadan-Diehl et al., 1997). The increase in AVPR-
1b expression seems to be mediated by AVP as well as by other neuropeptides 
in the pituitary portal blood and also by GC. While increased AVP mRNA 
expression in the PVN positively correlated with the number of AVP-R1b 
receptors and ACTH response to a novel stressor following chronic stress 
(Aguilera, 1994), GC were found to reduce AVPR-1b binding despite increasing 
its mRNA levels as well as the coupling of the receptor to PLC. The increased 
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coupling of the AVPR-1b to PLC facilitates the corticotroph response to AVP in 
spite of eleveated GC levels (Rabadan-Diehl and Aguilera, 1998; Aguilera and 
Rabadan-Diehl, 2000b). 
Given that in response to many chronic stress paradigms AVP, in contrast to 
CRH expression, is increased, this suggested for a long time that AVP plays a 
primary role in adaptation of the HPA axis response to chronic stimulation (de 
Goeij et al., 1991; Ma et al., 1997). However, studies conducted in AVP deficient 
Brattleboro rats or following pharmacological blockade of AVP receptors refuted 
the hypothesis of AVP becoming the main regulator during chronic stressor 
exposure. Administration of an AVPR-1b antagonist significantly reduced the 
response to acute restraint stress or lipopolysaccharide stimulation in rats (Spiga 
et al., 2009). AVP deficient Brattleboro rats showed a normal response to most 
acute stressors and only a slight reduction in ACTH release during repeated 
restraint stress (Zelena et al., 2004). Moreover, administration of a non-selective 
V1 receptor antagonist was not able to block the hyperresponsiveness of 
repeatedly restraint rats to an acute stressor, indicating that AVPR-1b up-
regulation, described for this stress paradigm, is not required for the sensitization 
of the ACTH response (Chen et al., 2008). Overall, these studies suggest that 
AVP is important for the full ACTH response in some acute stress paradigms, but 
it is not necessary for the ACTH hyperresponsiveness to a superimposed acute 
heterotypic stressor, indicating that AVP might play an alternative role in the 
process of stress adaptation (Aguilera et al., 2008). A role for AVP in stimulating 
proliferation of corticotroph cells has been shown in the murine corticotroph 
tumor cell line AtT20 (van Wijk et al., 1995), during GC deficiency and chronic 
stress (Subburaju and Aguilera, 2007). 
In chronic stress paradigms associated with ACTH hyperresponsivenss to a 
heterotypic stressor and also in chronic stress models associated with 
maintained ACTH release (repeated hypertonic saline injection) CRH-R1 gets 
down-regulated and desensitized, indicated by a reduced cAMP and ACTH 
response to CRH (Kiss and Aguilera, 1993; Aguilera, 1994). However, for the 
CRH-R1 it could be demonstrated that the receptor number in the pituitary does 
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not always correlate with the pituitary responsiveness. Thus, a decreased CRH 
binding following chronic homotypic stressor exposure (e.g. repeated restraint) 
resulted in increased POMC mRNA expression (Aguilera et al., 2001). In 
addition, there is no correlation between CRH-R1 binding and CRH-R1 mRNA 
levels, suggesting that CRH-R1 down-regulation seems to be mediated by 
changes in the translation efficiency and/or receptor internalization or 
desensitization (Aguilera et al., 2001). Down-regulation of CRH-R1 binding can 
be ascribed to CRH and was shown to be facilitated by concomitant 
administration of AVP (Hauger and Aguilera, 1993). In addition, administration of 
GC decrease CRH binding in vivo and in vitro (Childs et al., 1986; Schwartz et 
al., 1986; Hauger et al., 1987) while CRH-R1 mRNA levels decreased only 
transiently (Rabadan-Diehl et al., 1996; Iredale and Duman, 1997), suggesting an 
inhibition of the CRH-R1 by GC at the post-transcriptional level. Overall the 
studies indicate, that i) the number of CRH-R1 is not indicative for the 
corticotroph responsiveness, as a small number of receptors is sufficient for a full 
ACTH response and that ii) post-transcriptional mechanisms play the major role 
in the regulation of  its expression (Aguilera et al., 2004). 
 
1.3 Psychosocial stress 
Selye`s proposed concept of the general adaptation syndrome only referred to 
physical stressors like cold exposure or surgical injury (Selye, 1936b). 
Nevertheless, it became more and more evident, that the type of stressor, e.g. 
psychological, social or physical in nature, determines the consequences on 
behaviour and physiology. While water deprivation produced a duration-
dependent anxiolytic effect on the elevated plus-maze (EPM), restraint stress (1 
h) had an opposite effect even though plasma CORT levels were increased in 
both groups (McBlane and Handley, 1994). These differences in stress 
responsiveness clearly indicate that stress research should focus on those types 
of stressors that reflect the natural condition a mammalian species, especially 
humans, are normally exposed to, in order to find treatment strategies for e.g. 
stress-related disorders. In humans, the most naturalistic type of stressor every 
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individual is exposed to is of social and/or psychological nature (Brown and 
Prudo, 1981; Bartolomucci et al., 2005). Psychological stress can be caused by 
environmental demands that are thought to exceed the individual’s capability to 
deal with, implying the cognitive appraisal of the stimulus (Sapolsky, 2005; 
Cohen et al., 2007). Social stress is mainly the result of alterations in the social 
life of an individual, concerning the relationship and interaction between 
individuals including e.g. disputes over resources or the social rank (Blanchard et 
al., 2001). Given that chronic psychosocial stressors are acknowledged risk 
factors for the development of stress-related disorders in humans (Hemingway 
and Marmot, 1999; Wahrendorf et al., 2012), animal models mimicking this 
chronic psychosocial burden are important and powerful tools for studying the 
physiological, neuroendocrine and immunological mechanisms that underlie the 
development of these diseases.  
The chronic subordinate colony housing (CSC, 19 days) paradigm constitutes 
one of these appropriate animal models as it induces chronic psychosocial stress 
in male mice. Thereby four experimental mice are housed together with a larger 
dominant male mouse for 19 consecutive days, resulting in a number of 
physiological, neuroendocrine, immunological and also behavioural alterations. 
CSC mice develop somatic as well as affective disorders (Reber et al., 2007; 
Slattery et al., 2012; Uschold-Schmidt et al., 2012) and display typical signs of 
chronic stress, like adrenal hypertrophy and thymus involution (Reber et al., 
2007; Uschold-Schmidt et al., 2012). Moreover, following CSC exposure, mice 
exhibit basal hypocorticism in the evening and show a GC resistance in different 
cells in the periphery (Reber et al., 2007). But, interestingly, in response to an 
acute heterotypic stressor exposure (5 min elevated platform (EPF)), they show 
an exaggerated CORT release (Uschold-Schmidt et al., 2012). This indicates an 
adaptation to the chronic stressor exposure and a concomitant sensitization of 
the HPA axis in response to an acute challenge, at least at the level of the 
adrenal glands. Whether or not changes at higher HPA axis levels, for instance at 
the pituitary, are also contributing to these adaptation/sensitization processes 
have not been analysed in detail yet. 
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2 GC Signalling 
Upon binding of ACTH to the adrenal cortex GCs are released into the blood 
stream to exert a variety of effects, which are determined by a number of factors, 
like the availability of the corticosteroids in the cell as well as the type of receptor. 
 
2.1 Corticosteroid availability 
The activity of the HPA axis, i.e. ACTH and GC release, follows a circadian 
rhythm. Peak cortisol levels are secreted at the end of the resting period, i.e. in 
the morning. In contrast, nocturnal animals like rodents show the CORT peak at 
the end of the afternoon immediately before the start of the dark phase (Young et 
al., 2004; Lightman et al., 2008). Coordination of this rhythmic release pattern is 
orchestrated by the suprachiasmatic nucleus of the hypothalamus. This nucleus 
controls on the one hand CRH and AVP release (Reppert and Weaver, 2002) 
and on the other hand, via the autonomic nervous system, the adrenal gland`s 
sensitivity to ACTH (Ulrich-Lai et al., 2006), preparing the organism for the 
increased metabolic demand during the activity phase. 
Not only the release of GC from the adrenal glands is of importance but also the 
availability in the target tissue is regulated by multiple factors. Corticosteroids can 
be bound to specific carrier proteins, e.g. the corticosteroid-binding globulin 
(CBG) or albumin and they are also subjected to enzymatic conversions, both 
influencing the availability and, thus, bioactivity of these hormones. 
CBG is a glycoprotein, synthesized in the liver, to which under normal conditions 
about 80 – 90 % of circulating corticosteroids are bound. 10 – 15 % are bound to 
albumin, resulting in only about 5 - 10 % of free corticosteroids (Cizza and 
Rother, 2012). As only free corticosteroids are able to enter the target cells, the 
binding proteins constitute an important mechanism to protect, particularly the 
brain, from the dangerous effects of high corticosteroid levels. Regulation of CBG 
levels enables a fast mechanism of adaptation of the corticosteroid levels to 
different situations, e.g. ultradian or circadian variations, stress (Qian et al., 2011) 
or disease. Levels of circulating CBG rise in response to an acute stressor in 
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order to restrain the CORT rise (Qian et al., 2011) while chronic stressor 
exposure evoques a decrease in CBG leading to an increase in the free 
corticosteroid levels (Stefanski, 2000; Henley and Lightman, 2011) 
Entering the brain involves the passage of the blood-brain barrier, composed of 
specialized endothelial cells, protecting the brain from probably damaging 
compounds and maintaining the neuronal homeostasis. While the small and 
highly lipophilic CORT can pass the blood-brain barrier via diffusion, the 
penetration of cortisol as well as of synthetic GC, e.g. dexamethasone (Dex), is 
limited as they are substrates for the multidrug resistance (mdr) 1a P-
glycoprotein, located in the membrane of endothelial but also of other peripheral 
cells (Meijer et al., 1998; Karssen et al., 2001). In the cell, tissue specific 
enzymes, the most common one is the 11ß-hydroxysteroid dehydrogenase (11ß-
HSD), regulate the interconversion of active GC (cortisol, CORT) and their inert 
11-keto forms (cortisone, 11-dehydrocorticosterone). 11ß-HSD type 1 is 
expressed in the liver, adipose tissue, bone, lung and pituitary and in the CNS, 
especially in the hippocampus, cerebellum and neocortex, catalizing the 
conversion of the 11-keto in its active form (Harris et al., 2001; Cooper and 
Stewart, 2009). The type 1 form of this enzyme, therefore, plays a major role in 
regulating GC levels in the brain under basal and stress conditions (Harris et al., 
2001). 11ß-HSD type 2 is mainly expressed in mineralocorticoid target tissue, like 
kidney, colon, and salivary glands, converting GC in their inactive form, rendering 
them unable to bind to the mineralocorticoid receptor (MR) and, therefore, 
enabling aldosterone to exert its effects by binding to the MR (Cooper and 
Stewart, 2009). 
 
2.2 Corticosteroid receptor types in the brain 
The actions of the corticosteroids are mediated by two types of receptors; namely 
the MR and the glucocorticoid receptor (GR). Their names already implicate the 
processes they are involved in, mineral balance (Yang and Young, 2009) and 
gluconeogenesis (Revollo and Cidlowski, 2009), respectively. Binding studies 
revealed, that the MR binds GC with a 10-fold higher affinity (KD ~ 0.5 nM) than 
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GR (KD ~ 5 nM) (Reul and de Kloet, 1985; de Kloet et al., 1998). MR are mainly 
distributed in limbic brain structures with the highest density in the hippocampus 
and the lateral septum, while low expression levels are found in the amygdala, 
hypothalamus and also outside of the brain in the pituitary (Moguilewsky and 
Raynaud, 1980; Reul and de Kloet, 1985). GR are distributed all over the brain, 
e.g. in the lateral septum, hippocampus, nucleus tractus solitarii, LC, amygdala, 
and PVN (Reul and de Kloet, 1985). According to the binding studies, low freely 
circulating GC levels in the brain during the diurnal through (0.5 – 1 nM) already 
occupy most of the MR (Reul et al., 2000), whereas GR become additionally 
occupied at higher CORT levels, i.e. at the circadian peak and during stress 
(Reul and de Kloet, 1985). As under most circumstances the MR is already 
occupied, it is hypothesized that for the MR its protein expression while for the 
GR the ligand concentration constitute the most important regulators (de Kloet et 
al., 2000). For the GR, two main isoforms, the GRα and the shorter form, the 
GRß, are described which differ in their carboxy termini. While GRα binds GC 
and mediates a variety of GC effects, the GRβ is unable to bind GC and is, 
therefore, transcriptionally inactive and, in addition, can inhibit the transcriptional 
activity of GRα (Oakley et al., 1999; Revollo and Cidlowski, 2009). For the MR 
four isoforms exist, with the MRα and MRß representing the two main types 
which show different tissue-specific expression patterns (Zennaro et al., 1995; 
Zennaro et al., 1997).  
GR and MR are members of an evolutionary conserved family of nuclear 
receptors which are composed of three functional domains. The N-terminal 
transactivation domain with an activation function motif (AF-1) for the interaction 
with the transcriptional machinery and/or TF, the central DNA-binding domain 
(DBD) containing two zinc fingers for interaction with the DNA and receptor 
dimerization, and the C-terminal ligand-binding domain, containing a ligand-
binding motif, a nuclear localization signal (NLS) and a further activation motif 
(AF-2) for interaction with other TF (Giguere et al., 1986; Bamberger et al., 1996; 
Revollo and Cidlowski, 2009) (see Fig. 7).  
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Figure 7: Schematic illustration of the protein structure of the human GR. The gene 
is composed of a N-Terminal region, containing an activation function (AF-1) motif, a 
DNA binding domain (DBD), a C-Terminal region, containing a nuclear localization signal 
(NLS) and another activation motif (AF-2). [adapted from (Revollo and Cidlowski, 2009)] 
 
The properties of the different domains already give insight into the functions of 
these receptors. The unactivated receptor is bound to a multiprotein complex 
consisting of molecular chaperones, the heat shock proteins (hsp90 and hsp70), 
which serve the proper folding of peptides and proteins in the cytoplasm. Other 
co-chaperones, like the acidic protein p23 and immunophilins that bind via their 
tetratricopeptide repeat (TPR) domain to a TPR domain on the hsp90 
complement the complex (Tai et al., 1992; Hutchison et al., 1993; Pratt and Toft, 
1997). Immunophilins, disposing peptidylproly-isomerase activity, bind 
immunosuppressive drugs, like FK506, rapamycin and cyclosporine A. Some of 
these participate in the corticosteroid receptor-hsp90 complex, e.g. FK506-
binding protein 51 (FKBP51) and FK506-binding protein 52 (FKBP52). Given that 
both bind to the same site on the hsp90 independent heterocomplexes can be 
created (Pratt and Toft, 1997). The whole complex around the GR regulates the 
receptor folding, maturation, activation, and also trafficking into the nucleus (Grad 
and Picard, 2007). Upon ligand binding primarily a conformational change of the 
receptor takes place, exposing two NLS which promote the translocation into the 
nucleus (Picard and Yamamoto, 1987). The receptors then either form dimers 
which bind to the DNA on so called GC-responsive elements (GRE) enabling the 
transcription of different target genes or they can also act as monomers. The 
general opinion was that the GR has to dissociate from the hsp90 chaperone 
complex in order to promote translocation (de Kloet et al., 1998). Nevertheless, 
pharmacological inhibition of hsp90 has been shown to lead to a delay in nuclear 
translocation of the GR-ligand complex (Czar et al., 1997). Therefore, the 
translocation concept gets renewed by conveying the immunophilins FKBP51 
AF-1 DBD AAF-2NLS AF-2
N-Terminal C-Terminal
DNA
Binding
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and FKBP52 an important role in hormone-bound receptor trafficking (Galigniana 
et al., 2010a). It suggests that FKBP51, bound to hsp90, has to be exchanged by 
FKBP52 which binds to dynein, enabling the translocation to the nucleus via 
microtubules (Davies et al., 2002; Galigniana et al., 2010b) (see Fig. 8). 
 
 
Figure 8: Schematic illustration of the concept of glucocorticoid receptor (GR) 
nuclear translocation. In the cytoplasm, the GR is associated with heatshock proteins 
(hsp 90 and hsp70), two acidic proteins (p23) and one immunophilin, the FK506-binding 
protein 51 (FKBP51). Once CORT binds to the GR receptor complex FKBP51 is 
exchanged against FKBP52. In turn, dynein can bind and the receptor complex 
translocates into the nucleus through the nuclear pore where it can bind to the DNA. To 
simplify the illustration only a monomer of the receptor complex is depicted. [adapted 
from (Binder, 2009)]  
 
FKBP51 and FKBP52 
Since their discovery, the FK506 binding proteins gained more and more 
attention as they represent important regulators of GR (Denny et al., 2000) and 
also MR (Gallo et al., 2007). As already mentioned before, FKBP51 binds to 
hsp90 via a TPR-domain and lowers the receptors affinity for its ligand (Wochnik 
et al., 2005). The significance for FKBP51 was discovered in New World Monkey, 
a monkey line characterized by extremely high cortisol levels compared with 
other monkeys or humans. But, surprisingly, they show no behavioural or 
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physiological signs known to be linked with hypercorticism, as the target organs 
exhibit GC resistance mediated by an overexpression of FKBP51 (Denny et al., 
2000). In addition, in vitro studies demonstrated that increased FKBP51 levels 
not only reduce the affinity of the receptor for its ligand but also reduce 
subsequent nuclear translocation (Wochnik et al., 2005). Interestingly, GC induce 
FKBP51 transcription via GR which in turn restrains GR functionality, forming part 
of a short negative feedback loop regulating GR activity (Vermeer et al., 2003).  
Scharf and colleagues (2011) could show that FKBP51 is not only expressed in 
peripheral tissues but also in GR-expressing brain regions, like hippocampus, 
amygdala, and PVN. Stressor exposure was shown to induce FKBP51 
expression whereby the basal expression pattern influenced the extent to which 
its expression was induced. Regions containing low levels of FKBP51 under 
basal conditions showed a higher induction compared with regions showing 
higher basal expression levels. An evidence for FKBP51 regulating GR sensitivity 
and that high levels result in lower GR responsiveness which suggests the use of 
baseline FKBP51 levels as marker for GR sensitivity (Binder, 2009; Scharf et al., 
2011). Genetic polymorphisms in the gene encoding for FKBP51, associated with 
an increased FKBP51 expression, lead to decreased negative feedback 
regulation of the stress hormone system and, therefore, increase the risk for 
development of psychiatric disorders, like major depression, bipolar disorder, and 
post-traumatic stress disorder (Binder, 2009). 
In opposite to FKBP51, FKBP52 is a positive regulator for trafficking of GR and 
MR into the nucleus via interaction with dynein (Silverstein et al., 1999; 
Galigniana et al., 2010b). FKBP52 also stimulates GR-mediated gene 
transcription (Ning and Sanchez, 1993) but not the transcriptional activity of the 
MR (Gallo et al., 2007). 
 
2.3 Transcriptional Regulation 
Upon translocation into the nucleus, MR and GR can modulate gene transcription 
by binding to a GRE or by interaction with other TF (Beato and Sanchez-
Pacheco, 1996). GR and MR have a nearly identical DBD recognizing the GRE 
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on the DNA in the proximity of gene promoters where they can bind either as 
homo- (Karst et al., 2000) or heterodimers (Liu et al., 1995; Ou et al., 2001). It is 
hypothesized that GR are more potent transcription activators than MR and that 
heterodimers have different functions compared to homodimers (de Kloet et al., 
2000). Hence, according to the GC concentrations, three different dimer 
conformations are possible, that can bind to different DNA targets and regulate a 
variety of target genes in a distinct manner (Kellendonk et al., 2002). 
Heterodimers are observered predominantely at higher concentrations, i.e. under 
conditions of stressful events (Nishi and Kawata, 2007). Nevertheless not much 
is known about the exact differences between the binding of hetero- or 
homodimers to the promoter sequence of different genes. Upon binding to the 
GRE, a number of co-factors are recruited to the receptor complex and 
interaction with the general transcription machinery takes place. Transcription of 
target genes is then either enhanced, by binding to positive GRE, a process 
called transactivation, or repressed, by binding to negative GRE. Negative GRE 
are less commonly observed, but some are part of the negative feedback 
process of the HPA axis (see also Sec. 3.5) or of the immune system (Zhang et 
al., 1997; Datson et al., 2008). 
GR can also interact as monomer with other TF, e.g. activator protein 1, cAMP 
response element binding protein, or nuclear factor-kappa B, that are activated 
by other signalling pathways in response to inflammation or immune activation. 
Normally, GR repress the effects of these TF on gene transcription 
(transrepression), accounting for the inhibitory effects of GR on the immune 
system (de Kloet et al., 1998; Datson et al., 2008) (see Fig. 9). The 
transcriptional response is further regulated by phosphorylations of the receptor 
by cell-specific kinases (e.g. MAPK, cyclin-dependent kinase CDK, glycogen 
synthase kinase GSK-3) which can modulate the receptor activity (Galliher-
Beckley and Cidlowski, 2009). 
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Figure 9: Molecular mechanisms of glucocorticoid actions on gene expression. (1) 
Homodimerization: Upon binding of corticosteroids, mineralocorticoid receptor (MR) or 
glucocorticoid receptor (GR) can translocate into the nucleus, form homodimers and bind 
to specific elements on the DNA, the GC-responsive elements (GRE), in the promoter 
region of GC-responsive genes and increase (transactivation) or decrease their 
transcription. (2) Transrepression: Activated GR can interact with transcription factors 
(TF) by direct protein-protein interaction, inhibiting the binding of the TF to the TF 
elements (TFE), resulting in a down-regulation of TF and/or GC-responsive genes. (3) 
Heterodimerization: Activated MR and GR can build heterodimers and bind to GRE or yet 
unknown DNA elements (indicated by X), affecting expression of GC-responsive genes. 
[adapted from (de Kloet et al., 1998)] 
 
The transcriptional response mediated by the GR is highly dynamic, displaying 
different expression waves over the time. In hippocampal slices, administration of 
100 nM CORT down-regulated a majority of genes after 1 h, up-regulated some 
genes after 3 h and following 5 h of stimulation, gene transcription was nearly 
back to baseline (Morsink et al., 2006).  
GC regulate a wide number of genes involved in cellular processes like energy 
metabolism (e.g. glycolysis and gluconeognesis), signal transduction, regulation 
of neurotransmitters and their receptors, e.g. AVP-R1a, OXT receptor and in 
neuronal plasticity, e.g. the expression of the clock gene period 1 (Per1). 
Importantly, they are also implicated in the regulation of the HPA axis and in 
corticosteroid signalling itself (Datson et al., 2008; Lightman and Conway-
Campbell, 2010). 
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2.4 Non-genomic pathways 
GC-mediated effects, as described above, are mostly slow in onset. The 
translocation of the receptor to the nucleus (10 – 30 min) and the transcription (5 
– 120 min) are time consuming steps, indicating that it takes a delay of at least 
15 min or often hours until physiological responses occur (de Kloet et al., 1999; 
Haller et al., 2008). Therefore, rapid GC-mediated effects, seen after seconds to 
minutes (Di et al., 2003; Karst et al., 2005) cannot be ascribed to the classical 
effects at the transcriptional level while slow effects cannot automatically be 
ascribed to a genomic effect (Haller et al., 2008). Already 30 years ago, binding 
of steroids at the synaptic membrane was found (Towle and Sze, 1983) revealing 
early evidence that membrane-bound receptors may, most likely in addition to the 
cytoplasmic GR, play an important role in mediating these non-genomic GC 
effects. To support the concept of membrane-bound GR or MR, there are some 
criteria that have to be fulfilled. First of all, CORT applied in the intracellular 
compartment may not exert the rapid non-genomic effects. CORT or Dex 
conjucated to bovine serum albumin (BSA), which is, therefore, unable to enter 
the cell, must exert the same effects as the unbound homolog (Groeneweg et al., 
2012). The most compelling evidence for the presence of MR and GR at the 
membrane was done by demonstrating their localization via electron microscopy 
(Johnson et al., 2005; Prager et al., 2010). Nevertheless, as some of the GC-
mediated effects cannot be blocked with common MR and GR antagonists, a 
novel membrane-associated receptor seems to be implicated, from whom not 
much is known to date. GPCR are one of the most promising candidates, as 
blockade of these receptor types prevents some of the MR and GR independent 
GC effects (Di et al., 2003; Tasker et al., 2006).  
 
2.5 Negative feedback effects of GC 
Much of the attention drawn towards GC effects has focused on the termination 
of the HPA axis stress response, whereby the major sites for this negative 
feedback inhibition are the anterior pituitary gland (Miller et al., 1992), the 
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Hippocampus 
The hippocampus, also known as the hippocampal formation, forms a C-shaped 
structure, located dorsal and posterior to the septal nuclei and running to the 
temporal cortex. The hippocampal formation compromises four different 
structures; the dentate gyrus (DG), the Ammon`s horn (cornu Ammonis, CA1, 
CA2, CA3, CA4), the subicular complex, composed of subiculum, pre-subiculum 
and parasubiculum and the entorhinal cortex (EC), divided in medial and lateral 
subdivisions. All of these structures are interconnected via intrinsic structures 
(Amaral and Witter, 1989). 
The most important afferences of the hippocampus attain via the EC, which is 
connected to various parts of the cerebral cortex. Fibers of the perforant path 
start in the EC and travel to the DG, from where granule cells pass on the 
information via mossy fibers to the CA3 region. Shaffer collaterals, the axon 
collaterals of CA3 pyramidal cells, project to the CA1 region which gives the input 
to the subiculum (Sub). The Sub, representing the main output of the 
hippocampus, projects back to the EC. The EC can also directly project to the 
CA3, CA1 and Sub (Amaral and Witter, 1989; Braak et al., 1996) (see Fig. 11). 
 
 
Figure 11: Schematic illustration of the neuronal circuitry in the hippocampal 
formation. The entorhinal cortex (EC) projects via the perforant path to the dentate 
gyrus (DG) which in turn via mossy fibers provides input to the CA3 region, from where 
Shaffer collaterals project to the CA1 region. CA1 sends in turn projections to the 
subiculum (Sub). [adapted from (Zhang and Zhu, 2011)] 
CA3
DG
CA1
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EC
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The inhibitory influence of the hippocampus on the HPA axis activity was 
demonstrated by numerous lesion and stimulation studies. In rodents, 
hippocampal damage increased PVN CRH mRNA expression (Herman et al., 
1989; Herman et al., 1992) and ACTH release (Knigge and Hays, 1963). In turn, 
in humans (Rubin et al., 1966) as well as in rodents (Feldman and Weidenfeld, 
2001), stimulation studies revealed an inhibitory role of the hippocampus on HPA 
axis activity. Nevertheless, not the whole hippocampal formation is involved in 
the feedback, but rather the Sub, the major output of the HC. The Sub projects to 
many areas, e.g. to limbic cortices, nucleus accumbens, lateral septum, BNST, 
preoptic area and hypothalamus. Thereby especially the ventral Sub represents 
the major innervation of the hypothalamic regions. As the ventral Sub signals via 
the excitatory transmitter glutamate (Glu), and almost no direct connection to the 
PVN exists, an inhibitory relay must be available, whereat the posterior/lateral 
BNST was identified, projecting GABAergic neurons to the PVN (Forray and 
Gysling, 2004; Herman and Mueller, 2006).  
Rapid activation of CA1 hippocampal pyramidal cells within minutes (< 5 min) 
after CORT administration, promotes miniature excitatory postsynaptic currents 
(mEPSC) and, therefore, increases Glu release probability, mediated by the MR 
localized on the presynaptic membrane which signals via ERK1/2 signalling 
pathway (Karst et al., 2005; Olijslagers et al., 2008). Moreover, at the 
postsynaptic membrane, activation of membrane-bound MR coupled to a G-
protein, leads to a more depolarized potentials of the activation curve, increasing 
the likelihood for a postsynaptic action potential to occur (Olijslagers et al., 2008). 
Interestingly, this membrane-bound MR has a 10 fold lower affinity to CORT 
compared with the cytoplasmic MR, giving new insight in the role of the MR in 
HPA axis activity, as during low levels of circulating CORT, the cytoplasmic MR 
normally is already fully occupied (Karst et al., 2005). The nearly constant 
occupancy of the cytoplasmic MR is thought to contribute to the maintenance of 
the basal HPA axis activity and to determine the threshold or sensitivity for the 
stress response (de Kloet et al., 1998; Joels, 2007). 
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When CORT concentrations rise, also GR gets occupied, suppressing the 
hippocampal output which results in a disinhibition of the PVN (de Kloet et al., 
1998). These effects are generally delayed and genomic in nature. Ca2+ current 
amplitude gets enhanced several hours after CORT administration or stressor 
exposure, mediated by protein synthesis and DNA-binding of GR homodimers 
(Karst et al., 2000) which increase the number of L-type Ca2+ channels 
(Chameau et al., 2007). This supports Ca2+ dependent K+ conductances, leading 
to hyperpolarization and reduced spikes.  
Taken together, MR and GR in the hippocampus mediate opposite effects, while 
MR, especially the membrane-bound MR, activation maintains hippocampal 
output and, therefore, inhibits PVN activity, GR activation decreases hippoampal 
output, which in turn disinhibits the PVN (see Fig. 12). This contrary effectiveness 
of the two receptors, underlines the importance of the proper balance between 
MR and GR (de Kloet et al., 1998). 
 
 
Figure 12: Schematic illustration of the mechanisms of negative feedback 
inhibition in the CA1 region of the hippocampus (HC). Within minutes, membrane-
bound MR (mMR) get activated and enhance the release of glutamate (Glu). Activated 
GABAergic neurons in the posterior/lateral BNST in turn inhibit the PVN. In contrast, 
activation of cytoplasmic GR leads within hours to a decreased Glu release and in turn 
decreased GABA release from the posterior/lateral BNST and disinhibits the PVN.  
 
 
PVN 
The PVN not only gets inhibited or activated by the posterior/lateral BNST via 
hippocampus and medial PFC, but is itself subjected to the negative feedback 
regulation. Administration of CORT or Dex on parvocellular neurons of the PVN, 
including those producing CRH, decreased the release probability of Glu-
containing vesicles from presynaptic Glu neurons within 3 to 5 min, mediated by 
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a membrane-specific effect (Di et al., 2003). Further experiments revealed an 
involvement of a postsynaptic G-protein coupled GR located on parvocellular 
neurons, which gets activated by GC. This is dependent on the Gαs subunit, 
mediating via cAMP-PKA pathway the release of endocannabinoids which act as 
retrograde messengers on cannabinoid receptor 1 on presynaptic neurons, 
suppressing the Glu release from excitatory synaptic terminals. Thus, the 
frequency of mEPSC is suppressed in the PVN (Di et al., 2003). On 
magnocellular PVN neurons, similar effects were found, acting via the same 
signalling pathways (Di et al., 2005). In these cells, GC cause, in addition, an 
increase in GABA signalling, via the Gβµ subunit. Thereby, the activity of the nitric 
oxid synthase is increased leading to the release of nitric oxid which acts on 
inhibitory synaptic terminals leading to the release of GABA. Inhibition of Glu and 
concomitant increase in GABA release results in an overall rapid inhibition of the 
PVN mediated by GC (Di et al., 2003; Di et al., 2009).  
One of the most important targets for negative feedback regulation of the HPA 
axis is the CRH gene in the parvocellular neurons of the PVN (Imaki et al., 1995). 
A nGRE located on the CRH promoter, enables GR binding and in turn 
decreases transcription of CRH in a genomic fashion (Malkoski et al., 1997). 
Moreover, a nGRE was also found in the gene for AVP leading to a inhibition of 
AVP gene expression in parvocellular neurons of the PVN following stimulation 
with GC (Kim et al., 2001; Kuwahara et al., 2003).  
 
Pituitary 
Fast as well as delayed effects of GC have been observed at the level of the 
pituitary, where GR and also to a lesser extent MR are expressed (de Kloet et al., 
2000). Fast negative feedback occurs already within 5 – 15 min after 
administration of CORT or of a GR agonist, inhibiting CRH-induced ACTH 
release independent of the cytoplasmic GR and de novo mRNA synthesis (Hinz 
and Hirschelmann, 2000). This rapid, non genomic feedback is mainly regulated 
by annexin 1 (ANXA1), also known as lipocortin 1, a member of the annexins, a 
class of proteins that are able to bind Ca2+ and negatively charged phospholipids. 
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ANXA1 is expressed in many cell types involved in inflammation, but also in the 
neuroendocrine system, like anterior pituitary and hypothalamus (Buckingham 
and Flower, 1997). Within the cell, it is mainly localized in the cytoplasm, but also 
on the external surface of the cell membrane attached to binding proteins. 
Immunohistochemical (IHC) analysis revealed that in the pituitary ANXA1 is not 
located in the endocrine cells but in the surrounding folliculostellate cells, 
therefore, acting mainly as a paracrine agent on the ACTH release (Traverso et 
al., 1999). GC influence the subcellular localization of ANXA1, mediating its 
exportation from the cytoplasm to the outer surface of the plasma membrane 
where it is retained through a Ca2+ dependent mechanism (Philip et al., 1997). 
ANXA1 can then bind to a member of the N-formyl peptide receptors on the 
corticotroph cells (John et al., 2007). This is assumed to – via a couple of so far 
unknown mediators – finally cause actin polymerization preventing in turn vesicle 
fusion with the membrane and, therefore, ACTH release (John et al., 2007). 
While mediation of the transfer of ANXA1 to the cell membrane appears within 15 
min of GC administration, GCs also induce the synthesis of ANXA1 in a delayed 
manner (< 2 h) in order to replenish the protein stores in the cytoplasm (Philip et 
al., 1997).  
Another genomic effect exerted by GC in the pituitary constitutes the inhibition of 
POMC transcription by binding to a nGRE in the POMC gene promoter (Drouin et 
al., 1989; Drouin et al., 1993). GC also decrease CRH binding, whereas the 
mRNA expression of the CRH-R1 is only transiently decreased, favouring a post-
transcriptional mechanism of GC action (Aguilera et al., 2004).  
 
Other brain regions (PFC, Amygdala) 
The role of the medial PFC (cingulate gyrus) in regulating the stress response is 
very complex, as the different subdivision (mainly prelimbic (PL) and infralimbic 
(InL) subdivision) exert divergent effects. Furthermore, high GR and very low MR 
expression indicate that medial PFC is only responsive to high GC 
concentrations (Ulrich-Lai and Herman, 2009). Fibers from the InL and to a minor 
division of the PL innervate predominantely GABAergic relay stations that project 
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to the PVN, including amongst others the BNST, lateral hypothalamus and 
nucleus of the solitary tract. Moreover InL and PL also project to the amygdala, 
raphe nucleus and, thereby, modulate the HPA axis activation mediated by these 
brain structures (Herman et al., 2003). Both, the PL and InL, are involved in the 
termination of the HPA axis activation following an acute stressor. In detail they 
are implicated in the response to acute psychogenic (restraint) (Diorio et al., 
1993; McKlveen et al., 2013) but, at least the PL PFC, not to physical stress 
(Jones et al., 2011). However, they have distinct effects in terms of chronic stress 
(chronic variable stress) (McKlveen et al., 2013). While lesion of the InL PFC 
leads to HPA axis hyperresponsiveness in chronically stressed rats exposed to 
an acute heterotypic stressor, the PL is only involved in regulating the basal HPA 
axis activity under chronic stress conditions. This is indicated by increased CORT 
levels during chronic variable stress following knock-down of the GR in the InL 
PFC (McKlveen et al., 2013). Interestingly, knock-down of the GR in the InL PFC 
was shown to be responsible for the depressive-like behaviour the mice showed 
following exposure to the chronic variable stress (McKlveen et al., 2013).  
Contrary to the hippocampus and the medial PFC, stimulation of the amgydala 
promotes (Redgate and Fahringer, 1973; Vouimba and Richter-Levin, 2013) 
while lesions reduce the CORT release in response to stressful stimuli (Knigge, 
1961; Feldman and Conforti, 1981). Thereby, the CeA was found to be activated 
by homeostatic disruption and systemic stressors but not by psychogenic 
stressors, pointing towards a role in autonomic rather than in the HPA axis 
response to stress (Ulrich-Lai and Herman, 2009). In detail, Dayas and 
colleagues could show that physical stressors, like immune challenge and 
haemorrhage, preferentially activate CeA, while psychological stressors, like 
restraint or noise, preferentially activate medial amgydala (MeA) (Dayas et al., 
2001). CeA and MeA project to similar relay stations like the medial PFC, but in 
contrast, the upstream neurons release GABA, indicating that activation of the 
PVN mediated via these amygdala structures is accomplished via disinhibition 
(Ulrich-Lai and Herman, 2009). 
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3 Chronic stress and GC signalling  
HPA axis dysregulation 
Maintenance of the homeostasis, which is challenged by different internal and 
external stressors, is fundamental for the well-being of an organism. This is 
mainly achieved by activation of both, the SNS and the HPA axis, which regulate 
a variety of physiological and behavioural responses. A proper functionality of the 
HPA axis, therefore, is essential for survival and for adaptation to stressors while 
dysregulation of the HPA axis, as a result of chronic activation, is implicated in 
the pathogenesis of stress-related disorders. For instance, affective disorders like 
major depressive disorder, psychiatric and anxiety disorders, burn out, chronic 
fatigue syndrome, panic disorders as well as somatic disorders like inflammatory 
bowel disease, cardiovascular disorders, and cancerogenesis (Gold et al., 1988; 
Chrousos and Gold, 1992; Levenstein et al., 1994; Heim et al., 2000; Mawdsley 
and Rampton, 2006; Chrousos, 2009; Dhabhar, 2009; Yehuda and Seckl, 2011). 
The exact mechanisms underlying the development of these stress-related 
disorders are not known, partly due to the lack of appropriate animal models. 
Nevertheless, studies of the last years focused more and more on a reduced 
and/or insufficient GC signalling following chronic psychosocial stress (Heim et 
al., 2000). 
Decreased GC signalling can be either the result of a decreased hormone 
bioavailability, called hypocorticism, or of GC resistance in the target cells, or the 
combination of both (Raison and Miller, 2003). Hypocorticism was e.g. described 
in patients suffering from posttraumatic stress disorders (PTSD) while depressed 
patients displayed increased cortisol levels (Yehuda et al., 1996). However, 
despite the elevated cortisol levels, patients suffering from depression showed 
signs of reduced GC signalling as a consequence of GC insensitivity mediated by 
decreased GR expression and/or functionality (Holsboer, 1983; Pariante and 
Miller, 2001). Also the development of proinflammatory and autoimmune 
diseases and a decreased efficacy of wound healing are associated with a 
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decreased GC signalling and/or GC resistance mediated by prolonged increased 
GC levels (Dhabhar, 2009).  
As GR and MR are the main mediators of the GC effects, either during hyper- or 
hyposecretion, alterations in the functionality or expression can underlie the 
pathology of stress-related diseases. 
 
Alterations of the MR and GR expression following chronic stress  
Dysregulations and dysfunctions of the corticosteroid receptors result in an 
altered negative feedback response and are implicated in the development of a 
variety of stress-related psychiatric disorders, like major depression, PTSD, and 
anxiety disorders (Chrousos and Gold, 1992; Pariante and Lightman, 2008). 
Hyperactivity of the HPA axis, mediated by a reduced negative feedback 
response, is one of the major findings in humans suffering from major depression 
and is mainly mediated by a diminished GR expression and/or functionality 
(Carroll et al., 1981; Holsboer, 1983; Pariante and Miller, 2001). In contrast, 
patients suffering from PTSD show an enhanced negative feedback sensitivity of 
the HPA axis and an increased number of lymphocyte GR (Yehuda et al., 1993; 
Yehuda et al., 1995; Yehuda, 1998).  
Alterations of the gene and protein expression of GR and MR can have 
widespread effects on the stress response. In a receptor binding study using 
labeled Dex or aldosterone, Spencer and colleagues could show that 
adrenalectomy (ADX) in rats resulted in an increased GR binding in the brain 
(hippocampus, cortex, septum, hypothalamus) while MR binding was unaffected. 
Replacement with low doses of CORT blocked this effect while high doses of 
CORT resulted in a decreased MR and GR binding in the above mentioned brain 
regions in ADX rats, suggesting that expression of these receptors is subjected to 
the regulation by GC. Therefore, GC can regulate the extent of their actions not 
only by mediating the negative feedback inhibition but also by regulating their 
own receptor expression. Interestingly, receptors in the hippocampus were 
thereby shown to be extremely sensitive to these manipulations, while the 
pituitary was unaffected by ADX and CORT replacement (Spencer et al., 1991).  
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Regulation of MR and GR expression following chronic stressor exposure was 
overall found to be inconsistent. Some studies reported no alterations of the 
corticosteroid receptors (mRNA, binding, protein) in the hippocampus (Young et 
al., 1990; Djordjevic et al., 2009; Noguchi et al., 2010), in the pituitary (Sapolsky 
et al., 1984; Makino et al., 1995), and in the hypothalamus (Sapolsky et al., 1984) 
following chronic stress. In contrast, other studies reported a down-regulation of 
GR mRNA, binding and nuclear translocation in the hippocampus (Chao et al., 
1993; Makino et al., 1995; Kitraki et al., 1999; Mizoguchi et al., 2001; Noguchi et 
al., 2010) and PVN (Makino et al., 1995; Sterlemann et al., 2008) as well as of 
MR mRNA in the hippocampus (Chao et al., 1993; Sterlemann et al., 2008) 
following chronic stress. Nevertheless, there are also studies reporting increased 
levels of GR protein in the PFC (Djordjevic et al., 2009) and increased nuclear 
translocation of the pituitary GR (Noguchi et al., 2010).  
The different results clearly indicate that analysis of the receptor expression is 
not sufficient for analysis of the negative feedback and underlines the importance 
of the measurement of the receptor functionality. One possibility constitutes the 
testing of the inhibitory effectiveness of Dex in vivo on HPA axis activity/reactivity. 
As Dex is a synthetic steroid and as such only poorly passes the blood brain 
barrier - it is a ligand for the mdr 1a P-glycoprotein (see also Sec. 3.1) (Meijer et 
al., 1998) -  this method specifically determines the feedback response at the 
level of the pituitary (Cole et al., 2000). Chronic stress paradigms resulting in 
HPA axis hyper-activity are often associated with a decreased negative feedback 
inhibition, shown by the failure of Dex to suppress basal and/or stress- or CRH-
induced CORT levels, due to comprised GR functionality (Sapolsky et al., 1984; 
Mizoguchi et al., 2001). Another possibility would be to analyse the expression of 
GC-responsive genes in response to CORT or Dex stimulation in vitro to gain 
more insight into the transcriptional activity of the receptor. 
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4 Risk factors influencing the individual stress vulnerability 
Stress is an acknowledged risk factor for the development of a variety of stress-
related disorders like cardiovascular and inflammatory as well as psychiatric 
diseases like anxiety- or depression-related disorders in humans as well as in 
animals (McEwen, 2003; Dimsdale, 2008; Chrousos, 2009; Dhabhar, 2009). 
Interestingly, the effects of chronic stress also vary between individuals, with 
some being highly susceptible, while others being resilient to its negative 
consequences, a phenomenon found in humans as well as in rodents (Albeck et 
al., 1997; Feder et al., 2009; Stiller et al., 2011; Castro et al., 2012) (see Fig. 
13A). In contrast to susceptible individuals, resilient ones are able to adapt to 
adversity, trauma, tragedy or other sources of stress (Yehuda et al., 2006; 
Franklin et al., 2012). These differences in stress vulnerability are supposed to 
depend on the interplay between genetic predispositions (DeRijk and de Kloet, 
2005; Ising et al., 2008) and environmental factors like e.g. adverse events 
during early life, both affecting the adult stress response (Aisa et al., 2007; Eiland 
and McEwen, 2012) (see Fig. 13B). As the underlying mechanism are only poorly 
understood so far, the identification of behavioural and physiological 
characteristics involved in these differences in stress vulnerability is fundamental 
for the understanding of the development of stress-related disorders.  
 
 
 
Figure 13: (A) Exposure of healthy individuals to chronic stress results in a shift of the 
Gaussian distribution from health to disease. Interestingly, there are some individuals 
which remain resilient (left part of the curve), while some are more vulnerable (right part 
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of the curve). [taken from http://www.mpipsykl.mpg.de/en/research/groups/ 
schmidt_m/misc/ schmidt _ m _00_01.jpg] (B) Response to stressors in adulthood is 
dependent on the genetic predisposition as well as on the individual`s history, influenced 
mainly by early life events. These two components can also interact with each other by 
mean that the genetic background has also an influence on the early life events. All these 
factors shift the individual stress reactivity, either in direction of resilience or susceptibility. 
[adapted from (de Kloet et al., 2005)] 
 
Environmental factors 
Stability of a child`s social environment during early life constitutes the most 
important factor concerning life-long health (McEwen, 2003). Early life stress, 
including child maltreatment, sexual abuse, loss of a parent (Agid et al., 2000) or 
living with mentally ill parent (Goodman and Gotlib, 1999), represents a major risk 
factor for the development of mental disorders like anxiety, major depression and 
PTSD (Famularo et al., 1992; Famularo et al., 1993; Pelcovitz et al., 1994; Heim 
and Nemeroff, 2001; Heim et al., 2009) but also inflammatory disorders during 
adulthood (Danese et al., 2007). The manifestation of these diseases is thereby 
often related to acute negative life events or persistent stressor exposure later in 
life (Heim and Nemeroff, 2001).  
In rodents, pre- as well as postnatal stress, which occur in a period that is 
essential for the development of the pups, have profound consequences on 
stress vulnerability or resilience later in life. Maternal care was shown to play an 
important role, as high levels of maternal behaviour, like licking and grooming 
and nursing, have a beneficial effect on the offspring. In adulthood, the offspring 
showed a reduced ACTH and CORT responsiveness to an acute stressor 
exposure and enhanced GR-mediated feedback (Liu et al., 1997). Increased GR 
expression in the offspring of high licking and grooming mothers was mediated 
via an epigenetic mechanism, in detail by lowering the methylation of the GR 
promoter sequence in the hippocampus leading to an increased receptor 
expression (Zhang et al., 2013). In turn, the offspring of low locking and grooming 
mothers displayed reduced hippocampal GR expression (Meaney and Szyf, 
2005). Also maternal separation (MS), i.e. separation of the pups from their 
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mother (3 h per day, postnatal day 1 – 14 or 3 – 10), results in negative 
behavioural and neuroendocrine alterations, like increased anxiety or enhanced 
ACTH release following acute stressor exposure (Wigger and Neumann, 1999; 
Veenema et al., 2006). It further was shown to reduce hippocampal neurogenesis 
(Lajud et al., 2012). Given that aversive experiences early in life can have 
profound consequences on stress-related parameters, it is likely that there is an 
interplay between early life stress and stressor exposure in adulthood. 
Interestingly, in a recently published study of our lab, it was demonstrated that 
MS mice showed an increased susceptibility to the consequences of chronic 
psychosocial stress (CSC, 19 days) in adulthood (see also Sec. 5) (Veenema et 
al., 2008). 
 
Genetic predisposition 
In addition to the environmental component, the genetic predisposition strongly 
determines the individual stress susceptibility and, therefore, also the 
development of stress-related disorders. E.g. genetic polymorphisms in the GR, 
MR or FKBP51 have been shown to increase the risk for the development of 
stress-related diseases (DeRijk and de Kloet, 2005; Ising et al., 2008). 
Nevertheless, due to ethical limitations in humans, studies related to genetic 
effects have to be conducted in appropriate animal models. Here, different 
approaches are possible for studying the gene and environment interaction. 
Modifying the genome of an animal, i.e. creating knock-out or transgenic animals 
makes it possible to study the influence of selected candidate genes. Mice are, 
therefore, preferred as the knock-out can technically be applied more easily than 
in rats or other species. One example would be the use of FKBP51 knock-out 
mice for studying the vulnerability to chronic stressor exposure (Hartmann et al., 
2012b). A further possibility is to select a subpopulation within a large cohort of 
animals, according to behavioural or neuroendocrine parameters. E.g. following 
the recovery period of chronic social instability, animals were divided into two 
groups, one that recovered and one that was still affected from the chronic stress 
effects (Schmidt et al., 2010a). Also following chronic SD, two groups could be 
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separated – the susceptible and unsusceptible – characterized by the resistance 
to defeat-induced avoidance (Krishnan et al., 2007). These subpopulations would 
rather reflect a selected phenotype than only one single gene which helps to 
identify novel targets. Another advantage of this selection is the fact that effects 
that would normally not be detected in a large cohort can be detected by 
selection of extremes (Scharf and Schmidt, 2012). Another approach is to use a 
subpopulation generated by selective breeding. After breeding for several 
generations, the different phenotypes take more shape and allow the 
investigation of the underlying molecular mechanism.  
The last approach was used to selectively and bidirectionally breed Wistar rats or 
CD1 mice, respectively, to select for high (HAB) and low (LAB) anxiety-related 
behaviour on the EPM whereby in this thesis mice were used exclusively 
(Landgraf and Wigger, 2002; Landgraf and Wigger, 2003; Krömer et al., 2005). 
Both mouse lines significantly differ from non-selected “normal” CD1 (mNAB) 
mice, with mHAB spending less than 10 % and mLAB more than 50 % time on 
the open arm of the EPM (Krömer et al., 2005). These behavioural differences 
reached a maximum after approximately nine generations (Landgraf et al., 2007). 
Not only on the EPM, but also in the dark-light avoidance test (Krömer et al., 
2005) and in the open arm testing (Muigg et al., 2009) the extremes in trait 
anxiety were confirmed. Moreover, risk assessment during open arm exposure 
(Muigg et al., 2009) as well as during dark-light avoidance testing (Krömer et al., 
2005) was higher in mLAB compared with mHAB mice. Already in the pups, the 
lower trait anxiety of the mLAB mice was evident, as mLAB pups showed less 
ultrasound vocalization compared with mHAB pups (Krömer et al., 2005). 
Moreover, tail-suspension and FS testing revealed differences between the two 
mouse lines with mLAB mice displaying a more active coping style compared 
with mHAB mice which showed signs of depressive-like behaviour. In contrast to 
the anxiety-related behaviour, depressive-like behaviour was comparable 
between mHAB and mNAB mice (Krömer et al., 2005; Muigg et al., 2009). Not 
only behavioural, but also distinct neuroendocrine and genetic differences are 
found in the two breeding lines. Basal plasma CORT levels were similar in both 
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groups, while in response to acute immobilization (15 min), mLAB mice showed 
an increased CORT response compared with mHAB mice (Gonik et al., 2012). 
Nevertheless, synthetic fox fecal odor resulted in a similar CORT response in 
mHAB and mLAB mice (Sotnikov et al., 2011), indicating that the acute stress 
responsiveness clearly seems to be stressor-dependent.  
Interestingly, these differences in mHAB and mLAB mice can be ascribed to a 
single nucleotide polymorphism (SNP) in the AVP gene. AVP is involved in 
anxiety- and depression-like behaviour (Landgraf et al., 2007) hence a deficit in 
the synthesis and processing of this gene in mLAB mice results in the hypo-
anxious phenotype (Kessler et al., 2007). Interestingly, in rats, a SNP in the 
promoter region of the AVP gene results in the high anxious phenotype, as this 
contributes to an increased AVP activity (Landgraf and Wigger, 2003; Murgatroyd 
et al., 2004). The SNP in the mLAB mice moreover induces signs of central 
diabetes insipidus (Kessler et al., 2007). Regarding the influences of the genetic 
predisposition, in this case the trait anxiety of the mice, on the stress 
vulnerability, there is an increasing knowledge about the pronounced differences 
in acute stress responsiveness, while there is not much known about the 
response to chronic stressor exposure in this breeding line. Therefore, it would 
be of major interest to investigate the influence of the trait anxiety of these mice 
on the susceptibility to chronic psychosocial stress. According to the fact, that 
chronic stress is known to increase the state anxiety (Hata et al., 2001; Krishnan 
et al., 2007; Reber et al., 2007; Schmidt et al., 2007; Slattery et al., 2012), one 
can speculate that the low anxiety phenotype might be stress protective, making 
the mLAB mice less vulnerable to the behavioural, physiological, neuroendocrine 
and immunological consequences of CSC compared with mHAB and mNAB 
mice. In contrast, mHAB mice might be more stress vulnerable compared with 
mNAB mice.  
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5 Effects of chronic subordinate colony housing (CSC) on 
physiological, neuroendocrine, immunological and 
behavioural parameters 
 
CSC paradigm 
The CSC paradigm, established by Reber and colleagues (2007), was used as 
an appropriate and pre-clinically validated model for chronic psychosocial stress 
in male C57BL/6 mice. Four experimental mice are housed together with a larger 
and more aggressive male mouse (resident), which is supposed to occupy the 
dominant position, for 19 consecutive days. Once per week, the resident is 
exchanged to avoid any habituation (see Fig. 14). 
 
 
Figure 14: Schematic illustration of the time course of the chronic subordinate 
colony housing (CSC) paradigm. After arrival, all experimental mice are singly housed 
for one week before they are randomly assigned to the single-housed control (SHC) or 
the CSC group. In order to induce a chronic stressful situation, four male mice are 
housed together with a larger, dominant male mouse (resident) for 19 consecutive days. 
The resident (resident 1) is exchanged on days 8 (resident 2) and 15 (resident 3) by a 
new resident in order to avoid any habituation  
 
When the CSC paradigm starts, it has to be ensured that the four experimental 
mice are in a subordinate while the resident adopts the dominant position. 
Therefore, behavioural observations during the first hour after setting up the 
colony are done, whereby the resident normally shows offensive behaviours, like 
chasing, mounting and attacking towards the four experimental mice. In contrast, 
1 8 15 19
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the four CSC mice display a defensive behaviour characterized by flight and 
defensive upright (Reber and Neumann, 2008a). The experimental mice are then 
exposed to this chronic subordination for 19 consecutive days, while the control 
mice are single-housed (SHC) during this time. According to other studies 
(Bartolomucci et al., 2003; Gasparotto et al., 2005) single housing was 
convincingly demonstrated to be the adequate control group for the CSC 
paradigm, as group housing itself was shown to be stressful for the mice 
(Singewald et al., 2009). Compared to the SHC mice, CSC mice displayed typical 
signs of chronic stress, like physiological, neuroendocrine, immunological and 
behavioural alterations (Reber et al., 2007; Reber and Neumann, 2008a; 
Singewald et al., 2009; Slattery et al., 2012; Uschold-Schmidt et al., 2012) (see 
Fig. 15 A and B). 
 
Figure 15: Schematic illustration (A) and a representative image (B) of the CSC 
paradigm. Three of the four experimental mice sit in one corner and display defensive 
behaviour (defensive upright posture: the two subordinate mice in the left corner) while 
one mouse shows flight (one subordinate on the right). The resident in the middle shows 
offensive behaviour and attacks the mouse that tries to flee. [taken from http://epub.uni-
regensburg.de/10558/1/Version_Final_Offiziell.pdf] 
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offensive
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CSC-induced physiological and neuroendocrine alterations 
Analysis of physiological parameters revealed a reduced body weight gain and 
relative thymus weight following CSC exposure. Moreover, absolute adrenal 
weight and also pituitary weight, which was only measured 8 days following 
termination of the CSC exposure, was increased (see Fig. 16). 
 
 
Figure 16: 19 days of CSC result in a decreased body weight gain (A), decreased 
relative thymus weight (B), and increased absolute adrenal weight (C) compared with 
SHC mice. In addition, 8 days following termination of the CSC paradigm, absolute 
pituitary weight was increased (D) compared with SHC mice. ■ SHC; ■ CSC. Data 
represent mean + SEM; **, P < 0.01; ***, P < 0.001 vs. respective SHC mice. [adapted 
from (Reber et al., 2007; Slattery et al., 2012; Uschold-Schmidt et al., 2012)]  
 
Measurement of neuroendocrine parameters also revealed alterations in HPA 
axis functionality. Despite the increased adrenal weight, plasma morning CORT 
levels were unchanged, while plasma evening CORT levels were even 
decreased in CSC compared with SHC mice, indicating that CSC mice are not 
able to mount the circadian rise in plasma CORT (Reber et al., 2007). Stimulation 
of adrenal explants in vitro further revealed a decreased ACTH responsiveness in 
CSC compared with SHC mice further supporting the concept of an adrenal 
dysfunction (Reber et al., 2007; Uschold-Schmidt et al., 2012). Nevertheless, 
exposure to an acute heterotypic stressor (5 min EPM) resulted in an increased 
CORT release in CSC mice that even exceeded those of SHC mice, despite 
similar plasma ACTH levels. This indicates an increased capability to produce 
and secrete CORT upon an acute challenge. Overall this indicates that the 
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unchanged basal plasma CORT concentrations in the morning represent a 
mechanism of adaption protecting the body from increased GC levels during 
chronic stressor exposure while a sensitization process enables the organism to 
respond to a new challenge with an adequate GC response (Uschold-Schmidt et 
al., 2012) (see Fig. 17).  
 
 
Figure 17: On day 20 of CSC, CSC and SHC mice were exposed to the EPF (5 min). 
Plasma CORT levels determined 5 min after termination of EPF exposure were increased 
in CSC compared with SHC mice (A) while plasma ACTH levels were unchanged (B). ■ 
SHC; ■ CSC. Data represent mean + SEM. ***, P < 0.001 vs. respective SHC mice. 
[adapted from (Uschold-Schmidt et al., 2012)] 
 
Furthermore, CSC mice display signs of GC resistance in peripheral cells, shown 
by a reduced sensitivity to different doses of GC in isolated splenocytes 
stimulated with lipopolysaccharides as well as in Th2 cells from peripheral lymph 
nodes (Reber et al., 2007; Schmidt et al., 2010b).  
Analysis of CRH and AVP revealed an unchanged CRH mRNA and a decreased 
AVP mRNA expression in the PVN of CSC compared with SHC mice (Reber and 
Neumann, 2008a). Moreover, c-Fos expression in the PVN was similar under 
basal but higher under acute stress conditions in SHC compared with CSC mice 
(Singewald et al., 2009). 
  
A B
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CSC-induced immunological and behavioural alterations 
Concerning the immune system, anti-CD3 stimulated mesenteric lymph node 
cells (mesLNC) secreted increased amounts of interferon γ (IFN-y) following CSC 
exposure. In addition, the histological damage score, characterized by increased 
epithelial damage and leukocyte infiltration, was increased, pointing towards the 
development of a mild colonic inflammation (Reber et al., 2007). Not only the risk 
for development of a spontaneous colitis was enhanced, CSC mice also 
developed a more severe chemically-induced colitis following treatment with 
dextran sulfate sodium (DSS) (Reber et al., 2007; Veenema et al., 2008).  
Moreover, CSC mice displayed a profound increase in anxiety-related behaviour 
indicated by spending less time in the bright zone of the light dark box (Reber 
and Neumann, 2008a), on the open arm of the EPM (Reber et al., 2007; Slattery 
et al., 2012), in the outer zone of the EPF (Uschold-Schmidt et al., 2012) and by 
spending less time exploring a novel object compared with SHC mice (Veenema 
et al., 2008). The exact mechanisms underlying this anxiogenic effect of CSC are 
not unraveled yet, but there might be an influence of altered neuronal activity 
patterns in brain regions involved in emotionality, like PVN, parts of the lateral 
septum, the dorsal CA3 region in the hippocampus and different subregions of 
the nucleus accumbens (Singewald et al., 2009). Interestingly, CSC mice showed 
no signs of depressive-like behaviour indicated by a comparable time spent 
immobile in the tail suspension and FS test between SHC and CSC mice. In 
addition, anhedonic-like behaviour, assessed in the saccharine preference test, 
was not affected by CSC (Slattery et al., 2012). 
 
Influence of adverse early life events on the CSC-induced alterations 
Interestingly, early life stress (MS, 3 h/day, day 1 - 14) aggravated the 
consequences of CSC exposure in adulthood. CSC mice previously exposed to 
MS showed a decreased GC secretion even during the nadir of the HPA axis 
acitivity, despite adrenal hypertrophy. While plasma ACTH levels were 
unchanged, CRH mRNA expression in the PVN was increased in MS CSC 
compared with SHC mice, indicating a pituitary insufficiency in addition the the 
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insufficiency of the adrenal glands. Moreover, MS increased the vulnerability to 
DSS-induced colitis, shown by a higher histological damage score and an 
increased IFN-γ of mesLNC in CSC compared with mice (Veenema et al., 2008). 
Overall, the findings indicate a profound influence of MS early in life on the 
consequences of CSC in adulthood, especially aggravating the effects on HPA 
axis functionality and on the immune system. 
 
Taken together, CSC promotes a number of physiological, neuroendocrine, 
immunological and behavioural alterations. Basal evening hypocorticism and GC-
resistance in the periphery indicate an impaired GC signalling. The increased 
anxiety as well as the increased inflammation supports the use of the CSC 
paradigm as a model for studying the mechanisms underlying the development of 
stress-related somatic as well as affective disorders. And, interestingly, the CSC 
paradigm represents an adequate model to study the influences of both, the 
environment (early life stress) and the genetic predisposition (by the use of 
selectively bred mice) on the development of stress-related disorders.  
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6 Aim and outline of the present thesis 
 
Given the outlined informations in the sections above, the aims of my thesis 
were: 
 
1) To assess whether changes at the pituitary or PVN level are contributing 
to the changes in HPA axis functionality following CSC 
2) To investigate if CSC leads to alterations of the negative feedback 
inhibition at the level of the pituitary, PVN, hippocampus and PFC 
3) To determine if the genetic predisposition, in detail the trait anxiety of an 
animal, influences the vulnerability to the behavioural, physiological, 
neuroendocrine and immunological consequences of CSC 
 
The first aim of my thesis was to test the hypothesis that pituitary mechanisms 
are involved in the observed HPA axis adaptation/sensitization processes seen 
following CSC exposure, given that most of the studies so far focused only on the 
adrenals. Moreover, the increased pituitary weight in CSC compared with SHC 
mice 8 d after termination of CSC exposure already indicates that alterations at 
the level of the pituitary are not unlikely to occur. In addition, it can be 
hypothesized that the decreased AVP mRNA expression in the PVN following 
CSC might be mediated by an increased mRNA turn over due to an increased 
protein expression. 
Therefore, basal as well as acute stress-induced (6-min FS) plasma ACTH 
concentrations were analysed. Furthermore, pituitary weight, the number of 
pituitary and ACTH positive cells as well as POMC expression was measured in 
SHC and CSC mice. Moreover, the receptors of AVP and CRH, the main ACTH 
secretagogues, were investigated by analysis of AVPR-1b and CRH-R1 mRNA 
and protein expression. To address CSC-induced changes on the AVP system in 
the PVN, an IHC staining was established, in order to assess the number of AVP 
positive magnocellular and parvocellular PVN neurons. In addition, the number of 
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OXT positive PVN neurons was analysed, given that ACTH secretion can, 
amongst CRH, AVP and other factors, also be stimulated by this neuropeptide. 
 
The aim of the second part of this thesis was the analysis of the negative 
feedback inhibition at the level of the pituitary and at various brain sites, i.e. the 
hippocampus, PFC and PVN. Due to the GC resistance found in some peripheral 
cells following CSC exposure, one can speculate that also the negative feedback 
inhibition might be impaired. In the pituitary, the expression mRNA and/or protein 
expression of MR, GR and FKBP51 was assessed. To study the functionality of 
the GR, a dexamethasone suppression test (DST) was performed, whereby the 
in vivo response to Dex injection and subsequent acute heterotypic stressor (6-
min FS) exposure following 19 days of CSC was measured. Moreover, the 
translocation of the GR into the nucleus upon acute stressor exposure (6-min FS) 
was determined.  
At the different brain sites mentioned above, the mRNA and/or protein expression 
of MR, GR and FKBP51 (only in the hippocampus and PFC) was analysed. 
Moreover, at the level of the hippocampus, the functionality of the GR was 
assessed by stimulating isolated hippocampal cells in vitro with different CORT 
concentrations followed by measurement of the expression pattern of a GC-
responsive gene (Per1) as well as of the cell viability in response to 24 h CORT 
stimulation. 
 
The third part of the thesis mainly dealed with the influence of the genetic 
predisposition, in detail the trait anxiety of an animal, on the vulnerability to the 
consequences of CSC with respect to somatic and affective pathologies. 
Therefore, mice selectively bred for high (mHAB) and low (mLAB) anxiety-related 
behaviour and non-selected normal CD1 (mNAB) mice were exposed to the CSC 
paradigm and behavioural, physiological, neuroendocrine and immunological 
parameters were analysed. The hypothesis was that the low innate anxiety in 
mLAB mice might constitute a kind of stress-protective factor, as it is known from 
many studies that chronic stress has an anxiogenic effect. In turn, the high innate 
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anxiety might probably increase the vulnerable to the consequences of CSC 
compared mNAB mice. Therefore, mice of all three lines were either exposed to 
19 days of CSC or single-housed for control and were subsequently tested on the 
EPM (on day 19 of CSC) to determine the breeding line-specific differences in 
anxiety-related behaviour. In addition, on day 20 of CSC body weight gain, 
adrenal and spleen weight, plasma CORT and ACTH concentrations and in vitro 
adrenal CORT secretion in response to ACTH were determined. Moreover, IFN-γ 
secretion from isolated mesLNC in response to anti-CD3 stimulation and the 
histological damage score of the colon were assessed. Finally, the influence of 
the genotype as well as of CSC on the GR, MR and FKBP51 protein expression 
was determined in the pituitary. 
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1 Material 
1.1 Antibodies for protein, immunohistochemical and immunological 
analysis 
1.1.1 Primary Antibodies  
DENOTATION COMPANY SPECIES RAISED IN 
 
GR (M-20) 
sc-1004 
 
Santa Cruz Biotechnology, Inc., 
Heidelberg, Germany 
 
rabbit polyclonal 
MCR (H-300) 
sc-11412 
Santa Cruz Biotechnology, Inc., 
Heidelberg, Germany 
rabbit polyclonal 
AVP Receptor V3               
(D-20) sc-18105 
Santa Cruz Biotechnology, Inc., 
Heidelberg, Germany 
goat polyclonal 
CRF-R1 (V-14) 
sc-12381 
Santa Cruz Biotechnology, Inc., 
Heidelberg, Germany 
goat polyclonal 
POMC (FL-267) 
sc-20148 
Santa Cruz Biotechnology, Inc., 
Heidelberg, Germany 
rabbit polyclonal 
FKBP51 (F-14) 
sc-11518 
Santa Cruz Biotechnology, Inc., 
Heidelberg, Germany 
goat polyclonal 
ß-Tubulin  
#2146 
Cell Signaling Technology, 
GmbH, Frankfurt am Main, 
Germany 
rabbit polyclonal 
TATA binding 
Protein ab63766 
Abcam, Cambridge, UK rabbit polyclonal 
Anti-ACTH 
ab74976 
Abcam, Cambridge, UK rabbit polyclonal 
AVP P41 Dr. Gainer, NIH, USA mouse polyclonal 
OXT P38 Dr. Gainer, NIH, USA mouse polyclonal 
aCD3 – raised 
against CD3 epsilon 
chain 
provided by Prof. Dr. Werner 
Falk, Department of Internal 
Medicine, University Hospital 
Regensburg 
hamster 
monoclonal 
 
56  CHAPTER 2 – MATERIAL AND METHODS 
  
 
1.1.2 Secondary antibodies  
DENOTATION COMPANY 
SPECIES 
RAISED IN 
   
Anti goat (HRP-linked) 
sc-2020 
Santa Cruz Biotechnology, Inc., 
Heidelberg, Germany 
Donkey 
Anti rabbit (HRP-
linked) #7074 
Cell Signaling Technology, GmbH, 
Frankfurt am Main, Germany 
Goat 
Anti mouse 
(biotinylated) BA-9200 
Vector Laboratories, Burlingname, 
USA 
Goat 
  
1.2 Oligonucleotides 
The following oligonucleotides were used as primers for qPCR amplifications. All 
primers were designed with the help of Primer Express 2.0 (Applied Biosystems, 
Forster City, CA, USA and purchased from Metabion (Martinsried, Germany). 
GENE  5` - 3`SEQUENCE 
   
GR Fwd CGGGACCACCTCCCAAA 
 Rev CCCCATAATGGCATCCCGAA 
 Probe TCTGCCTGGTGTGCTCC 
MR Fwd GGACCAAATTACCCTCATCCA 
 Rev GTAT GTTTGTACGATCTCCAACTCAAG 
 Probe ATTCTTGGATGTGTCTATCATC 
CRH-R1 Fwd GTGACAGCCGCCTACAACTACTT 
 Rev GTAGCAGCCCTCACCGAACA 
 Probe CACGTAACCAACTTCTTCT 
AVPR-1b Fwd GCTCACAGCTTGCTATGGCCTCAT 
 Rev CCAGC CTGT GTCTTGACTTTCAG 
 Probe TGCCACGAGATCTACAAGAAC 
POMC Fwd CGGTGAAGGTGTACCCCAACGT 
 Rev GGACCTGCTCCA AGCCTAATGGCC 
 Probe AGGCCTTTCCCCTAGAGTTCA 
Per1 Fwd GTGCGCACGTAAGGGAACTG 
 Rev CCCATGCCATGTCCATACC 
 Probe TCTCCACGCTGGTGTT 
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1.3 RNA isolation and quantitative real-time PCR (qPCR) 
PRODUCT COMPANY 
  
RNA later Applied Biosystems, Forster City, 
CA, USA 
RNeasy Mini Kit Qiagen, Hilden, Germany 
QIAshredder Qiagen, Hilden, Germany 
Reverse Transcription System Promega, Mannheim, Germany 
RNase-Free DNase Set Qiagen, Hilden, Germany 
Quant-iTTM RiboGreen® RNA Assay Kit Molecular Probes, Eugene, Oregon, 
USA 
Affinity ScribtTM Multiple Temperature 
cDNA Synthesis Kit 
Stratagene, Agilent Technologies 
Company, USA 
Rodent GAPDH Control Reagents Applied Biosystems, USA 
Brilliant II QPCR Master Mix with High 
Rox 
Stratagene, Agilent Technologies 
Company, USA 
Brilliant III Ultra-Fast QPCR Master Mix  Stratagene, Agilent Technologies 
Company, USA 
 
1.4 Protein Extraction and Western Blotting 
PRODUCT COMPANY 
  
Complete mini protease inhibitor 
Roche Applied Science, Mannheim, 
Germany 
Bicinchoninic Acid Protein Assay Kit Thermo Scientific, Rockford, USA 
Enhanced Chemiluminescence Western 
Blotting Detection Reagent 
GE Healthcare, Freiburg, Germany 
PageRuler™ Prestained Protein              
Ladder Plus 
Fermentas, Thermo Scientific, 
Rockford, USA 
Re-Blot Plus Mild/Strong Solution Millipore, Temecula, USA 
Nitrocellulose membrane, 0.45 µm Bio-Rad, München, Germany 
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1.5 Immunohistochemical analysis 
PRODUCT COMPANY 
  
Streptavidin-biotin-peroxidase-complex 
Vectastain ABC Kit Elite (PK-6100) 
Vector Laboratories, Burlingname, 
USA 
DAB Peroxidase Substrate Kit (SK-
4100) 
Vector Laboratories, Burlingname, 
USA 
Vector Nova Red Peroxidase Substrate 
Kit (SK-4800) 
Vector Laboratories, Burlingname, 
USA 
Vectashield Mounting Medium (H-1400) 
Vector Laboratories, Burlingname, 
USA 
 
1.6 Neuroendocrine analysis 
PRODUCT COMPANY 
  
ACTH Elisa Kit IBL International, Hamburg, Germany 
CORT Elisa Kit IBL International, Hamburg, Germany 
EDTA tubes Sarstedt, Nürnbrecht, Germany 
 
1.7 Immunological analysis 
PRODUCT COMPANY 
  
Cell strainer 70 µm 
Beckton Dickinson Biosciences, 
Heidelberg, Germany 
Fetal bovine serum (FBS) PAA laboratories, 
IFN-y ELISA Kit Biolegend, San Diego, USA 
Penicillin 
PAA Laboratories GmbH, Cölbe, 
Germany 
Streptomycin 
PAA Laboratories GmbH, Cölbe, 
Germany 
RPMI 1640 
Sigma-Aldrich, Deisenhofen, 
Germany 
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PRODUCT COMPANY 
Embedding cassettes 
Simport Plastics Ltd., Bernard-Pilon, 
Beloeil QC, Canada 
Eosin Y solution 
Sigma-Aldrich, Deisenhofen, 
Germany 
Harris haematoxylin 
Sigma-Aldrich, Deisenhofen, 
Germany 
Microscope slides 
Gerhard Menzel GmbH, 
Braunschweig, Germany 
Mounting solution, Roti Histokitt II Carl Roth, Karlsruhe, Germany 
 
1.8 In vitro studies 
PRODUCT COMPANY 
  
Hippocampal cell isolation and stimulation 
DMEM, high glucose, pyruvate, no 
glutamine  #21969 
Invitrogen GmbH, Karlsruhe, Germany 
10 x Trypsin solution Sigma-Aldrich, Deisenhofen, Germany 
Deoxyribonuclease (DNaseI) Sigma-Aldrich, Deisenhofen, Germany 
Fetal bovine serum (FBS) 
PAA Laboratories GmbH, Cölbe, 
Germany 
Hank`s balanced salt solution 
(HBSS) without Ca, Mg, phenol red 
Invitrogen GmbH, Karlsruhe, Germany 
Corticosterone minimum 92% Sigma-Aldrich, Deisenhofen, Germany 
CellTiter96 Aqueous One Solution       
Cell Proliferation Assay 
Promega GmbH, Mannheim, Germany 
  
Adrenal in vitro stimulation  
DMEM/F-12, L-Glutamine, no Hepes 
buffer or phenol red 
Invitrogen GmbH, Karlsruhe, Germany 
Adrenocorticotropic hormone  
Fragment 1-2 
Sigma-Aldrich, Deisenhofen, Germany 
Bovine serum albumin (BSA) Sigma-Aldrich, Deisenhofen, Germany 
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1.9 Chemicals, Enzymes, Reagents and Equipment 
Chemicals, enzymes and reagents used in this thesis were obtained from BioRad 
(München, Germany), Beckman Coulter (Krefeld, Germany), Biomol (Hamburg, 
Germany), BMG Labtech (Offenbach, Germany), Braun (Melsungen, Germany), 
Carl Roth GmbH (Karlsruhe, Germany), Merck (Darmstadt, Germany), Sigma-
Aldrich (Deisenhofen, Germany). Cell culture materials, general plastic material 
and other equipment were purchased from Beckman Coulter (Krefeld, Germany), 
Eppendorf AG (Hamburg, Germany), BD Biosciences (Heidelberg, Germany), GE 
Healthcare (München, Germany), Gibco® Life Technologies GmbH (Darmstadt, 
Germany), Leica Microsystems (Wetzlar, Germany), Sarstedt (Nürnbrecht, 
Germany), Thermo Scientific (Rockford, USA) and VWR GmbH (Darmstadt, 
Germany). 
 
1.10 Software 
SOFTWARE PURPOSE SOURCE 
   
Endnote 9.0 
Reference 
Management 
Thomson 
Leica QWin V3 
analysis of IHC 
staining 
Leica Microsystems 
SPSS Statistics 21.0 Statistical analysis IBM 
Microsoft Office XP 2007 Text processing Microsoft 
Image Lab 4.1 Western Blot analysis BioRad Laboratories 
SigmaPlot 11 Graph processing Systat Software 
SPSS Statistics 21.0 Statistical analysis IBM 
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2 Methods 
2.1 Animal models 
2.1.1 Mice 
Male C57BL/6 mice (Charles River, Sulzfeld, Germany) weighing 19 - 22 g 
(experimental mice) were individually housed in standard polycarbonate mouse 
cages (16 x 22 x 14 cm) for one week before the CSC paradigm started.  
For studying the influence of the trait anxiety on the consequences of chronic 
psychosocial stress, adult male CD1 mice selectively inbred for high (mHAB) and 
low (mLAB) anxiety-related behaviour and non-selected normal CD1 (mNAB) 
mice (22 - 37 g body weight; bred at the Max Planck Institute of Psychiatry in 
Munich, Germany) were used as experimental mice. Importantly, differences in 
trait anxiety of these mice were not verified by testing those mice on the EPM 
prior to CSC exposure, as usually performed (Sotnikov et al., 2011). This is 
based on evidence showing that repeated (all mice are tested on the EPM on day 
19 of CSC) EPM testing should be avoided as prior experience with this test can 
influence performance during retesting (File et al., 1993; Holmes and Rodgers, 
1998; Roy et al., 2009).  
The male offspring (weighing 30 - 35 g) of mHAB female mice (kindly provided by 
Prof. Dr. R. Landgraf, Max Planck Institute of Psychiatry in Munich) and C57BL/6 
male mice (Charles River, Sulzfeld, Germany) were used as dominant animals. 
All mice were kept under standard laboratory conditions (12 h light/dark cycle, 
lights on at 0600 h, 22°C, 60 % humidity) and had free access to tap water and 
standard mouse diet. All experimental protocols were approved by the 
Committee on Animal Health and Care of the local government, and conformed 
to international guidelines on the ethical use of animals. All efforts were made to 
minimize the number of animals used and their suffering. 
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2.1.2 Chronic subordinate colony housing (CSC) 
The CSC paradigm was conducted as described previously (Reber et al., 2007; 
Reber and Neumann, 2008a; Reber et al., 2008b; Uschold-Schmidt et al., 2012; 
Füchsl et al., 2013). Briefly, one week after arrival, experimental mice were 
weighed and in a weight-matched manner assigned to the SHC or CSC group. 
Four experimental CSC mice, either four C57BL/6 mice or four mice of the same 
genotype, were housed together with a dominant male mouse for 19 consecutive 
days in order to induce a chronic stressful situation. During the first hour after 
putting the mice together, the behaviour was observed to guarantee that a 
hierarchical structure, with the resident obtaining the dominant and experimental 
mice the subordinate position, was established (Reber and Neumann, 2008a). 
Before the CSC procedure, the future dominant males were tested for their 
aggressive behaviour. Males that started to injure their opponents by harmful 
bites were not used. To avoid habituation, each dominant male was replaced by 
a novel dominant male at days 8 and 15. SHC mice remained undisturbed in their 
home cage except for change of bedding once a week. In a previous study it was 
convincingly demonstrated in our lab that single housing is the adequate control 
group for the CSC paradigm, as group housing itself was shown to be stressful 
for the mice (Singewald et al., 2009). 
 
2.1.3 Acute heterotypic stressor exposure - Forced swim (FS)  
The FS exposure on day 20 was used as acute heterotypic stressor and was 
conducted as described previously (Nyuyki et al., 2012; Slattery et al., 2012). 
Briefly, the FS tank consisted of an open top cylinder (25 cm height, 13 cm 
diameter) filled with tap water (21 + 1°C) to a depth of about 13 cm. Mice were 
immersed into the water tank for 6 min and decapitated 10 min folling termination 
of FS exposure (under CO2 anaesthesia). Trunk blood was collected and stored 
(see Sec. 2.3) and pituitaries were removed (see Sec 2.5.1). The water was 
changed after every animal. 
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2.2 Elevated plus-maze (EPM) 
To assess the genotype-specific effects of CSC on anxiety-related behaviour, 
SHC and CSC mHAB, mNAB, and mLAB mice were transported to the EPM 
room on day 18. The next day (day 19 of CSC exposure), all mice were tested on 
the EPM between 0800 and 1100 h for 5 min as previously described (Reber et 
al., 2007). The EPM consisted of two open (6 x 30 cm) and two closed (6 x 30 x 
17 cm) arms radiating from a central platform (6 x 6 cm) forming a plus shaped 
platform elevated 130 cm above the floor. To avoid falling, the edges of the open 
arms were 0.3 cm in height. Each mouse was placed on the central platform 
facing a closed arm. The maze was cleaned thoroughly before each test. A 
computer setup calculated the percentage of time spent on and the percentage of 
entries into the open arms of the EPM and the number of full entries. The number 
of closed arm entries was taken as measurement of locomotion. Afterwards, CSC 
mice were put back in their respective CSC colony and SHC mice were kept 
singly. 
 
2.3 Trunk blood sampling and analysis of plasma ACTH and CORT 
On day 20 SHC and CSC mice were rapidly killed by decapitation within 3 min 
after entering the animal room between 0800 and 1000 h. Therefore, all four CSC 
mice were simultaneously taken out and were rapidly killed under CO2 
anaesthesia within 3 min. Trunk blood was collected in EDTA-coated tubes 
(Sarstedt, Nürnbrecht, Germany) on ice and centrifuged at 4°C (5000 rpm, 10 
min). Plasma samples were stored at -20°C until ACTH and/or CORT 
concentrations were assessed.  
Plasma samples were analysed using a commercially available ELISA kit for 
ACTH (analytical sensitivity 0.22 pg/ml, intra-assay and inter-assay coefficients of 
variation < 7.1%) and/or for CORT (analytical sensitivity < 0.564 ng/ml, intra-
assay and inter-assay coefficients of variation < 6.35%, IBL International, 
Hamburg, Germany). When applicable, plasma CORT:ACTH ratio (ACTH and 
CORT concentrations were applied in ng/ml) was calculated for each animal. 
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2.4 Dexamethasone suppression test (DST) 
On day 20 SHC and CSC mice received an ip injection of either water-soluble 
Dex phosphate (dexamethasone 21-phosphate disodium salt, Sigma-Aldrich 
Deisenhofen, Germany) solved in sterile 0.9 % saline (3 µg/100 g body weight in 
100 µl) or 0.9 % saline between 0700 and 0800 h and afterwards were returned 
to their home cage (SHC) or CSC cage, respectively. The dose of Dex was 
chosen according to another study conducted in mice (Ridder et al., 2005). Four 
hours following the injection, SHC and CSC were subjected to an acute 
heterotypic stressor (FS, 6 min, conducted as described in 2.1.3). 10 min 
following termination of FS exposure, mice were decapitated and trunk blood was 
collected and stored for the analysis of ACTH concentrations. 
 
2.5 Preparation of organ tissue 
2.5.1 Removal of different brain regions 
The brain was taken out of the cranium, whereby the dura mater was removed to 
avoid any damage of the brain.  
The PFC was obtained, by cutting off about 2 - 3 mm of the frontal part of the 
brain and was frozen in liquid nitrogen for protein analysis.  
For withdrawal of the hippocampus, the two hemispheres were separated by a 
median cut and the hippocampus was exposed by applying tweezers and a razor 
blade. After that, the left and right hippocampus were dissected, pooled, weighed 
and either frozen in liquid nitrogen (protein analysis), stored in RNA later (mRNA 
analysis) or stored in HBSS on ice (hippocampal cell isolation). 
For removal of the PVN, brains were taken out, snap-frozen in isopentane and 
stored at -80°C (protein analysis) or immersed in fixative (IHC analysis, see Sec. 
2.8.2). For protein analysis, 200 µm cryo-sections were cut using a cryostat (at -
20°C) and the PVN was punched out according to the mouse brain atlas 
(Paxinos and Franklin, 2001) and stored at -80°C until further preparation. 
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2.5.2 Determination of pituitary weight and pituitary cell number 
After decapitation on day 20 the pituitary of each mouse was removed, weighed 
and either frozen in liquid nitrogen (protein analysis), stored in RNA later (mRNA 
analysis), stored in Hank`s balanced salt solution (HBSS) on ice (pituitary cell 
number) or embedded in protective freezing medium (IHC analysis) 
For determination of the pituitary cell number, the whole pituitary was 
enzymatically digested in 2 ml HBSS (Life Technologies, Inc., Grand Island, NY, 
USA) containing Trypsin (Sigma-Aldrich, Deisenhofen, Germany) for 20 min at 
37°C (95 % O2, 5 % CO2). Digestion was stopped by adding HBSS containing 10 
% FCS. After two washing steps with HBSS, the pituitary was triturated with a 
pasteur pipette in 1 ml Dulbecco`s Modified Eagle Medium (DMEM/F-12, Life 
Technologies, Inc., Grand Island, NY, USA). After centrifugation (20°C, 10 min, 
1500 rpm), cells were resuspended in DMEM/F-12 and the number of isolated 
cells per pituitary was assessed using a Cell Viability Analyzer (Vi-Cell™ XR, 
Beckman Coulter, Krefeld, Germany).  
 
2.5.3 Determination of body weight gain, adrenal and spleen weight 
On day 20 mice were weighed immediately before decapitation to assess the 
effects of CSC on body weight gain. Afterwards, the spleen and left and right 
adrenal glands of each animal were removed, pruned from fat and weighed 
separately. In addition, the sum of left and right absolute adrenal weights was 
calculated for each mouse. Values represent absolute weight (in mg). Until all 
mice were killed and adrenals removed, the latter were stored in ice-cold 
DMEM/F-12 containing 0.1 % BSA. 
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2.6 Molecular Techniques - quantitative real-time PCR (qPCR) using 
Taqman technology 
mRNA in the tissue was quantified by use of quantitative real-time PCR (qRT-
PCR), using TaqMan™ PCR (Applied Biosystems, Forster City, CA, USA). In 
addition to the common primer pair, a TaqMan probe containing a fluorophore at 
the 5`-end of the oligonucleotide probe and a quencher at the 3` -end is used. In 
this case, 6-carboxyfluorescein (FAM) was used as fluorophor and 6-
carboxytetra-methylrhodamine (TAMRA) was used as quencher. As long as the 
probe is intact, the quencher represses the fluorescence signal of the fluorophor. 
When primer and probe bind to specific regions on the cDNA, the Taq-
polymerase extends the primer and synthesizes the strand, whereby the 5` to 
3`exonuclease activity of the polymerase degrades the probe, which leads to the 
release of the fluorophore. The fluorescence can subsequently be detected and 
is proportional to the released amount of fluorophor and in turn to the amount of 
PCR product.  
 
RNA isolation 
Tissue used for mRNA analysis was stored in RNA later (Applied Biosystems, 
Forster City, CA, USA) until extraction of the RNA. Therefore, the RNeasy Mini 
Kit (Qiagen, Hilden, Germany) was used and the amount of RNA was measured 
by a nanophotometer (Implen, München, Germany).  
 
Reverse transcription into cDNA and semiquantitative RT-PCR 
1000 ng/ml RNA was then reverse transcribed into first-strand cDNA by the use 
of the Reverse Transcription System (Promega, Mannheim, Germany). 
Expression levels of desired genes were quantified by TaqMan-qPCR (ABI 
PRISM 7900HT Sequence Detection System; Applied Biosystems, Foster City, 
CA, USA) as single-tube reactions (20 µl) in 384-well plates. The sequences of 
the primers and probes are depicted in Sec. 1.2. Glyceraldehyde-3-
phosphatedehydrogenase (GAPDH)-Mix (Applied Biosystems, Foster City, CA, 
USA) served as housekeeping or reference gene.  
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TAQMAN-QPCR:   CYCLING:   
     
1 µl cDNA  50°C 2 min   
1 µl (18 µM) Fwd primer  95°C 10 min   
1 µl (18 µM) Rev primer  95°C 15 s  
40 repeats 
1 µl (5 µM) Probe  60°C 1 min  
10 µl  Brilliant II QPCR Master 
Mix with High Rox 
     
1 µl  GAPDH mix      
Ad 20 µl sterile H2O      
 
Average expression value of three individual measures normalized to GAPDH 
mRNA expression was quantified for each mouse.  
 
For measurement of Per1 hnRNA expression in hippocampal cells a different 
TaqMan-qPCR protocol was applied: 
TAQMAN-QPCR:   CYCLING:   
       
2 µl cDNA  95°C 3 min   
0.3 µl (150 nM) Fwd primer  95°C 15 s  
40 repeats 
0.3 µl (150 nM) Rev primer  60°C 30 s  
0.35 µl (350 nM) Probe      
10 µl  Brilliant III Ultra-Fast 
QPCR Mastermix 
     
0.6 µl  GAPDH mix      
Ad 20 µl sterile H2O      
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2.7 Protein Techniques 
2.7.1 Preparation of total cell lysates  
In general, tissue used for protein analysis was rapidly removed and immediately 
frozen in liquid nitrogen and stored at -80°C until further preparation. All following 
analysis steps were carried out on ice to avoid any protein degradation. For 
preparation of total cell lysates an EDTA lysis buffer supplemented with complete 
mini protease inhibitor was used. Initially, tissue was homogenized with a Dounce 
homogenisator in an appropriate volume of EDTA lysis buffer. Samples were 
allowed to rotate at 4°C for 1h and subsequently cellular debris were pelleted by 
centrifugation (13.000 rpm, 30 min, 4°C; Eppendorf 5415R) and the total protein 
concentration was determined by using a commercial kit (see Sec. 2.7.3). 
 
EDTA lysis buffer 
  
0.5 mM EDTA 
250 mM NaCl 
50 mM HEPES 
0.5 %  Igepal (v/v) 
 
2.7.2 Preparation of fractionated cell lysates 
For preparation of cytoplasmic and nuclear protein extract, the protein extraction 
was done according to the method of Kitchener and colleagues (Kitchener et al., 
2004). All procedures were performed on ice or at 4°C. The tissue was 
homogenized using a Dounce homogenisator in an appropriate volume of S1 
buffer supplemented with 0.5 mM dithiothreitol (DTT), 0.2 mM sodium 
orthovanadate (Na3VO4), 2 mM sodium fluoride (NaF) and subsequently 
centrifuged (7.000 rpm, 10 min, 4°C; Eppendorf 5415R). For the cytoplasmic 
fraction, the supernatant was transferred to a new reaction tube and centrifuged 
again (13.000 rpm, 30 min, 4°C, Eppendorf 5415R) and the final supernatant was 
stored at -80°C. 
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The remaining pellet was resuspended in an appropriate volume of S1 buffer 
supplemented with 0.5 mM DTT, 0.2 mM Na3VO4, 2 mM NaF and passed 
through a 25 gauge needle for 10 times using a 1 ml syringe to ensure complete 
disruption of all plasma membranes. The suspension was centrifuged (5.000 
rpm, 10 min, 4°C, Eppendorf 5415R), the S/N was discarded and the pellet was 
gently resuspended in S1 buffer. After one more centrifugation step (5.000 rpm, 
10 min, 4°C, Eppendorf 5415R), the pellet was washed 2 times with S1 buffer. In 
a next step, the nuclear proteins were extracted in 1.2 pellet volume of cold S2 
buffer supplemented with 0.5 mM DTT, 0.2 mM Na3VO4, 2 mM NaF. After 1 h 
incubation on ice and subsequent vortexing, the sample was centrifuged and the 
protein concentration of the supernatant was determined (see also Sec. 2.7.3). 
 
S1 buffer  S2 buffer 
     
10 mM Hepes  10 mM Hepes 
10 mM KCl  400 mM NaCl 
1.5 mM MgCl2  1.5 mM MgCl2 
0.1 mM EDTA  0.1 mM EDTA 
 
2.7.3 Quantitative Determination of protein concentrations 
Protein concentrations in the samples of the total and fractionated cell lysates 
were determined by using a commercial kit (Bicinchoninic Acid (BCA) Protein 
Assay Kit, Thermo Scientific, Rockford, USA). The assay is based on the the 
reduction of Cu2+ to Cu+ by the peptide bonds of proteins. Thereby the amount of 
reduction is proportional to the amount of protein present in the sample. The BCA 
in the kit forms a purple-blue complex with Cu+ and the absorbance can be 
measured at 562 nm. 5 µl of sample was, therefore, mixed with 200 µl of the BCA 
working reagent, incubated for 30 min at 37°C and the absorbance measured in 
an ELISA plate reader (Fluostar Optima, BMG Labtech, Offenburg, Germany). 
The originated BSA standard curve (0 – 2 µg/µl) was used to calculate the protein 
concentration of each sample. 
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2.7.4 SDS Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
Protein lysates were subjected to electrophoresis on sodium dodecyl sulfate-
polyacrylamide gels (SDS-PAGE) to separate them according to their molecular 
weights. 10 % Polyacrylamide gels were prepared using the BioRad system, 
consisting of a stacking and a resolving gel. Equal amounts of protein lysates 
were mixed with denaturating buffer according to Laemmli (Laemmli, 1970), 
boiled for 5 min at 99°C in a thermoblock (Thermomixer Comfort, Eppendorf) and 
subjected to electrophoresis. PageRuler Prestained Protein Ladder Plus 
(Fermentas, Thermo Scientific, Rockford, USA) was used to determine the 
molecular weight of the proteins. The electrophoresis procedure was performed 
with Mini-PROTEAN® Tetra Cell in electrophoresis buffer at 110 V.  
 
4 x Resolving gel buffer, pH 8.8  4 x Stacking gel buffer, pH 6.8 
     
1.5 M  Tris  0.5 M 1 M Tris 
10 % SDS (w/v)  10 % SDS (w/v) 
Stacking gel (5 %)  Resolving gel (10 %) 
     
670 µl 30 % Acrylamide  4 ml 30 % Acrylamide 
1 ml 4 x stacking gel buffer  3 ml 4 x resolving gel buffer 
2.3 ml H2O bidest.  5 ml H2O bidest. 
30 µl APS  90 µl APS 
5 µl TEMED  9 µl TEMED 
4 x Loading dye  Electrophoresis buffer 
     
2.4 ml 1 M Tris pH 6.8  25 mM Tris 
0.8 g SDS  86 mM Glycin 
4 µl Glycerol  3.5 mM SDS 
1 ml ß-Mercaptoethanol  ad 1 l H2O bidest. 
2.8 ml H2O bidest.    
0.01% Bromphenol blue    
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2.7.5 Western Blottting 
Transfer of the proteins onto nitrocellulose membranes 
For immunoblotting, the separated proteins were transferred onto nitrocellulose 
membrane (BioRad, Munich, Germany) using Trans-Blot® Electrophoretic 
Transfer Cell (BioRad, München, Germany). Therefore, two fiber pads, two 
whatman papers, gel, nitrocellulose membrane, two whatman papers and two 
fiber pads were assembled in a gel holder cassette. The electrophoretic transfer 
was performed in a blotting chamber filled with transfer buffer at 100 V for 1h. 
Afterwards, nitrocellulose membranes were incubated in blocking solution (see 
Table 1) on an orbital shaker, to saturate unspecific antibody binding sites on the 
nitrocellulose membrane.  
 
Transfer buffer (pH 8.3)  
   
25 mM Tris  
192 mM Glycin  
20 % Methanol (v/v)  
 
Antibody staining 
After blocking of the membrane, the blocking solution was discarded and the 
membrane was incubated with the primary antibody. The kind of blocking solution 
as well as the incubation time and dilution of the primary antibodies were 
determined for each antibody individually to ensure the optimal conditions (see 
Table 1). Following the incubation with the primary antibody, the nitrocellulose 
membrane was washed three times for 15 min with TBS-T or PBS-T respectively 
and incubated for 30 – 60 min with a horseradish-peroxidase (HRP)-conjugated 
secondary antibody at RT (see Table 1). Afterwards, the membrane was again 
washed three times for 15 min with TBS-T or PBS-T. 
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Protein visualization using Enhanced Chemiluminescence. 
Immunoreactive bands were visualized by incubating the membrane with 
Enhanced Chemiluminescent Western Blotting detection reagent (ECL, GE 
Healtcare, Freiburg, Germany) according to the manufacturer`s instructions and 
using a Molecular Imager® ChemiDoc™ XRS+ system (Bio-Rad Laboratories, 
München, Germany). Semiquantitative densitometric analysis of the signals was 
performed using Image Lab™ Software (Bio-Rad Laboratories, München, 
Germany). Protein expression for each mouse was normalized to ß-Tubulin 
(whole cell lysate and cytoplasmic fraction) or TATA binding protein (nuclear 
fraction) expression and averaged per group. 
 
Stripping of Western Blot membranes 
For detection of various proteins on one membrane, each membrane was 
stripped, i.e. the antibody used before was effectively removed, using Re-Blot 
Plus Mild Antibody Stripping Solution (Millipore GmbH, Schwalbach, Germany). 
Following incubation with blocking solution (2 x 5 min), the nitrocellulose 
membrane was incubated with another antibody. The stripping procedure was 
mainly used to detect the housekeeping gene ß-Tubulin which was used as 
loading control for whole cell lysates and cytoplasmic fraction, whereby TATA 
binding protein was used as loading control for the nuclear fraction. 
 
10 x TBS (pH 7.4)  TBS-T 
     
500 mM Tris   0.1 % Tween (v/v) 
 in TBS 1.5 M NaCl   
PBS (pH 7.4)  PBS-T 
     
140 mM NaCl  0.1 % Tween (v/v)  
in PBS 3 mM KCl   
1.5 mM KH2PO4    
4 mM Na2HPO4    
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PROTEIN 
OF 
INTEREST 
BLOCKING 
PROTOCOL 
PRIMARY 
ANTIBODY 
PROTOCOL 
SECONDARY 
ANTIBODY 
PROTOCOL 
SIZE 
[KDA] 
     
CRH-R1 
5 % BSA/TBS-T 
1 h at RT 
1/200 in 5 % 
BSA/TBS-T 
o/n at 4°C 
Anti goat, 1/8500 in 
3%BSA/TBS-T  
30 min 
~48  
AVPR-1b 
5 % MP/TBS-T 
2h at RT 
1/400 in 5 % 
MP/TBS-T 
o/n at 4°C 
Anti goat, 1/1500 in 
TBS-T 
30 min at RT 
~ 45 - 
50  
GR 
5 % MP/TBS-T 
1h at RT 
1/700 in 5 % 
MP/TBS-T for 
cytoplasm, 
1/300 in 5 % 
MP/TBS-T for 
nucleus, o/n 4°C 
Anti rabbit, 1/1000 
in TBS-T 
1 h at RT 
~ 86  
MR 
5 % MP/PBS-T 
o/n at 4°C 
1/200 in 5 % 
MP/PBS-T 
2 h at RT  
Anti rabbit, 1/2000 
in PBS-T 
1 h at RT 
~107  
FKBP51 
5 % MP/TBS-T 
1h at RT 
1/500 in 5 % 
MP/TBS-T 
 o/n at 4°C 
Anti goat, 1/6000 in 
2.5 % MP/TBS-T 
30 min at RT 
~ 51  
POMC 
3 % MP/TBS-T 
1h at RT 
1/700 in 3 % 
MP/TBS-T 
o/n at 4°C 
Anti rabbit, 1/2000 
in TBS-T 
30 min at RT 
~ 27  
ß-Tubulin 
5 % MP/TBS-T, 
1h at RT or o/n 
at 4°C 
1/1000 in 5 % 
MP/TBS-T, 1h at 
RT or o/n at 4°C 
Anti rabbit, 1/1000 
in TBS-T 
30 min at RT 
~ 50  
TATA 
binding 
protein 
5 % BSA/TBS-T 
1 h at RT 
1/200 in 5 % 
BSA/TBS-T, o/n 
at 4°C 
Anti rabbit, 1/1000 
in TBS-T 
30 min at RT 
~ 38  
 
Table 1: Incubation protocols for every individual antibody. Blocking solution contained 
either milk powder (MP) or bovine serum albumin (BSA) in TBS-T or PBS-T 
respectively. Blocking or antibody staining was either performed at room temperature 
(RT) or at 4°C overnight (o/n).  
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2.8 Immunohistochemistry 
2.8.1 ACTH immunostaining in pituitary cryo-sections  
Cryo-sectioning of pituitary tissue 
After removal on day 20 of CSC pituitaries were weighed and embedded in 
protective freezing medium (Tissue-Tek, Sakura Finetek Europe, Zoeterwoude, 
The Netherlands) and stored at -80°C. Subsequently, one series of five 5-µm 
cryo-sections were cut using a cryostat (at -20°C) and then thaw-mounted onto 
pre-coated slides (SuperFrost Plus, Menzel-Gläser, Braunschweig, Germany). 
 
ACTH immunostaining in pituitary cryo-sections 
Frozen sections were fixed with ice-cold acetone for 10 min, air-dried for 20 min 
and washed 2 times with PBS for 10 min. IHC slices were then blocked with 
PBS/10 % normal goat serum (NGS, Biozol Diagnostica, Eching, Germany) for 
20 min followed by incubation with rabbit anti-ACTH antibody (1:200, Abcam, 
Cambridge, UK) in PBS/0.1% NGS overnight at 4°C. After washing 3 times with 
PBS for 5 min, IHC slices were incubated with the respective biotinylated anti-
rabbit secondary antibody (1:500, Vector Laboratories, Loerrach, Germany) for 
30 min at RT and afterwards washed 3 times with PBS for 5 min. Respective 
positive cells were visualized by the use of Vectastain ABC Kit followed by Vector 
NovaRed Substrate Kit (Vector Laboratories, Loerrach, Germany). Finally, 
sections were mounted with Vectashield Mounting Medium (Vector Laboratories, 
Loerrach, Germany) and covered with a glass cover slip. Per slide, the area 
positively stained for ACTH and the visible area of the anterior pituitary were 
quantified in digitized images of three to six sections using Leica QWin V3 (Leica 
Microsystems, Wetzlar, Germany). Positively stained pituitary tissue was 
expressed in percent of total anterior pituitary tissue. Furthermore, the number of 
ACTH positive pituitary cells [n] was counted in the same three to six digitized 
images and averaged per animal to provide individual means. 
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2.8.2 AVP and OXT immunostaining in brain cryo-sections 
Cryo-sectioning of brain tissue 
Immediately after decapitation the brains were collected and immersed for 24 h in 
fixative consisting of 4 % paraformaldehyde in PBS (pH 7.4). Afterwards they 
were cryo-protected in 30 % sucrose in PBS, snap-frozen in isopentane and 
stored at -80°C. Serial sections (20 µm) containing the PVN, according to the 
mouse brain atlas (Paxinos and Franklin, 2001), were cut using a cryostat (at -
20°C) for AVP immunostaining and put in PBS containing 0.01 % sodium azide 
for free floating staining. 
 
AVP and OXT immunostaining in brain cryo-sections 
Free floating sections were incubated in PBS containing 10 % NGS (Biozol 
Diagnostica, Eching, Germany) and 0.3 % Triton-X (PBS/Triton) for 2 h at RT to 
block unspecific binding. This was followed by incubation with primary antibody 
against AVP or OXT (1:400, p41 (AVP), p38 (OXT) mouse monoclonal, which 
were a generous gift of Dr. Gainer, NIH, USA) in PBS/Triton/1 % NGS overnight 
at 4°C. Afterwards, sections were washed 3 times in PBS/Triton for 5 min and 
incubated with the respective biotinylated goat anti-mouse antibody (1:300, 
Vector Laboratories, Loerrach, Germany) for 2 h at RT and washed again 2 times 
with PBS/Triton for 5 min. Respective positive cells were visualized by the use of 
a Vectastain ABC Kit followed by DAB Peroxidase Substrate Kit (Vector 
Laboratories, Loerrach, Germany). Finally, the free floating sections were put on 
pre-coated slides (SuperFrost Plus, Menzel-Gläser, Braunschweig, Germany), 
mounted with Vectashield Mounting Medium (Vector Laboratories, Loerrach, 
Germany) and covered with a glass cover slip. Counting of positive cells was 
performed in digitized images using Leica QWin V3 (Leica Microsystems, 
Wetzlar, Germany). For analysis of AVP positive neurons, parvocellular neurons 
in the PVN were differentiated histologically from magnocellular neurons 
according to their smaller size and their lower level of AVP expression (Agid et 
al., 1999). According to the literature (Kadar et al., 2010), the size of 
magnocellular neurons was approximately set to > 14 µm and for parvocellular 
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neurons < 14 µm. For each animal, five to six sections, containing the regions 
rostral, rostral-medial, medial
Numbers of parvocellular and magnocellular AVP 
within each region (1 – 2 sections per region) of the PVN and the average value 
for each mouse was calculated to provide individual means. 
number of OXT positive cells was done a
no differentiation between magno
Omission of the primary antibody resulted in no immunoreactivity, confirming 
specificity of the antibody used. 
are further described in the original publication 
 
Rostral 
medial-caudal 
Figure 18: Representative images of mouse brain slices stained for AVP in the 
PVN. The images represent the 
caudal and caudal which were analys
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-caudal and caudal, were counted bilaterally. 
positive neurons were counted 
The analysis for the 
ccordingly to the AVP analysis, whereby 
- and parvocellular neurons was performed.
The characteristics of the AVP and OXT antibody 
(Whitnall et al., 1985). 
 
rostral-medial 
 
caudal 
four different regions, i.e. rostral, rostral-medial, medial
ed for AVP and OXT protein expression. 
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2.9 In vitro Techniques  
2.9.1 ACTH stimulation of adrenal explants in vitro 
ACTH stimulation was performed as described previously (Uschold-Schmidt et 
al., 2012). Briefly, the adrenal were cut into two halves, each containing cortical 
and medullary tissue. The halves were then weighed and pre-incubated in 200 µl 
DMEM/F-12 containing 0.1 % BSA for 4 h (37°C, 95 % O2, 5 % CO2) before any 
further treatment. Culture medium was then replaced and each half of one 
adrenal was incubated with either medium containing saline (basal) or medium 
containing ACTH (pharmacological dose of 100 nM) for 6 h at 37°C (95 % O2, 5 
% CO2). Afterwards, supernatants were carefully removed and stored at -20°C 
until analysed using a commercially available ELISA for CORT (IBL International, 
Hamburg, Germany). CORT concentrations were calculated in relation to the 
weight of the respective adrenal explants (i.e. relative CORT secretion). To 
illustrate the in vitro adrenal CORT secretion in relation to the whole organism, 
relative CORT secretion from left and right adrenal gland of each mouse was 
summed up (total CORT secretion).  
 
2.9.2 Hippocampal cell isolation und stimulation 
Hippocampal cell isolation 
For the hippocampal cell stimulation, left and right hippocampi were dissected, 
pooled and collected in 1.8 ml ice-chilled HBSS (Invitrogen GmbH, Karlsruhe, 
Germany). Thereafter 200 µl of Trypsin stock solution (Sigma- Aldrich, 
Deisenhofen, Germany) was added and the hippocampi were incubated for 20 
min at 37°C/5% CO2. Next, 50 µl of 10 mg/ml Deoxyribonuclease (Sigma- 
Aldrich, Deisenhofen, Germany) was added for 30 s in order to break down DNA 
and to avoid clumping of tissue during the subsequent trituration. Afterwards the 
tissue was washed once with HBSS/10% fetal bovine serum (FBS, PAA 
Laboratories GmbH, Cölbe, Germany) to stop the digestion and twice with HBSS. 
After discarding the S/N the tissue was homogenized with a plastic pasteur-
pipette in 1 ml of DMEM (Invitrogen GmbH, Karlsruhe, Germany) and centrifuged 
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at 1000 rpm for 10 min at 20°C. The S/N was again discarded and the pellet was 
resuspended in 1 ml DMEM and the cell number was determined using a cell 
viability analyser (Vi-Cell XR, Beckmann Coulter, Krefeld, Germany). Afterwards 
the cell suspension was again centrifuged at 1000 rpm for 10 min at 20°C and 
the pellet was resuspended in the appropriate volume of DMEM/0.1 % BSA for 
the determination of the cell viability after 24 h and in DMEM without BSA for the 
measurement of the Per1 hnRNA expression. As BSA is necessary for cell 
survival but also contains small amounts of GC, it was not used for the 30 min 
stimulation (for Per1 hnRNA) but was included in the 24 h stimulation (cell 
viability measurement). All work was done under the clean bench.  
 
Hippocampal cell viability measurement 
2 x 105  hippocampal cells were plated onto a Poly-L-Lysine (Sigma Aldrich, 
Deisenhofen, Germany) coated 96-well plate and incubated with different CORT 
concentrations (0.1 µM, 1 µM, 10 µM, 100 µM, 1000 µM) (Sigma Aldrich, 
Deisenhofen, Germany) or vehicle for 24 h at 37°C/5 % CO2. CORT was first 
dissolved in Ethanol (EtOH, 60 % of the total volume) and then further diluted to 
the appropriate concentration with saline. Vehicle consisted of saline containing 
comparable amounts of EtOH as used in the respective CORT stimulation 
condition. The cell viability of the hippocampal cells was determined 24 h later 
with a commercial available colorimetric assay (Cell Titer AQueous One Solution 
Cell Proliferation Assay Promega, Mannheim, Germany). Thereby a yellow 
solution, containing a tetrazolium compound [3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxy-methoxyphenyl)-2-(4-sulfophenyl)-2H- tetrazoli um, inner salt (MTS)] and 
an electron coupling reagent [phenazine ethosulfate (PES)], was added to the 
samples. Metabolic active cells produce NADH+, which converts the tetrazolium 
compound into Formazan, a soluble red dye. The cell viability can be measured 
via the absorbance of Formazan in a photometer at a wavelength of 485 nm. The 
NADH+ amount produced by the cells thereby correlates with the cell viability. In 
this case, 20 µl of MTS were added to the cell solution and incubated for 2 h at 
37°C/5% CO2. Afterwards the absorbance was measured with an ELISA plate 
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reader (BMG Labtech GmbH, Ortenberg, Germany) whereby all measurements 
were done in duplicates. To account for differences in background activity, the 
absorbance of wells containing only medium and vehicle or CORT was 
subtracted from the absorbance of wells containing cells and the corresponding 
treatment.  
 
Hippocampal gene expression in response to CORT treatment 
For measurement of the CORT-induced expression of Per1 hnRNA, 7 x 105 
hippocampal cells were plated onto a Poly-L-Lysine (Sigma Aldrich, Deisenhofen, 
Germany) coated 96-well plate and incubated for 1 h (37°C, 95 % O2, 5 % CO2), 
to allow seeding of the cells in the wells. Afterwards the cells were incubated with 
0.1 µM or 100 µM CORT or vehicle for 30 min (37°C, 95 % O2, 5 % CO2). CORT 
was first dissolved in EtOH (60% of the total volume) and then further diluted to 
the appropriate concentration with saline. Vehicle consisted of saline containing 
comparable amounts of EtOH as used in the respective CORT stimulation 
condition. A 30 min stimulation was chosen given that at this time point a maximal 
induction of hnRNA after an applied CORT pulse was demonstrated (Conway-
Campbell et al., 2010). Thereafter the samples were centrifuged for 8 min at 800 
rpm, the S/N was discarded and the pellet was resuspended in 150 µl of RLT 
buffer (Qiagen, Hilden, Germany) containing 1% beta-mercaptoethanol. The cell 
solution was stored at -80 °C until RNA extraction and qPCR were performed.  
 
2.10 Analysis of immunological parameters 
2.10.1 Determination of the histological damage score of the colon 
In order to assess the histological damage score of the colon, the colon was 
removed and mechanically cleaned of faeces. Afterwards, 1 cm of the distal third 
was cut longitudinally, laid on a filter paper and fixed in 10 % formalin overnight. 
The next day the fixed tissue was embedded in paraffin and cut longitudinally. 
Three 3 µm sections were taken at 100 µm distance, stained with haematoxylin-
eosin stained distance and were evaluated by histological scoring performed by 
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an investigator blind to treatment. For statistics, each individual score represents 
the mean of the three sections.  
 
Haematoxylin-eosin staining: 
Xylol 5 min  Eosin 30 s – 2 min 
Xylol 5 min  dest H2O Rinsing 
100 % ethanol 1 min  70% ethanol 1 min 
100 % ethanol 1 min  70% ethanol 1 min 
90 % ethanol 1 min  90% ethanol 1 min 
70% ethanol 1 min  100% ethanol 1 min 
dest H2O 1 min  100% ethanol 1 min 
Haematoxylin 10 – 15 min  Xylol 5 min 
Hot water 3 min  Xylol 5 min 
Cold water 3 min    
 
Histology was scored as follows (Obermeier et al., 2003; Reber et al., 2007): 
Epithelium. 0, normal morphology; 1, loss of goblet cells; 2, loss of goblet cells in 
large areas; 3, loss of crypts and 4, loss of crypts in large areas 
Infiltration. 0, no infiltration; 1, infiltrate around crypt basis; 2, infiltrate reaching to 
lamina muscularis mucosae; 3, extensive infiltration reaching the L. muscularis 
mucosae and thickening of the mucosa with abundant oedema; 4, infiltration of 
the L. submucosa.  
The total histological score of each mouse represents the sum of the epithelium 
and infiltration score and ranges from 0 to 8.  
 
2.10.2 Isolation and incubation of mesenteric lymph node cells 
To determine the effects of CSC on the IFN-γ secretion of anti-CD3-stimulated 
mesLNC, mesLN (pooled from all mice per experimental group) were pruned 
from fat and collected on ice in RPMI medium. Lymph nodes were mechanically 
disrupted and filtered through a cell strainer (70 µm nylon, Falcon; Becton 
Dickinson Biosciences, Heidelberg, Germany). The cell suspension was 
centrifuged (1000 rpm, 15 min, 4°C, Allegra X-12R, Beckman Coulter), the 
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supernatant was discarded and cells were washed three times in RPMI medium. 
After the last washing step, the cells were resuspended in 5 ml RPMI medium 
and the cell number was assessed using a Cell Viability Analyser (Vi-Cell™ XR, 
Beckman Coulter, Krefeld, Germany) and adjusted to a concentration of 106 
cells/ml.  
One day before the cell stimulation, a 96-well plate had to be precoated with 2.5 
µg/ml anti-CD3 antibody. Shortly before the cells were plated, the antibody was 
discarded and the wells were washed two times with PBS. Then 2 x 105 (200 µl) 
mesLNC were transferred to wells of the precoated 96-well plate. Eight wells 
were transferred with the respective number of cells per experimental group. 
After incubation for 24 h (37°C, 95 % O2, 5 % CO2), IFN-γ levels were measured 
in the supernatants of four wells per experimental group by ELISA (Biolegend, 
San Diego, CA, USA) according to the manufacturer and averaged per group. 
The results are depicted as individual values per treatment group for each of the 
two experiments and the respective mean.  
 
 
 
 
 
 
2.11 Statistics 
For statistical comparisons, the software package SPSS statistics (version 21.0) 
was used. Data of two experimental groups (SHC versus CSC) were analysed 
using the parametric Student’s t-test. The number of AVP and OXT positive 
neurons (factor region and factor CSC), plasma ACTH levels following DST 
(factor CSC and factor stimulus), hippocampal cell viability and stimulation of 
Per1 hnRNA expression in hippocampal cells in vitro (factor CSC and factor 
CORT) were compared using a two-way analysis of variance (ANOVA) followed 
RPMI Medium (1640)  
   
10 % FBS (v/v)  
100 u/ml Penicillin  
100 µg/ml Streptomycin  
3 x 10-5 M Mercaptoethanol  
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by a post hoc Bonferroni test when appropriate. All parameters depending on two 
factors (factor CSC and factor genotype) were analysed by using a two-way 
ANOVA, followed by a post hoc Bonferroni test when appropriate. In vitro adrenal 
CORT secretion was compared by three-way ANOVA (factor genotype, factor 
CSC, factor ACTH), followed by a post hoc Bonferroni test when appropriate. 
Data represent the mean + SEM. Significance was taken at P < 0.05. For 
determination of IFN-γ secretion by mesLNC no SEM was calculated and no 
statistical analysis was performed, due to the low number of data pools (two 
pools per treatment group). 
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1 Effects of 19 days of CSC on different parameters of the 
pituitary  
 
1.1 Basal and acute heterotypic stress-induced plasma ACTH levels 
First of all, basal plasma ACTH levels on day 20 of CSC were assessed. 
Moreover, another set of animals was exposed to an acute heterotypic stressor, 
in this case 6-min FS, on day 20 of CSC and trunk blood was collected 10 min 
following termination of the acute stressor exposure.  
Compared with SHC mice, basal morning plasma ACTH concentrations were 
significantly increased in CSC mice (P = 0.001; Fig. 19A), as were plasma ACTH 
concentrations 10 min following termination of FS exposure (6 min) (P = 0.030; 
Fig. 19B). 
 
 
Figure 19: Effects of CSC on the basal morning and forced swim (FS)-induced 
plasma ACTH concentrations in trunk blood. 
Following decapitation on day 20 of CSC between 0800 and 1000 h, basal morning 
plasma ACTH [pg/ml] concentrations were determined in trunk blood of SHC (n = 42) and 
CSC (n = 61) mice (A). Another set of SHC (n = 7) and CSC (n = 6) mice was exposed to 
6 min forced swim (FS) on day 20 of CSC and decapitated 10 min following FS exposure 
whereby trunk blood was collected for determination of plasma ACTH [pg/ml] 
concentrations (B).  SHC;  CSC. Data represent the mean + SEM. * represent P < 
0.05, ** represent P < 0.01 vs. respective SHC mice. [adapted from (Füchsl et al., B 
submitted)] 
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1.2 Absolute pituitary weight and total pituitary cell number 
The increased pituitary weight found on day 28 (Slattery et al., 2012), i.e. 8 days 
following termination of the CSC paradigm, already indicated that the pituitary 
might be implicated in alterations of HPA axis functionality. Nevertheless, to 
confirm this result also on day 20 of CSC, pituitary weight, as well as the number 
of pituitary cells was determined immediately after 19 days of CSC.  
Absolute pituitary weight was significantly increased (P = 0.001, Fig. 20A) on day 
20 of CSC, supporting the finding of the previous study. Given that also the 
number of isolated pituitary cells was significantly increased (P = 0.030; Fig. 20B) 
in CSC compared with SHC mice, indicates that the increased pituitary weight is 
mediated by hyperplasia. 
 
 
Figure 20: Effects of CSC on pituitary weight and pituitary cell number.  
Following decapitation on day 20 of CSC the pituitaries of SHC (n = 42) and CSC (n = 61) 
mice were removed and absolute pituitary weight [mg] was determined (A). The pituitary 
cells of one set of SHC (n = 6) and CSC (n = 14) mice were isolated and subsequently 
quantified (per ml) by means of a Cell Viability Analyser (B).  SHC;  CSC. Data 
represent the mean + SEM. * represent P < 0.05, ** represent P < 0.01 vs. respective 
SHC mice. [adapted from (Füchsl et al., B submitted)] 
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1.3 ACTH staining in the pituitary 
As only corticotroph cells are implicated in the regulation of the ACTH release, an 
IHC staining for ACTH in the pituitary was established in order to measure the 
percentage of ACTH positive tissue as well as the number of ACTH positive cells 
in the anterior pituitary. 
A statistically significant increase in the percentage (in relation to anterior 
pituitary tissue) of ACTH positive tissue (P = 0.019; Fig. 21A/C), as well as in the 
number of ACTH positive cells (P = 0.009; Fig. 21B/C) was found in CSC 
compared with SHC mice. This finding indicates that the newly built pituitary cells 
determined in Sec. 1.2 are corticotroph cells. 
 
 
C 
Figure 21: Effects of CSC on the percentage of ACTH positive tissue and on the 
number of ACTH positive cells. 
Following decapitation on day 20 of CSC the pituitaries of SHC (n = 6) and CSC (n = 6) 
mice were removed and cut on a cryostat and subsequently one series of cry-sections 
was stained with an antibody against ACTH. Per animal, three to six different sections 
were analysed and averaged for the percentage of ACTH positive anterior pituitary tissue 
in relation to the total tissue (C). Moreover, the number of ACTH positive pituitary cells [n] 
was counted in the same three to six digitized images and averaged per animal to 
provide individual means. (D).  SHC;  CSC. Data represent the mean + SEM. * 
represent P < 0.05, ** represent P < 0.01 vs. respective SHC mice. (C) Representative 
images of cryo-sections stained with antibody against ACTH depicting anterior and 
intermediate pituitary. [adapted from (Füchsl et al., B submitted)] 
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1.4 POMC mRNA and protein expression 
To get a hint if the newly built corticotroph cells are really functional and, 
therefore, able to produce ACTH, in a next step the mRNA and protein 
expression of the precursor of ACTH, namely POMC, was analysed.  
Statistical analysis revealed no differences between CSC and SHC mice 
regarding POMC mRNA (Fig. 22A) and protein (Fig. 22B/C) expression.  
 
 
Figure 22: Effects of CSC on POMC mRNA and protein expression in the pituitary. 
Following decapitation on day 20 pituitaries of both SHC and CSC mice were removed. 
RNA of SHC (n = 7) and CSC (n = 6) mice was extracted and reverse transcribed into 
cDNA for determination of mRNA expression [arbitrary units] for POMC via qPCR using 
TaqMan technology normalized to the mRNA expression of the housekeeping gene 
GAPDH (A). Protein was extracted from the pituitaries for determination of POMC 
expression [grey density] normalized to the loading control ß-Tubulin in SHC (n = 13) and 
CSC (n = 13) mice (B/C)  SHC;  CSC. Data represent the mean + SEM. * 
represents P < 0.05 vs. respective SHC mice. (C) Representative images of bands 
detected for POMC (~ 27 kDa), and respective loading control ß-Tubulin (~ 50 kDa) are 
shown for SHC and CSC mice. [adapted from (Füchsl et al., B submitted)] 
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1.5 CRH-R1 and AVPR-1b mRNA and protein expression  
Another important regulatory mechanism for the ACTH release at the level of the 
pituitary constitutes the expression of the CRH-R1 and AVPR-1b. Hence the 
expression pattern of both receptors was analysed, whereby also mRNA as well 
as protein was measured as it is known from the literature that both do not 
always correlate. 
While mRNA expression of CRH-R1 was comparable (Fig. 23A), protein 
expression was significantly reduced in CSC compared with SHC mice (P = 
0.029; Fig.23B/C). Both, mRNA (Fig 23D) and protein expression (Fig. 23E/F) 
expression of the AVPR-1b were not affected by CSC. The two bands detected 
for the AVPR-1b (Fig. 23F) represent the glycosylated and unglycosylated form 
of the receptor. 
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Figure 23: Effects of CSC on CRH-R1 and AVP-R1b mRNA and protein expression 
in the pituitary. 
Following decapitation on day 20 pituitaries of both SHC and CSC mice were removed. 
RNA of SHC (n = 7) and CSC (n = 6) mice was extracted and reverse transcribed into 
cDNA for determination of mRNA expression [arbitrary units] for CRH-R1 or AVP-R1b via 
qPCR using TaqMan technology normalized to the mRNA expression of the 
housekeeping gene GAPDH (A/D). Protein was extracted from the pituitaries for 
determination of of CRH-R1 (SHC: n = 9, CSC: n = 12; B/C) and AVPR-1b (SHC: n = 8, 
CSC: n = 20; E/F) protein expression [grey density] normalized to the loading control ß-
Tubulin.  SHC;  CSC. Data represent the mean + SEM. * represents P < 0.05 vs. 
respective SHC mice. Representative images of bands detected for CRH-R1 (~ 48 kDa; 
C) and AVP-R1b (~ 45 - 50 kDa; F) and respective loading control ß-Tubulin (~ 50 kDa; 
C/F) are shown for SHC and CSC mice. [adapted from (Füchsl et al., B submitted)] 
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2 Effects of 19 days of CSC on AVP and OXT expression in 
the PVN 
In a previous study, AVP and OXT mRNA (Reber and Neumann, 2008a) 
expression were already analysed, whereby the former one was found to be 
decreased while the latter one was unchanged following CSC exposure. To 
further extent the knockwledge about the expression of these two neuropeptides, 
an IHC staining was established in order to measure also the protein expression 
of AVP and OXT in the PVN, whereby the whole PVN was cut from rostral to 
caudal, in order to loose no informations, as there might probably be differences 
in the different layers of the PVN. The PVN slices were thereby assigned to four 
different regions (rostral, rostral-medial, medial-caudal, caudal) (see Fig.18).  
 
2.1 Number of AVP positive neurons in the PVN 
Two-way ANOVA considering the factors region (rostral, rostral-medial, medial-
caudal, caudal) as well as factor CSC only revealed significant effects for factor 
region in parvocellular (F1,55 = 19.886; P < 0.001; Fig. 24A) and magnocellular 
(F1,55 = 64.861; P < 0.001; Fig. 24B) AVP positive neurons. In detail, the number 
of AVP positive parvocellular and magnocellular neurons was significantly 
increased within the rostral-medial part of the PVN compared to the rostral 
(parvocellular: P = 0.037; magnocellular: P < 0.001), medial-caudal 
(parvocellular: P = 0.008; magnocellular: P < 0.001) and caudal part 
(parvocellular and magnocellular: P < 0.001). 
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Figure 24: Effects of CSC on the number of AVP positive neurons in the PVN. 
Following decapitation on day 20 of CSC brains were removed and immersed in fixative. 
One series of cryo-sections (5 – 7 sections per animal), containing the regions rostral, 
rostral-medial, medial-caudal and caudal was stained for AVP employing a free-floating 
approach. Number of parvocellular (A) and magnocellular (B) AVP positive neurons were 
counted within each region (1 – 2 sections per region) of the PVN and averaged per 
animal for SHC (n = 8 per region) and CSC (n = 7 – 8 per region).  SHC;  CSC. 
Data represent the mean + SEM. + represent P < 0.05, ++ represent P < 0.01, +++ 
represent P < 0.001 vs. rostral-medial region. (C) Representative image of cry-section 
stained for AVP in the PVN (magnification: 5 x; scale bar 50 µm). (D) Higher 
magnification (400 x) of the magnocellular (black arrow) and parvocellular (white arrow) 
AVP positive neurons depicted in the white frame of Figure 4D (scale bar 20 µm). 
[adapted from (Füchsl et al., B submitted)] 
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2.2 Number of OXT positive neurons in the PVN 
Two-way ANOVA considering the factors region (rostral, rostral-medial, medial-
caudal, caudal) as well as factor CSC only revealed significant effects for factor 
region (F1,54 = 28.019; P < 0.001; Fig. 25A). In detail, the number of OXT positive 
neurons was significantly increased within the rostral part of the PVN compared 
to the rostral-medial (P = 0.014.), medial-caudal (P < 0.001) and caudal part (P < 
0.001). 
 
Figure 25: Effects of CSC on the number of OXT positive neurons in the PVN. 
Following decapitation on day 20 of CSC brains were removed and immersed in fixative. 
One series of cryo-sections (5 – 7 sections per animal), containing the regions rostral, 
rostral-medial, medial-caudal and caudal was stained for OXT employing a free-floating 
approach. Number of OXT positive neurons (A) were counted within each region (1 – 2 
sections per region) of the PVN and averaged per animal for SHC (n = 7 - 8 per region) 
and CSC (n = 7 – 8 per region).  SHC;  CSC. Data represent the mean + SEM. + 
represent P < 0.05, ++ represent P < 0.01, +++ represent P < 0.001 vs. rostral region. (B) 
Representative image of cry-section stained for OXT in the PVN (magnification: 5 x). 
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3 Effects of 19 days of CSC on the negative feedback 
regulation at different levels 
Negative feedback inhibition plays an important role in regulating ACTH release 
from the HPA axis, whereby the pituitary, hippocampus, PVN, and PFC are 
mainly involved. To determine if there are alterations in the negative feedback 
following 19 days of CSC, GR and MR expression was analysed in the pituitary, 
hippocampus, PVN and PFC. In addition, a DST was performed, to specifically 
test the feedback of the pituitary under in vivo conditions. At the level of the 
hippocampus, first of all the hippocampus weight as well as the number of 
isolated hippocampal cells was determined, as this might be sensitive to the 
effects of chronic stress. In addition, hippocampal cells were isolated and the in 
vitro ability of CORT to induce hnRNA of a GC-responsive gene (Per1) and the 
cell viability of isolated hippocampal cells in response to 24 h of CORT 
stimulation in vitro were analysed. Furthermore, the expression of FKBP51, 
involved in the regulation of GR sensitivity and/or functionality was measured in 
the pituitary, hippocampus and PFC. Due to methological problems, GR 
expression in the nucleus in response to an acute stressor (6-min FS), as 
indicator for the translocation efficiency of the receptor could only be measured in 
the pituitary and not in the various brain regions.  
 
3.1 Analysis of the negative feedback at the level of the pituitary 
3.1.1 GR and MR mRNA and protein expression  
Statistical analysis revealed that under basal conditions GR mRNA (P = 0.01; 
Fig. 26A) as well as cytoplasmic protein expression (P = 0.011; Fig. 26B/C) were 
decreased in CSC compared with SHC mice. Moreover, while MR mRNA 
expression was comparable between CSC and SHC mice (Fig. 26D) MR protein 
expression (P = 0.014; Fig. 26E/F) was increased following CSC. 
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Figure 26: Effects of CSC on GR and MR mRNA and protein expression in the 
pituitary. 
Following decapitation on day 20 pituitaries of both SHC and CSC mice were removed. 
Afterwards, either RNA of SHC (n = 6) and CSC (n = 5) mice was extracted and reverse 
transcribed into cDNA for determination of GR and MR expression [arbitrary units] via 
qPCR using TaqMan technology normalized to the mRNA expression of the 
housekeeping gene GAPDH (A/D) or protein was extracted from the pituitaries of SHC 
(GR: n = 11; MR: n = 8) and CSC (GR: n = 10; MR: n = 7) mice for determination of GR 
and MR protein expression [grey density] normalized to the loading control ß-Tubulin 
(B/E).  SHC;  CSC. Data represent the mean + SEM. * represent P < 0.05 vs. 
respective SHC mice. Representative images of bands detected for GR (~ 86 kDa; C) or 
MR (~ 107 kDa; F) and respective loading control ß-Tubulin (~ 50 kDa; C/F) are shown 
for SHC and CSC mice. [adapted from (Füchsl et al., B submitted)] 
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3.1.2 Dexamethasone suppression test (DST) 
To check if the reduced GR expression in the pituitary results in a diminished in 
vivo feedback inhibition, SHC and CSC were injected with Dex or vehicle. Four 
hours later they were exposed to 6-min FS and 10 min following termination of 
FS exposure, trunk blood was collected for plasma ACTH analysis. 
Plasma ACTH release during FS was dependent on both factor CSC (F1,42 = 7.18; 
P = 0.010) and factor treatment (F1,42 = 29.74; P < 0.001; Fig. 27). Post hoc 
analysis revealed an increased ACTH response to FS in vehicle-injected CSC 
compared with respective SHC mice (P = 0.002), an effect that was absent in 
Dex-blocked mice. Moreover, FS-induced ACTH release was significantly lower 
in Dex-blocked SHC (P = 0.018) and CSC (P < 0.001) mice compared with 
respective vehicle-injected mice. 
 
 
Figure 27: Effects of CSC on the plasma ACTH concentrations in trunk blood 
following DST. 
On day 20 of CSC, between 0700 and 0800 h, SHC and CSC mice were injected with 
vehicle or Dex (30 µg/kg, ip). Four hours later all animals were exposed to forced swim 
for 6 min. 10 min after termination of the acute stressor exposure all mice were 
decapitated and trunk blood was collected for determination of plasma ACTH [pg/ml] 
(SHC: n = 11; CSC: n= 12).  SHC;  CSC. Data represent the mean + SEM. ** 
represent P < 0.01 vs. respective SHC mice; # represent P < 0.05, ### represent P < 
0.001 vs. respective vehicle group. [adapted from (Füchsl et al., B submitted)] 
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3.1.3 FKBP51 protein expression  
Pituitary FKBP51 protein expression was significantly increased in CSC 
compared with SHC mice (P = 0.006; Fig. 28A/B).  
 
 
Figure 28: Effects of CSC on FKBP51 protein expression in the pituitary. 
Following decapitation on day 20 of CSC pituitaries of both SHC (n = 13) and CSC (n = 
13) mice were removed for protein extraction and subsequent determination of FKBP51 
protein expression [grey density] normalized to the loading control ß-Tubulin (A).  SHC; 
 CSC. Data represent the mean + SEM. ** represents P < 0.01 vs. respective SHC 
mice. (B) Representative images of bands detected for FKBP51 (~51 kDa) and the 
loading control ß-Tubulin (~ 50 kDa) are shown for SHC and CSC mice. [adapted from 
(Füchsl et al., B submitted)] 
 
3.1.4 GR protein expression in the nuclear fraction  
For measurement of the GR protein expression in the nucleus, SHC and CSC 
mice were exposed to 6-min FS and 10 min following termination of the acute 
stressor exposure, mice were decapitated and pituitaries were removed.  
Pituitary GR expression in the nucleus after 6-min FS exposure was similar in 
SHC and CSC mice (Fig. 29A/B).  
 
98  CHAPTER 3 – RESULTS 
  
 
 
Figure 29: Effects of CSC GR nuclear protein expression in the pituitary following 
acute stress (6-min FS). 
On day 20, SHC and CSC mice were exposed to 6 min FS and decapitated 10 min 
following FS exposure and pituitaries were removed. Afterwards nuclear protein was 
extracted from the pituitaries of SHC (n = 5) and CSC (n = 5) mice for determination of 
nuclear GR protein expression [grey density] normalized to the loading control TATA 
binding protein (A/B).  SHC;  CSC. Data represent the mean + SEM. Representative 
images of bands detected for nuclear GR (~ 86 kDa) and the loading control TATA 
binding protein (~36 kDa) are shown for SHC and CSC mice (B).  
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3.2 Analysis of the negative feedback at the level of the hippocampus 
3.2.1 Absolute hippocampus weight and number of hippocampal cells 
Statistical analysis revealed that CSC had no effect on the absolute hippocampus 
weight [mg] (Fig. 30A) as well as on the number of isolated hippocampal cells 
(Fig. 30B). 
 
 
Figure 30: Effects of CSC on hippocampus weight and on hippocampal cell 
number. 
Following decapitation on day 20 of CSC the left and right hippocampus of SHC (n = 20) 
and CSC (n = 27) mice were removed and weighed. Depicted is the absolute weight [mg] 
of the left and right hippocampus (sum of both, A). The hippocampal cells of SHC (n = 33) 
and CSC (n = 34) mice were isolated and subsequently quantified (per ml) by means of a 
Cell Viability Analyser (B).  SHC;  CSC. Data represent the mean + SEM.  
 
3.2.2 GR and MR mRNA and protein expression  
Statistical analysis revealed a decrease in GR mRNA (P = 0.011; Fig. 31A) and 
protein (P = 0.023; Fig 31B/C) expression in the hippocampus of CSC compared 
with SHC mice. In contrast, MR mRNA (Fig. 31D) and protein expression (Fig 
31E/F) were not affected by CSC exposure.  
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Figure 31: Effects of CSC on hippocampal GR and MR mRNA and protein 
expression. 
Following decapitation on day 20 hippocampi of both SHC and CSC mice were removed. 
Afterwards, either RNA (A, D) of SHC (n = 13) and CSC (n = 19) mice was extracted and 
reverse transcribed into cDNA for determination of GR and MR mRNA expression 
[arbitrary units] via qPCR using TaqMan technology normalized to the mRNA expression 
of the housekeeping gene GAPDH (A/D) or protein (B, C, E, F) was extracted from the 
hippocampi of SHC (GR: n = 9; MR: n = 6) and CSC (GR: n = 7; MR: n = 6) mice for 
determination of GR (B/C) and MR (E/F) protein expression [grey density] normalized to 
the loading control ß-Tubulin  SHC;  CSC. Data represent the mean + SEM. * 
represent P < 0.05 vs. respective SHC mice. Representative images of bands detected 
for GR (~ 86 kDa; C) or MR (~ 107 kDa; F) and respective loading control ß-Tubulin (~ 50 
kDa; C/F) are shown for SHC and CSC mice. 
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3.2.3 FKBP51 protein expression  
Statistical analysis revealed that FKBP51 protein expression in the hippocampus 
(Fig. 32A/B) was not affected in CSC mice. 
 
 
Figure 32: Effects of CSC on FKBP51 protein expression in the hippocampus. 
Following decapitation on day 20 hippocampi of both SHC (n = 8) and CSC (n = 8) mice 
were removed and protein was extracted for determination of FKBP51 protein expression 
[grey density] normalized to the loading control ß-Tubulin (A/B).  SHC;  CSC. Data 
represent the mean + SEM. (B) Representative images of bands detected for FKBP51 (~ 
51 kDa) and the loading control ß-Tubulin (~ 50 kDa) are shown for SHC and CSC mice. 
 
3.2.4 Per1 hnRNA expression in hippocampal cells in vitro 
In vitro stimulation of hippocampal cells with two different CORT concentrations 
in order to stimulate Per1 hnRNA expression revealed a significant effect of both 
factor CSC (F1,50 = 9.34; P = 0.004) and factor CORT (F 2,50 = 16.67; P < 0.001; 
Fig. 33). Post hoc analysis indicated a significant increase of Per1 hnRNA in 
response to 0.1 µM (P = 0.023) and 100 µM (P < 0.001) CORT compared with 
basal conditions in CSC mice. Hippocampal cells of SHC mice showed a 
significant increase of Per1 hnRNA expression in response to 100 µM (P = 0.049) 
and a trend towards an increase in response to 0.1 µM (P = 0.063) CORT 
compared with basal conditions. Moreover, Per1 hnRNA expression was higher 
in hippocampal cells from CSC compared with SHC mice when stimulated with 
100 µM CORT (P = 0.004). 
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Figure 33: Effects of CSC on CORT-mediated increase in Per1 hnRNA expression in 
hippocampal cells in vitro. 
Following decapitation on day 20 hippocampi of SHC and CSC mice were removed and 
hippocampal cells were isolated. 7 x 105 hippocampal cells were stimulated with vehicle 
(basal, SHC and CSC: n = 14), 0.1 µM (SHC and CSC: n = 7) or 100 µM CORT (SHC 
and CSC: n = 7) for 30 min. Afterwards, RNA of the cells was extracted and reverse 
transcribed into cDNA for determination of Per1 hnRNA [arbitrary units] via qPCR using 
TaqMan technology normalized to the mRNA expression of the housekeeping gene 
GAPDH (A).  SHC;  CSC. Data represent the mean + SEM. ** represent P < 0.01 
vs. respective SHC mice; # represent P < 0.05; ### represent P < 0.001 vs. respective 
basal; (#) represent a trend vs. respective basal. B Representative image of the Cell 
Viability analyser showing living hippocampal cells (thin black arrow) and a dead cell 
(bold black arrow). 
 
3.2.5 Hippocampal cell viability in response to corticosterone (CORT) 
stimulation 
Hippocampal cell viability in response to 24 h in vitro stimulation with different 
CORT concentrations was dependent on the interaction of factors CSC and 
CORT (F5,223 = 3.35; P = 0.006; Fig. 34). Post hoc analysis revealed that in CSC 
mice 1 µM and 10 µM CORT and in SHC mice 100 µM CORT increase the cell 
viability compared with respective basal conditions. The highest CORT 
concentration (1000 µM) decreased cell viability in hippocampal cells of CSC 
mice compared with basal (P = 0.007) and also compared with those of 
respective SHC mice (P = 0.005).  
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Figure 34: Effects of CSC on CORT-induced changes in hippocampal cell viability 
in vitro. 
Following decapitation on day 20 hippocampi of SHC and CSC mice were removed and 
cells were isolated. 2 x 105 hippocampal cells were stimulated with vehicle (basal: SHC: 
n = 36; CSC: n = 36) or different CORT concentrations (0.1 µM (SHC: n = 10; CSC: n = 
9); 1 µM (SHC: n = 10; CSC: n = 9); 10 µM (SHC: n = 10; CSC: n = 9); 100 µM (SHC: n 
= 26; CSC: n = 27); 1000 µM (SHC: n = 26; CSC: n = 27)] over24 h and subsequently 
cell viability [absorbance] was assessed via a commercially available cell proliferation 
assay (A).  SHC;  CSC. Data represent the mean + SEM. * represent P < 0.05 vs. 
respective SHC mice; # represent P < 0.05; ### represent P < 0.001 vs. respective 
basal. B Representative image of wells containing substrate of the proliferation assay 
and cells (red, 1) or substrate of the proliferation assay without cells (only medium; 
yellow, 2). 
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3.3 Analysis of the negative feedback at the level of the PVN 
Statistical analysis revealed that GR (Fig. 35A/C) as well as MR (Fig. 35B/D) 
protein expression in the PVN were not changed following CSC exposure. 
 
 
Figure 35: Effects of CSC on GR and MR protein expression in the PVN. 
Following decapitation on day 20 brains of both SHC and CSC mice were removed and 
PVN tissue was punched out. Afterwards, protein was extracted from PVN punches for 
determination of GR (SHC: n= 11; CSC: n= 11; A/C) and MR (SHC: n= 7, CSC: n = 10; 
B/D) protein expression [grey density] normalized to the loading control ß-Tubulin.  
SHC;  CSC. Data represent the mean + SEM. Representative images of bands 
detected for GR (~ 86 kDa; C) and MR (~ 107 kDa; D) and the loading control ß-Tubulin 
(~ 50 kDa C/D) are shown for SHC and CSC mice. 
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3.4 Analysis of the negative feedback at the level of the PFC 
3.4.1 GR and MR protein expression  
Statistical analysis revealed GR (P = 0.031; Fig. 36A/C) as well as MR (P = 
0.003; Fig. 36B/D) protein expression in the PFC were increased in CSC 
compared with SHC mice. 
 
 
Figure 36: Effects of CSC on GR and MR protein expression in the PFC. 
Following decapitation on day 20 brains were removed and the PFC was dissected of 
both SHC and CSC mice. Afterwards, protein was extracted for determination of GR 
(SHC and CSC: n = 18; A/C) and MR (SHC and CSC: n = 17; B/D) protein expression 
[grey density] normalized to the loading control ß-Tubulin.  SHC;  CSC. Data 
represent the mean + SEM. * represent P < 0.05, ** represent P < 0.01 vs. respective 
SHC mice Representative images of bands detected for GR (~ 86 kDa; C), MR (~ 107 
kDa, D) and the loading control ß-Tubulin (~ 50 kDa C/D) are shown for SHC and CSC 
mice. 
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3.4.2 FKBP51 protein expression 
Statistical analysis revealed that FKBP51 protein expression in the PFC was 
increased in CSC compared with SHC mice (P = 0.015; Fig. 37). 
 
 
Figure 37: Effects of CSC on FKBP51 protein expression in the PFC. 
Following decapitation on day 20 brains were removed and the PFC was dissected of 
both SHC (n = 16) and CSC (n = 17) mice. Afterwards, protein was extracted for 
determination of FKBPy51 protein expression [grey density] normalized to the loading 
control ß-Tubulin (A/B).  SHC;  CSC. Data represent the mean + SEM. * represent P 
< 0.05 vs. respective SHC mice. (B) Representative images of bands detected for 
FKBP51 (~ 51 kDa) and the loading control ß-Tubulin (~ 50 kDa) are shown for SHC and 
CSC mice. 
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4 Influence of trait anxiety on the consequences of 19 days 
of CSC 
 
To assess whether the genetic predisposition of high versus low anxiety-related 
behaviour determines the vulnerability to the consequences of chronic 
psychosocial stress, mHAB, mNAB and mLAB mice were either exposed to 19 
days of CSC or kept as control (SHC) mice. First of all, SHC and CSC mice of all 
three genotypes were tested on the EPM (on day 19 of CSC) to determine the 
breeding line-specific as well as the chronic stress-induced consequences on 
anxiety-related behaviour. The next day, effects of CSC on physiological, 
neuroendocrine and immunological parameters were determined under basal 
conditions. This included assessement of the body weight gain as well as adrenal 
and spleen weight, measurement of plasma ACTH and CORT concentrations, in 
vitro adrenal CORT secretion in response to ACTH, GR, MR and FKBP51 protein 
expression in the pituitary, IFN-γ secretion from isolated mesLNC in response to 
anti-CD3 stimulation, and the histological damage score of the colon. 
 
4.1 Anxiety-related behaviour on the EPM 
The percentage of time spent on the open arm of the EPM was found to be 
dependent on the interaction of factors genotype and CSC (F2,46 = 14.75; P < 
0.001; Fig. 38A). Post hoc analysis revealed an effect of CSC on anxiety-related 
behaviour only in mNAB mice which spent significantly less time on the open arm 
compared with respective SHC mNAB mice (P < 0.001). In contrast, CSC 
exposure did not alter anxiety-related behaviour in the mHAB and mLAB groups. 
Line-dependent differences in anxiety could be confirmed, as both SHC and CSC 
mice in the mLAB group spent significantly more time on the open arm compared 
to respective mice in the mNAB (P < 0.001) and mHAB groups (P < 0.001), and 
mNAB SHC mice further spent significantly more time on the open arm compared 
to the respective mice in the mHAB group (P < 0.001).  
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The percentage of entries into the open arm was found to be dependent on the 
interaction of factors genotype and CSC (F2,46 = 3.82; P = 0.029; Fig. 38B). Post 
hoc analysis revealed that CSC mice showed a decreased percentage of open 
arm entries compared with SHC mice in the mNAB (P = 0.045), but not in the 
mHAB and mLAB groups. Moreover, CSC mice in the mLAB group showed a 
significantly higher percentage of open arm entries compared with respective 
mice in the mHAB (P < 0.001) and mNAB groups (P < 0.001). Line-dependent 
differences were confirmed as SHC mice of the mNAB and mLAB group showed 
a higher percentage of open arm entries compared to respective mice in the 
mHAB group (P < 0.001). 
Full entries into the open arms as additional indicative of anxiety-related 
behaviour were also found to be dependent on the interaction of factors genotype 
and CSC (F2,46 = 3.80; P = 0.030; Fig. 38C). Post hoc analysis revealed that CSC 
mice showed less full entries compared with SHC mice in the mNAB (P = 0.004), 
but not in the mHAB and mLAB group. Again, line-dependent differences were 
confirmed as both SHC and CSC mice in the mLAB group showed more full 
entries compared to respective mice in the mNAB (SHC: P = 0.010; CSC: P < 
0.001) and mHAB (P < 0.001) groups, and mNAB SHC mice showed a higher 
number of full entries compared to mHAB SHC mice (P = 0.002).  
The number of entries into the closed arms, indicative of locomotor activity, was 
not affected by CSC exposure (Fig. 38D). However, a genotype effect (F2,46 = 
5.45; P = 0.007) was found, with SHC mice of the mLAB group showing less 
closed arm entries compared to respective mice of the mHAB group (P = 0.002).  
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Figure 38: Genotype specific effects of CSC exposure on anxiety-related behaviour. 
To assess chronic psychosocial stress effects on anxiety-related behaviour, SHC (mHAB 
(n = 9); mNAB (n = 10); mLAB (n = 9)) and CSC (mHAB (n = 8); mNAB (n = 9); mLAB (n 
= 7)) were exposed to the elevated plus-maze (EPM) on day 19 of CSC. Data show the 
% of time on open arms (OA; A), the % of entries on OA (B), the number of full OA 
entries [n] (C) and the number of entries into closed arms (CA) (D). Symbols indicating 
significant differences are only shown for effects between SHC and CSC. For significant 
within-group differences see detailed information given in the results.  SHC;  CSC. 
Data represent the mean + SEM. * represent P < 0.05, ** represent P < 0.01, *** 
represent P < 0.001vs. respective SHC mice. [adapted from (Füchsl et al., A submitted)] 
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4.2 Assessement of physiological parameters 
Body weight gain 
The body weight gain during CSC was also dependent on the interaction of 
factors genotype and CSC (F2,46 = 4.25; P = 0.02; Fig. 39A). Post hoc analysis 
revealed that mLAB CSC mice gained significantly more body weight compared 
with respective SHC mice (P = 0.005), as well as compared with CSC mice in the 
mHAB (P = 0.006) and mNAB (P = 0.034) groups.  
 
Absolute adrenal weight 
Two-way ANOVA revealed that absolute adrenal weight was dependent on factor 
CSC (F1,45 = 9.27; P = 0.004) and factor genotype (genotype: F2,45 = 37.01; P < 
0.001; Fig. 39B). In detail, CSC caused an increase in absolute adrenal weight in 
the mNAB (P = 0.043) and mHAB (P = 0.007), but not mLAB group when 
compared with respective SHC mice. With respect to line-difference, adrenal 
weight of both SHC and CSC mNAB mice was higher compared with respective 
mHAB (SHC and CSC: P < 0.001) and mLAB (SHC: P = 0.005; CSC: P < 0.001) 
mice and adrenal weight of mLAB SHC mice was increased compared with 
respective mHAB mice (P = 0.008). 
 
Absolute spleen weight 
Absolute spleen weight was found to be dependent on the interaction of factors 
CSC and genotype (F2,20 = 3.67; P = 0.044; Fig. 39C). Post hoc analysis revealed 
that CSC significantly (mNAB: P < 0.001) or by trend (mHAB: P = 0.059) 
increased absolute spleen weight in the mNAB and mHAB, but not in mLAB, 
groups when compared with respective SHC mice (P < 0.001). Moreover, 
absolute spleen weight in mLAB SHC was higher than in respective mHAB (P < 
0.001) and mNAB (P < 0.001) mice as was spleen weight in mLAB CSC 
compared with mHAB CSC mice (P = 0.011) and, by trend, with mNAB CSC 
mice (P = 0.051). 
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Figure 39: Genotype specific effects of CSC exposure on body weight gain, adrenal 
and spleen weight. 
 
Before being killed by decapitation on day 20 of CSC between 0800 and 1000 h, body 
weight was assessed in SHC (mHAB (n = 10); mNAB (n = 10); mLAB (n = 9) and CSC 
(mHAB (n = 7)); mNAB (n = 9); mLAB (n = 7)) mice and body weight gain between day 1 
and 20 was calculated (A). Afterwards, left and right adrenal glands were removed, 
pruned of fat and weight separately. Depicted is the absolute weight [mg] of the left and 
right adrenal glands (sum of both) of SHC (mHAB (n = 10); mNAB (n = 9); mLAB (n = 9)) 
and CSC (mHAB (n = 8); mNAB (n = 8); mLAB (n = 7)) mice (B). Spleens of SHC (mHAB 
(n = 5); mNAB (n = 5); mLAB (n = 4)) and CSC (mHAB (n = 4); mNAB (n = 4); mLAB (n = 
4)) mice were also removed, pruned of fat and weighed (C). Symbols indicating 
significant differences are only shown for effects between SHC and CSC. For significant 
within-group differences see detailed information given in the results.  SHC;  CSC. 
Data represent the mean + SEM. * represent P < 0.05, ** represent P < 0.01, *** 
represent P < 0.001vs. respective SHC mice, (*) represent a trend vs. respective SHC 
mice. [adapted from (Füchsl et al., A submitted)]  
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4.3 Assessement of neuroendocrine parameters 
4.3.1 Plasma CORT and ACTH concentrations 
Plasma ACTH concentrations 
Basal plasma ACTH concentrations were only found to be dependent on factor 
CSC (F1,45 = 8.57; P = 0.005; Fig. 40A) with CSC mHAB mice showing increased 
plasma ACTH concentrations compared with respective SHC (P = 0.003) mice. 
CSC exposure did not alter plasma ACTH in mNAB and mLAB mice.  
 
Plasma CORT concentrations 
Plasma morning CORT concentrations were also dependent on the interaction of 
factors genotype and CSC (F2,43 = 6.04; P = 0.005; Fig. 40B). Post hoc analysis 
revealed that CSC only reduced plasma CORT concentrations in mNAB mice (P 
= 0.001 versus SHC), but not in the mHAB and mLAB groups. Moreover, plasma 
CORT concentrations of mNAB SHC mice were higher compared with those of 
SHC mice in the mHAB (P < 0.001) and mLAB (P = 0.001) groups, but no 
significant difference was found between mHAB and mLAB SHC mice. 
 
Plasma CORT:ACTH ratio 
Statistical analysis revealed that the plasma CORT:ACTH ratio was only 
dependent on factor CSC (F1,42 = 9.53; P = 0.004; Fig. 40C) with CSC compared 
with SHC mice showing a significantly (mNAB: P = 0.027) or by trend (mHAB: P 
= 0.061) reduced plasma CORT:ACTH ratio in the mHAB and mNAB, but not in 
the mLAB, groups.  
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Figure 40: Genotype specific effects of CSC exposure on basal morning plasma 
ACTH and CORT concentrations in trunk blood. 
Following decapitation on day 20 of CSC between 0800 and 1000 h, basal morning 
plasma ACTH [pg/ml] (A) and plasma CORT [ng/ml] (B) concentrations were determined 
in trunk blood of SHC (ACTH: mHAB (n = 10); mNAB (n = 10); mLAB (n = 9); CORT: 
mHAB (n = 10); mNAB (n = 9); mLAB (n = 9)) and CSC (ACTH: mHAB (n = 8); mNAB (n 
= 7); mLAB (n = 7); CORT: mHAB (n = 7); mNAB (n = 7); mLAB (n = 7)) mice in the 
mHAB, mNAB and mLAB groups. Moreover, the plasma CORT : ACTH ratio was 
calculated for each mouse and averaged per treatment group (SHC: mHAB (n = 10); 
mNAB (n = 9); mLAB (n = 9); CSC: mHAB (n = 7); mNAB (n = 6); mLAB (n = 7); C). 
Symbols indicating significant differences are only shown for effects between SHC and 
CSC. For significant within-group differences see detailed information given in the results. 
 SHC;  CSC. Data represent the mean + SEM. * represent P < 0.05, ** represent P 
< 0.01 vs. respective SHC mice, (*) represent a trend vs. respective SHC mice. [adapted 
from (Füchsl et al., A submitted)] 
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4.3.2 Adrenal in vitro ACTH responsiveness 
In vitro CORT secretion during the stimulation of adrenal explants with ACTH 
(100 nM) was dependent on the interaction of factors genotype and ACTH (F2,40 = 
16.33; P < 0.001; Fig. 41). Post hoc analysis revealed that in response to ACTH, 
a significant increase in CORT release was found in SHC mice of all three 
genotypes (mNAB: P = 0.001; mHAB: P = 0.028; mLAB: P < 0.001) when 
compared with basal conditions. In contrast, ACTH-induced increase in CORT 
secretion in CSC mice was seen only in the mLAB (P < 0.001 versus basal), but 
not in the mHAB and mNAB group. Moreover, ACTH-stimulated CORT secretion 
was significantly higher in both SHC and CSC mice of the mLAB group compared 
with respective mice of both the mHAB (SHC and CSC: P < 0.001) and mNAB 
(SHC: P = 0.046; CSC: P < 0.001) group.  
 
 
Figure 41: Genotype specific effects of CSC exposure on in vitro adrenal CORT 
secretion in response to ACTH. 
Following decapitation on day 20 of CSC between 0800 and 1000 h, left and right adrenal 
glands were removed, pruned of fat and weighed separately. Afterwards, left and right 
adrenal glands were cut into two halves each. These halves of SHC (mHAB, mNAB: n = 
5; mLAB: n = 4) and CSC (n = 4) mice were weighed again and incubated with medium 
containing either saline (basal) or 100 nM ACTH for 6 h. Afterwards, CORT 
concentrations [ng/ml/mg tissue] were determined in the supernatants. Symbols 
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indicating significant differences are only shown for effects between basal and ACTH 
values. For significant within-group differences see detailed information given in the 
results.  SHC;  CSC. Data represent the mean + SEM. $ represent P < 0.05, $$ 
represent P < 0.01, $$$ represent P < 0.001 vs. respective basal values. [adapted from 
(Füchsl et al., A submitted)] 
 
 
4.4 Assessement of immunological parameters 
IFN-γ secretion from isolated and anti-CD3-stimulated mesenteric lymph 
node cells (mesLNC) 
To determine genotype-specific effects of CSC on the IFN-γ secretion from anti-
CD3-stimulated mesLNC, mesLN from all 4 – 5 mice of each treatment group per 
experiment were pooled before isolation of mesLNC. IFN-γ concentrations of 
each single pool (2 pools per treatment group, as the experiment has been 
repeated) as well as the respective mean (both in pg/ml) are depicted in Figure 
42A. Although proper statistical analysis has not been performed due to the low 
number of pools per treatment group (n = 2), our data indicate that CSC caused 
an increase in IFN-γ secretion from isolated and anti-CD3-stimulated mesLNC 
compared with SHC mice in the mHAB (SHC: 80 + 20 pg/ml; CSC: 2071 + 1375 
pg/ml) and NAB (SHC: 178 + 31 pg/ml; CSC: 743 + 164 pg/ml), but not the mLAB 
(SHC: 96 + 22 pg/ml; CSC: 122 + 5 pg/ml), group.  
 
Histological damage score of the colon  
The histological damage score was neither affected by factor CSC nor by factor 
genotype (Fig. 42B). 
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Figure 42: Genotype specific effects of CSC exposure on the anti-CD3-stimulated 
IFN-γ secretion from isolated mesenteric lymph node cells and on the histological 
damage score. 
In each experiment (experiment 1 and 2) mice were decapitated on day 20 of CSC 
between 0800 and 1000 h. Afterwards, mesenteric lymph node cells were isolated and 
pooled per treatment group (one pool per experiment) for assessment of anti-CD3-
induced IFN-γ secretion [pg/ml] (A). The respective means per treatment group are 
shown by bars; circles (SHC) and triangles (CSC) represent single pools of each 
experiment. Furthermore, the colon of each SHC (mHAB (n = 10); mNAB (n = 10); mLAB 
(n = 9)) and CSC (mHAB (n = 8); mNAB (n = 9); mLAB (n = 7)) mouse of experiment 1 
and 2 was removed, mechanically cleaned, rinsed, embedded in paraffin, and cut in 3 µm 
sections on a microtome. Afterwards all sections were stained with haematoxylin-eosin 
and histological scoring was performed (B).  SHC;  CSC. Data represent the mean + 
SEM. [adapted from (Füchsl et al., A submitted)] 
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4.5 GR, MR and FKBP51 protein expression in the pituitary 
GR (Fig. 43A) and MR (Fig. 43B) protein expression in the pituitary following 
CSC exposure were neither dependent of the factor genotype nor on the factor 
CSC. Only FKBP51 protein expression was dependent on the factor genotype 
(F2,20 = 4.14; P = 0.031; Fig. C). Post hoc analysis revealed that in mNAB CSC 
mice, FKBP51 was significantly higher expressed compared with respective 
mHAB mice (P = 0.033). 
 
 
 
Figure 43: Genotype specific effects of CSC exposure on GR, MR and FKBP51 
protein expression in the pituitary. 
Following decapitation on day 20 of CSC pituitaries of both SHC and CSC mice were 
removed for protein extraction and subsequent determination of GR (SHC: n = 5, CSC: n 
= 4; A), MR (SHC: mNAB and mLAB (n = 5), mHAB (n = 4), CSC: n = 4; B) and FKBP51 
(SHC: n = 5, CSC: n = 4; C) protein expression [grey density] normalized to the loading 
control ß-Tubulin.  SHC;  CSC. Data represent the mean + SEM.  
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1 Effects of CSC on HPA axis functionality – a closer look 
at the level of the pituitary and PVN  
1.1 Do adaptations at the level of the pituitary contribute to changes 
in HPA axis functionality following CSC? 
The acute stress response, i.e. the activation of the SNS and the HPA axis, 
represents an adaptive and beneficial mechanism, promoting the survival of an 
organism. In contrast, prolonged activation of these stress systems under 
conditions of chronic stressor exposure can have deleterious effects on the body, 
contributing to the development of somatic as well as affective disorders 
(McEwen, 1998a; Chrousos and Kino, 2009). Therefore, to protect the organism 
from the consequences of prolonged or repeated stimulation with the same 
(homotypic) stressor, which is not life threatening, a process called adaptation is 
of major importance. This was shown in human (Kirschbaum et al., 1995; 
Schommer et al., 2003) as well as in animal studies (De Boer et al., 1988; 
Dobrakovova et al., 1993). However a process called sensitization enables the 
organism to respond to a subsequent acute heterotypic and probably dangerous 
stressor with an enhanced HPA axis response (Aguilera, 1994).  
Such processes of adaptation and sensitization were also shown to occur in mice 
exposed to chronic psychosocial stress induced by the CSC paradigm. Thereby, 
especially the adrenal glands seem to play a major role (Uschold-Schmidt et al., 
2012; Füchsl et al., 2013). Nevertheless, given that also other levels of the HPA 
axis might be involved in the prozess of adaptation/sensitization, the first aim of 
my thesis was to test the hypothesis that also pituitary mechanisms are involved 
in the observed HPA axis processes seen following 19 days of CSC.  
In contrast to a desensitized HPA axis response to many repeated or chronic 
physiological and psychological stress paradigms (Hauger et al., 1990; Aguilera, 
1994; Zelena et al., 2003), mice exposed to 19 days of CSC displayed increased 
basal plasma ACTH concentrations in the morning, even though plasma CORT 
levels were unchanged at that time of the day (Reber et al., 2007; Uschold-
Schmidt et al., 2012), which gives further insight into the adrenal functionality and 
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ACTH sensitivity. Under in vitro conditions, enlarged adrenals showed a reduced 
responsiveness to ACTH stimulation following CSC exposure (Reber et al., 2007; 
Uschold-Schmidt et al., 2012). This could now also be demonstrated under in 
vivo conditions, as increased plasma ACTH levels were not paralleled by 
enhanced CORT levels. This adrenal ACTH insensitivity during/following CSC 
exposure might be beneficial in terms of protecting the body from increased 
CORT levels one would normally expect regarding the increased adrenal weight 
and ACTH levels. Interestingly, in a recently published study, me and colleagues 
could show that hyperplasia of adrenal cortical cells goes along with an 
enhanced availability and also capability to mobilize cholesterol in CSC mice 
(Füchsl et al., 2013), demonstrating that adrenals are still functional and, in case 
of normal ACTH responsiveness, probably would produce and secret more 
CORT than normally needed, resulting in hypercorticism. 
In addition, ACTH release in response to a subsequent heterotypic stressor (6-
min of FS) was exaggerated in CSC compared with SHC mice, indicating not only 
a hyper-activity under basal but also a hyper-reactivity of the pituitary following 
acute stressor exposure. This facilitation of the ACTH response to this novel 
superimposed stressor is in line with other chronic stress studies (Hauger et al., 
1990; Bhatnagar and Vining, 2003) but in contrast to our own recent data 
showing increased plasma CORT and similar plasma ACTH levels 5 min 
following termination of a 5-min EPF exposure (Uschold-Schmidt et al., 2012). 
This might be due to the fact that the type of acute stressor as well as the 
temporal study design differed between the two studies. Given that plasma ACTH 
levels following FS were 5 – 10 times higher compared with those following EPF 
exposure clearly indicates that FS represents a much more severe stressor. The 
second main difference is the time span that elapsed between acute stressor 
exposure and plasma sampling. While mice in the Uschold-Schmidt study (2012) 
were killed only 5 min after termination of the EPF exposure, in the present study 
10 min elapsed. The comparison of both studies suggests that the increased 
plasma ACTH response to an acute heterotypic stressor following CSC exposure 
needs a certain time and/or stressor intensity to develop. Unfortunately, due to 
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methological limitations, repeated assessement of plasma ACTH levels following 
acute stressor exposure in order to get more information about the ACTH release 
over the time is not possible in mice.  
Overall, measurement of plasma CORT and ACTH levels under chronic and 
subsequent heterotypic stressor exposure in previous studies and the present 
thesis indicate that the adaptation to the chronic stressor is mainly achieved at 
the level of the adrenal gland (Uschold-Schmidt et al., 2012). This mechanism 
protects the body from high CORT levels one would normally expect regarding 
the pituitary hyper-activity and adrenal enlargement. Moreover, the process of 
facilitation/sensitization of the HPA axis response to an acute heterotypic stressor 
seems to be realized by the interplay of adrenal (Uschold-Schmidt et al., 2012; 
Füchsl et al., 2013) and pituitary mechanisms.  
One intention of the present thesis was, therefore, to unravel the mechanisms 
underlying the increased pituitary activity under basal as well as re-activity 
following acute heterotypic stressor exposure in CSC compared with SHC mice.  
 
1.2 Are increased plasma ACTH levels mediated by the pituitary? 
The increased pituitary weight on day 28 of CSC, i.e. 8 days after termination of 
the CSC exposure (Slattery et al., 2012) gives a first hint how the increased 
plasma ACTH levels in CSC mice might be mediated. Also on day 20 of CSC I 
was able to confirm the enlargement of the pituitary which is already an important 
finding per se, demonstrating that the CSC-induced effects are reliable and long-
lasting. An increased number of isolated pituitary cells and, most importantly, 
corticotroph pituitary cells in CSC compared with SHC mice indicates that the 
increase in the pituitary weight is mediated by hyperplasia of ACTH producing 
cells. The latter was indicated by an increased percentage of ACTH positive 
pituitary tissue as well as number of ACTH positive cells in CSC compared with 
SHC mice. This finding is of importance, given that the pituitary consists of five 
major cell types (Yeung et al., 2006) in the anterior pituitary, whereby the 
corticotroph cells are characterized by the production and secretion of ACTH. 
There are only a few studies examining alterations of the pituitary morphology 
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following chronic stress or long-term GC administration. Chronic mild (placing 
rats in a plastic holder) or severe (restraining rats with limbs extended) 
immobilization (5 h/day, 7 days) resulted in an increase in the relative pituitary 
weight as well as in the number of ACTH-immunoreactive cells (Kapitonova et al., 
2010). Also ADX caused a sustained proliferation of corticotroph cells, probably 
mediated by AVP (Subburaju and Aguilera, 2007) while Dex administration in 
pregnant and lactating rats reduced the number of corticotroph cells in the 
offspring (Theogaraj et al., 2005). Nevertheless the increased number of ACTH 
positive cells in CSC compared with SHC mice together with unchanged relative 
(per mg pituitary tissue) POMC mRNA and protein expression strongly suggest 
that the newly formed corticotroph cells are fully functional and, therefore, 
mediate the increased basal and acute stressor-induced ACTH secretion in CSC 
mice.  
Together, these findings, i.e. the increased pituitary weight mediated by 
hyperplasia of corticotroph cells, suggest that the increased plasma ACTH levels 
in CSC mice might be the result of changes at the level of the pituitary. 
Nevertheless, one cannot exclude that the increased pituitary activity and re-
activity might in addition be mediated by an increased stimulatory input from the 
PVN, acting on AVPR-1b and CRH-R1, the two main ACTH secretagogue 
receptors. Unaffected CRH-R1 mRNA and decreased protein expression in CSC 
compared with SHC mice are in line with the described discrepancy between 
CRH-R1 mRNA and CRH binding (Aguilera et al., 2004) and also with the 
decreased expression found in chronic stress paradigms associated with an 
hyperresponsiveness to an acute heterotypic stressor (Kiss and Aguilera, 1993; 
Aguilera, 1994). These stress paradigms are also characterized by increased 
AVPR-1b expression, mediated by AVP, GC or other neuropeptides in the 
pituitary portal blood (Aguilera, 1994; Aguilera and Rabadan-Diehl, 2000b). 
However, this could not be confirmed following CSC exposure given that AVPR-
1b mRNA as well as protein expression were not affected. This might probably 
be due to the different type of stressors used or to differences in the release 
pattern of the factors mediating this increased expression. 
CHAPTER 4 - DISCUSSION  125 
 
 
Importantly, while the relationship between AVPR-1b expression and corticotroph 
responsiveness is supposed to correlate, this seems not to be the case for the 
CRH-R1 (Aguilera, 1994; Aguilera et al., 1994; Nikodemova et al., 2002). In 
chronically restraint rats, despite down-regulated CRH-R1 expression in the 
pituitary, the in vitro response to CRH was only partially diminished, while the 
ACTH release in vivo was not constrained at all (Hauger et al., 1988). 
Transferred to the results of the present thesis, this suggests that despite a 
decreased CRH-R1 protein expression, the response to CRH should be 
unchanged in CSC mice, which might also be the case in respone to AVP 
regarding the unchanged AVPR-1b mRNA and protein expression following CSC 
exposure. Together, these findings indicate that an increased receptor-mediated 
stimulation of pituitary cells seems, at the first glance, not to be responsible for 
the increased plasma ACTH levels following CSC exposure.  
However, the data of the relative receptor expression might also implicate, that 
the newly formed corticotroph cells preferentially express the AVPR-1b and not 
the CRH-R1 indicating a shift in the sensitivity from CRH to AVP following CSC 
exposure. This would be in line with other studies, assigning AVP an important 
role during chronic or prolonged stressor exposure (Ma et al., 1999). 
Nevertheless, to really confirm this hypothesis, further studies are needed. First 
of all, the ACTH release in pituitary explants or in isolated pituitary cells in 
response to different doses of CRH, AVP and the combination of both must be 
quantified in vitro. Moreover, the signalling pathways of both receptors should be 
checked by measurement of cAMP or IP3 release in response to CRH or AVP 
stimulation, respectively. In addition an IHC staining for the co-expression of 
proliferation markers with ACTH, AVPR-1b and CRH-R1 would give further 
insights into the exact receptor expression pattern.  
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1.3 Is there an influence of the PVN on the increased plasma ACTH 
secretion? 
Not only changes in receptor expression of the CRH-R1 and AVPR-1b might be 
implicated in an enhanced pituitary activity but also an increased stimulatory 
input due to an exaggerated production and/or release of the ACTH 
secretagogues. Based on the fact that the analysis of the AVPR-1b already 
suggested a more prominent role for AVP than for CRH on the ACTH secretion 
pattern following CSC, I decided to focus on the quantification of the number of 
AVP positive neurons in the PVN via IHC. 
Further support for the analysis of PVN AVP protein is provided by previous data, 
revealing a decrease in AVP mRNA expression in the PVN following CSC 
exposure (Reber and Neumann, 2008a). At least in the SON, a reduction in the 
mRNA level was shown to be the result of an increased mRNA turn over, 
resulting in increased AVP protein synthesis (Yoshii et al., 2008). Moreover, AVP 
has been shown to exert a mitogenic effect in a number of cell types, amongst 
others corticotroph cells (van Wijk et al., 1995; Aguilera et al., 2008), indicating 
that AVP might be implicated in mediating the increased number of corticotroph 
cells following CSC  
For the analysis of AVP protein expression, the PVN was divided into four 
different layers, namely the rostral, rostral-medial, medial-caudal and caudal part 
of the PVN (see also Fig. 18). Moreover, the analysis included the discrimination 
between magno- and parvocellular AVP positive neurons in the PVN, as 
magnocellular neurons are thought to be mainly involved in osmotic functions 
(Cunningham and Sawchenko, 1991), while parvocellular neurons are 
responsible for mediating the stress-induced effects (Rivier and Vale, 1983). This 
was done according to the literature (Ma and Aguilera, 1999; Kadar et al., 2010), 
whereby the criteria were staining intensity, localization pattern within the PVN 
and size. Magnocellular neurons were characterized by their larger size (~ > 14 
µm) and their higher AVP expression compared with parvocellular neurons.  
However, analysis of the magno- and parvocellular AVP containing neurons 
revealed no differences between SHC and CSC mice in any of the measured 
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regions, refuting the hypothesis of an increased involvement of AVP itself. The 
finding is at first glance also in contrast to other chronic or repeated stress 
studies, reporting an increase in AVP mRNA and/or protein synthesis and 
release (Ma and Lightman, 1998; Ma and Aguilera, 1999). Nevertheless, the 
experimental approach and the way in which the analysis of the AVP positive 
PVN neurons was performed seem to be in accordance with other studies. In 
detail, according to my analysis, it was evident that AVP neurons are mainly 
localized in the mid part of the PVN, which is also described in another study 
conducted in mice (Kadar et al., 2010).  
With respect to CRH, only mRNA data from previous studies are available, 
revealing no differences between SHC and CSC mice (Reber et al., 2007) and, 
therefore, indicate most likely no involvement of CRH in the increased ACTH 
release following CSC.  
Overall, the available data of CRH and AVP indicate that these neuropeptides 
are not involved in the enhanced pituitary activity and reactivity. However, to 
further reveal the role of the two peptides, secretion of AVP and CRH has to be 
measured by analysis of the peptide stores in the zona externa of the median 
eminence in future studies. Therefore, animals are administered a low, nontoxic 
amount of colchicine, which disrupts the axonal transport of the secretagogues 
from their production (PVN) to their release site (median eminence). 
Consequently the amount of peptide in the median eminence can be measured 
(Berkenbosch et al., 1989; De Goeij et al., 1992; Romero et al., 1993). 
Not only CRH and AVP, but also other hypothalamic factors, like OXT, can 
stimulate the ACTH release. OXT, at physiological concentrations stimulated 
ACTH release via mobilization of Ca2+ in pituitary cells in vitro (Link et al., 1992). 
Given that OXT receptors are only rarely expressed on corticotroph cells, the 
effect of OXT on ACTH secretion was shown to be mediated via the AVPR-1b 
(Schlosser et al., 1994). Regarding the CSC paradigm, in a previous study OXT 
mRNA expression was found to be unchanged at all time points measured during 
as well as at the end of the CSC (Reber and Neumann, 2008a). This was further 
supported by the finding of the present study indicating also no differences in the 
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number of OXT positive neurons in the PVN following CSC exposure. This 
finding indicates that an increased expression of OXT cannot account for the 
enhanced ACTH secretion following CSC exposure. Expression and release of 
OXT in response to chronic stress is only poorly investigated. Following chronic 
homotypic stressor exposure (restraint stress), an increase in the number of 
OXT-positive magnocellular neurons in the PVN (Zheng et al., 2010; Yoshimoto 
et al., 2012) and an increase in central OXT release was found (Babygirija et al., 
2012). OXT release was demonstrated in response to various acute stressors, 
like shaker stress (Nishioka et al., 1998) or FS (Wotjak et al., 1998) or Morris 
water maze testing (Engelmann et al., 2006), while SD elicited no increased OXT 
release in the PVN and SON (Wotjak et al., 1996). 
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2 Effects of CSC on the negative feedback inhibition at 
different levels 
Negative feedback inhibition of the HPA axis is another important regulatory 
mechanism, essential for the termination of the stress response. Alterations or 
especially a down-regulation of the negative feedback might be implicated in the 
increased basal as well as acute stress-induced plasma ACTH levels following 
CSC exposure and was, therefore, another key aspect of my thesis.  
The feedback, mediated via MR and GR, takes place at four major sites, i.e. in 
the pituitary, PVN, hippocampus, and PFC. As following CSC exposure a 
decreased GC sensitivity in peripheral cells, namely in splenocytes (Reber et al., 
2007) and in T helper 2 cells from peripheral lymph nodes (Schmidt et al., 2010b) 
was found, alterations in the negative feedback inhibition are not unlikely to 
occur. In addition, an increased pituitary weight in patients suffering from 
depression and psychosis (Garner et al., 2005; Pariante et al., 2005), is often 
associated with a decreased negative feedback inhibition which might also 
underlie Addison`s Disease, a disorder characterized by hyperplasia of 
corticotroph cells and adrenal insufficiency (McNicol and Carbajo-Perez, 1999). 
Therefore, I analysed, MR and GR mRNA and/or protein expression and to some 
extent also GR functionality at the different sites involved in the HPA axis 
feedback response. 
 
2.1. Effects of CSC on MR, GR and FKBP51 expression in different 
brain regions 
Hippocampus 
Chronic stressor exposure, like repeated restraint stress is associated with 
neuronal cell damage, indicated by neuronal atrophy and decreased dendritic 
branches in the hippocampus (Watanabe et al., 1992). Whether this neuronal 
atrophy also results in changes in the hippocampus weight or volume is only 
poorly investigated. One study could show via magnetic resonance imaging, that 
hippocampal volume in repeatedly restraint rats was decreased (Lee et al., 
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2009). Following CSC exposure, I could not detect any alterations in 
hippocampus weight as well as in the number of isolated hippocampal cells, 
whereby future studies are needed to clarify if other morphological changes, like 
loss of dendritic branching or if impairments in learning or memory took place. 
A decreased GR mRNA and protein expression in the hippocampus at first 
glance indicated an increased negative feedback function. A down-regulation of 
GR mRNA and protein in the hippocampus is well known in response to 
stimulation by its own ligand, as well as in response to chronic stressor exposure 
(Spencer et al., 1991; Makino et al., 1995; Kitraki et al., 1999). Since plasma 
CORT levels were only elevated on day 2 of the CSC procedure and returned to 
basal levels afterwards (Reber et al., 2007) CORT levels alone cannot be 
ascribed to this effect. This would support a study showing that GC are causative 
for a first decrease of the GR, but their availability is not necessary for a 
sustained down-regulation of the receptor (Kitraki et al., 1999). Therefore, also 
other factors, like neurotransmitters or catecholamines are discussed (Herman, 
1993; Tritos et al., 1999).  
While chronic SD exposure resulted in an increased FKBP51 expression in the 
hippocampus (Wagner et al., 2012) no changes in the FKBP51 expression were 
found following CSC exposure. However, it is not easy to draw conclusions from 
the FKBP51 expression data. The unchanged FKBP51 expression together with 
the decreased GR expression might on the one hand indicate a reduced GR 
sensitivity and/or functionality. On the other hand, an increased GR functionality 
and, therefore, transcriptional activity might be implicated in the sustained 
FKBP51 expression despite reduced receptor levels. The latter hypothesis would 
be supported by other studies showing that repeated stressor exposure did not 
affect GR affinity for GC despite a decreased receptor expression in the 
hippocampus (Sapolsky et al., 1984). Therefore, to examine potential functional 
alterations of the hippocampal GR in vitro, I analysed its ability to induce gene 
expression of a GC-responsive gene in isolated hippocampal cells and the 
hippocampal cell viability in response to CORT stimulation. Activation of GR in 
hippocampal slices with 100 nM CORT (~ 34 ng/ml CORT), a concentration 
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measured following acute FS exposure in the hippocampus of rats (Droste et al., 
2008), resulted in different transcriptional responses over time (Morsink et al., 
2006). Importantly, the hnRNA of the Per1 gene has been shown to be up-
regulated in the hippocampus 30 min after administration of CORT in rats 
(Conway-Campbell et al., 2010; Lightman and Conway-Campbell, 2010). In 
response to 0.1 µM (100 nM) CORT, a concentration were binding to the GR 
occurs (Karst and Joels, 2005), hippocampal cells of CSC mice showed a 
significant increase in Per1 hnRNA expression compared with vehicle stimulated 
cells, while only a trend towards an increase was found in SHC mice. Application 
of an extremely high CORT concentration (100 µM) increased Per1 hnRNA 
expression in SHC and to a much greater extent in CSC mice. Overall these data 
indicate that despite the decrease in hippocampal GR expression in CSC mice 
the receptor seems to even show an enhanced sensitivity and/or functionality 
regarding GC-mediated gene transcription.  
Prolonged exposure of hippocampal cells to GCs leads to neuronal damages, an 
effect that can also be mimicked in primary hippocampal cells in vitro. Thereby, 
an impaired energy metabolism (de Leon et al., 1997) or increased Glu release, 
leading to excitotoxicity (Dragunow et al., 1985; Huxtable, 1989), are discussed 
as underlying mechanisms. In the present study I used CORT concentrations 
ranging from 0.1 to 1000 µM. Already the lower concentrations (1 and 10 µM) 
induced an increase in cell viability in CSC mice, indicating a stimulatory effect on 
cell proliferation. An effect seen in SHC mice only with a concentration of 100 
µM, indicating that hippocampal cells of CSC mice are more sensitive towards 
lower CORT concentrations than those of SHC mice. In contrast, the extremely 
high concentration of 1000 µM CORT diminished cell viability in CSC compared 
with SHC mice and, therefore, induced hippocampal cell death, a phenomenon 
already described above, indicating again a higher sensitivity of the GR towards 
CORT in CSC mice. The results of the CSC mice are also in accordance to the 
literature, where GCs are shown to regulate neuronal processes in an U-shaped 
manner, i.e. low levels of CORT increase while high levels decrease neuronal 
excitability (Joëls and de Kloet, 1992; Kellendonk et al., 2002; Joëls, 2006). 
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Taken together, despite decreased GR expression in the hippocampus, analysis 
of GR-mediated Per1 gene expression and cell viability measurement in 
response to CORT stimulation clearly points towards an unaltered or even 
enhanced sensitivity and/or functionality of the GR, which might probably also 
underlie the unchanged FKBP51 expression. Nevertheless, future studies are 
needed to unravel the factors mediating the increased GR activity. Thereby, one 
possibility would be to analyse the phosphorylation pattern of the GR which plays 
an important role in its transcriptional activity (Galliher-Beckley and Cidlowski, 
2009). 
Owing to the high occurrence of MR in the hippocampus, the balance between 
MR and GR is of major importance in this brain region. Thus, the unchanged MR 
together with the decreased GR expression indicate that the balance is shifted 
towards the MR. Talking about MR and GR in the hippocampus, one has to keep 
in mind, that there are remarkable differences between these two receptors in 
coordinating the negative feedback response. Activation of the MR, whereby the 
rapid effects are mediated via the membrane-bound MR, maintains hippocampal 
output, resulting in an activation of the posterior/lateral BNST which in turn 
inhibits the PVN. In contrast, activated cytoplasmic GR decreases, in a delayed 
manner, hippocampal output, resulting in a disinhibiton of the PVN, a discrepancy 
which underlines the importance of the proper balance between MR and GR (de 
Kloet et al., 1998). In CSC mice the balance between both receptors is shifted 
towards an increased impact of MR-mediated effects in the hippocampus, 
favouring an increased inhibitory influence on the PVN. But, as the in vitro 
studies measuring GR functionality revealed even an increased functionalit, it 
makes it hard to clearly interpret the overall influence of the hippocampal 
receptors on the negative feedback regulation in CSC mice. Therefore, further 
studies are needed applying MR and GR antagonists to differentiate the influence 
of each receptor. This is also of importance for unraveling the functionality of the 
MR given the possibility that despite the unchanged expression its functionality is 
altered. 
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Interestingly, the basal mRNA expression pattern clearly shows that MR mRNA is 
at least 2 times higher expressed compared with GR mRNA, while the protein 
expression is regulated the other way round. This finding is in accordance to the 
literature, describing a 1.5 to 5 fold higher abundance of MR compared to GR 
mRNA in the rat hippocampus and a binding capacity 2 to 3 times higher for GR 
compared to MR (Herman, 1993). This discrepancy implicates a shorter half-life 
and an increased transcription rate of the MR to keep the protein expression at a 
stable level (Herman, 1993). 
 
Prefrontal Cortex 
In the PFC, protein expression of GR, MR and FKBP51 was increased in CSC 
compared with SHC mice. Regarding GR expression, the result is in line to what 
was found in chronically isolated rats (Djordjevic et al., 2009; Djordjevic et al., 
2010) and is suggested to be mediated by an enhanced phosphorylation at 
serine 232 of the GR gene. This leads to an increased transcriptional activity 
mediated by the GR itself in the absence of high CORT concentrations (Adzic et 
al., 2009). Nevertheless, one has to keep in mind, that regulation of HPA axis 
activity during/following chronic stress is differentially regulated in the PFC, 
whereby the PL and the InL exert distinct functions (Jones et al., 2011; McKlveen 
et al., 2013). Given that in the present thesis Western Blot analysis was used for 
GR measurement, it was not possible to differentiate between PL and InL PFC. 
Following acute stressor exposure, the GR in the PL as well as in the InL PFC is 
implicated in the inhibition of the ACTH and CORT response (Jones et al., 2011; 
McKlveen et al., 2013). Loss of the receptor in the InL PFC leads to increased 
CORT release in response to an acute heterotypic stressor in rats that underwent 
chronic stressor exposure. Moreover, the GR in the InL PFC seems to be 
involved not only in the physical but also in the emotional response to chronic 
stress, as a decrease of the GR in this locus seems to be responsible for the 
depressive-like behaviour observed in rats exposed to chronic variable stress 
(McKlveen et al., 2013). Given that CSC mice show no signs of depressive-like 
behaviour (Slattery et al., 2012) this might probably or at least in part, be due to 
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the increased GR expression mediated by the InL PFC. However, according to 
the study of McKlveen and colleagues (2013), an increased GR expression in the 
InL PFC decreases the CORT respone to an acute stressor in chronically 
stressed rats. This is clearly in contrast to what we see in CSC mice following 5-
min of EPF exposure (Uschold-Schmidt et al., 2012), but might be due to the 
different kind of stressors and the temporally study design used. During chronic 
stressor exposure, the PL PFC is only implicated in regulating the basal morning 
CORT release (McKlveen et al., 2013). As plasma morning CORT levels are 
unchanged and plasma evening levels are decreased following CSC exposure 
(Reber et al., 2007; Uschold-Schmidt et al., 2012), this might be due to an 
increased GR-mediated effect of the PL region.  
Importantly, with regard to the differences in GR expression and functionality in 
the hippocampus, it might also be possible that the increased GR expression is 
accompanied by an altered or even reduced functionality. Therefore, future 
studies are needed to reveal first of all via IHC if the GR is increased in both 
divisions and secondly, if the functionality of the GR in the PFC is altered. 
Interestingly, in a recent study it could be shown that CRH neurons located in the 
PFC colocalize with GR which can be recruited to the CRH promoter and 
regulate CRH expression (Meng et al., 2011). Hence the increased GR levels in 
the PFC of CSC mice could probably contribute to an altered CRH expression 
which might be implicated in the increased anxiety-related behaviour displayed 
by CSC mice (Reber et al., 2007; Slattery et al., 2012; Uschold-Schmidt et al., 
2012). 
The role of the MR in the PFC in regulating HPA axis feedback inhibition is not as 
pronounced as that of the GR and to my knockwledge no studies are available 
examing its role following chronic stressor exposure. Forebrain-specific knock-
down of the MR had no influence on basal as well as peak response to acute 
stress (Berger et al., 2006). Moreover, inhibition of the acute stress response 
under conditions of increased MR expression in the forebrain was only found in 
female mice (Rozeboom et al., 2007). Interestingly, forebrain MR over-expression 
reduced GR expression in the hippocampus (Rozeboom et al., 2007) a finding 
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which could also account for the decreased GR expression found in the 
hippocampus of CSC mice.  
The mechanisms underlying the enhanced expression of FKBP51 in CSC 
compared with SHC mice are again not easy to unravel. Increased FKBP51 
expression might implicate a reduced GR sensitivity and/or functionality, thereby, 
the increase in GR might represent a kind of compensatory mechanism. Another 
possibility might be that increased GR expression can increase the transcription 
of FKBP51. However, as CORT levels are unchanged following CSC exposure, 
this is only possible when GR sensitivity and/or functionality is concomitantly 
increased. This clearly demonstrates the necessity of future studies examining 
the functionality of the GR in the PFC. 
 
PVN 
The PVN is indirectly modulated by mainly GABAergic input from upstream 
corticolimbic structures, like the PFC and hippocampus, but it also expresses GR 
as well as MR itself. Protein expression of both receptors was not altered 
following CSC exposure. Chronic unpredictable stress and repeated 
immobilization elicited a decrease in GR (Herman et al., 1995; Makino et al., 
1995) and an increase in MR mRNA (Makino et al., 1995) expression in the PVN. 
In contrast, chronic water immersion stress for 4 weeks had no influence on the 
GR expression in the hypothalamus (Mizoguchi et al., 2003). The inconsistent 
effects observed might be due to the kind of stressor applied and whether the 
whole hypothalamus or only the PVN was analysed. Nevertheless, to really 
confirm that negative feedback at the level of the PVN is unchanged, which is 
indicated at least by means of the receptor expression data, future studies are 
needed analysing the functionality of both receptors in the PVN. 
Fornix transection, i.e. transection of the major path between hippocampus and 
hypothalamus, was shown to increase CRH and, interestingly, also GR and MR 
mRNA expression in the parvocellular PVN, indicating that also the expression of 
these two receptors in the PVN is regulated by the hippocampus (Han et al., 
2007). This would support the finding of an unaltered hippocampal input to the 
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PVN following CSC exposure, as expression of MR and GR was unchanged. 
FKBP51 expression was not measured in the PVN, as the punches contained 
only small amounts of protein only sufficient for measurement of the receptors. 
 
2.2 Effects of CSC on the negative feedback at the level of the 
pituitary 
Less feedback inhibition at the level of the pituitary was at the first glance 
indicated by the decreased GR mRNA and protein expression in CSC mice, 
shown in other studies to result in an increased release of ACTH vesicles in the 
periphery (Philip et al., 1997; John et al., 2007) and increased POMC expression 
(Drouin et al., 1989; Drouin et al., 1993). As, at least relative POMC protein 
expression was unchanged, this was the first hint pointing towards an altered GR 
functionality in the pituitary. Therefore, to test if the feedback response under in 
vivo conditions is really compromised, a DST was performed. Dex (3 µg/100 g 
body weight) or vehicle (Saline) was injected ip in the morning and four hours 
later, mice were exposed to 6-min FS and blood was collected 10 min following 
termination of the acute heterotypic stressor exposure, to analyse if Dex is able 
to block the stress-induced increase in plasma ACTH. In contrast to what one 
would expect regarding the GR expression data, Dex was able to block the acute 
stress-induced rise in plasma ACTH in SHC as well as in CSC mice to a 
comparable or even increased extent. This indicates that despite the decreased 
GR expression, the functionality under in vivo conditions is not compromised, but 
even seems to be enhanced following CSC exposure.  
Importantly, as described in Sec. 1.1, in un-injected mice, exposure to FS 
resulted in a significantly more pronounced rise in plasma ACTH in vehicle-
injected CSC compared with SHC mice. This is of importance and indicates that 
the injection per se is not likely to mask possible effects in this approach.  
Together with the decreased GR expression but unaffected Dex suppression I 
found an increased FKBP51 protein expression. Given that an ultra-short 
feedback loop increases FKBP51 expression via GC, an increased expression of 
this protein in CSC mice might be taken as a marker for increased ligand binding 
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of the GR and subsequent nuclear translocation and DNA binding in CSC 
compared with SHC mice (Binder, 2009). To my knowledge, there are no studies 
investigating the effects of chronic stress on FKBP51 expression in the pituitary, 
only in the hippocampus it was found to be increased following chronic SD stress 
(Wagner et al., 2012). The increased FKBP51 expression was paralleld by an 
increased GR translocation as well as an increased expression of a GR-sensitive 
gene (Wagner et al., 2012). Consequently, under in vivo conditions it is hard to 
disentangle whether increased FKBP51 is the consequence of an increased GR 
sensitivity and if consequently the enhanced FKBP51 expression in turn 
decreases GR sensitivity.  
To clarify whether the decrease in relative GR expression is compensated by an 
increased GR translocation, I measured the GR protein expression in the nucleus 
following acute stressor exposure (6-min FS). Given the fact that there was no 
difference between SHC and CSC mice, this indicates that there is no increased 
GR translocation in CSC mice. Nevertheless, as only a low number of mice was 
tested, the measurement of the translocation has to be repeated as it seems that 
there might be a slight increase. Moreover, it underlines the importance of 
measuring further parameters, like phosphorylation of the GR or binding 
capability of CORT which might also be implicated in an increased GR 
functionality. 
Moreover, to really disentangle the influence of FKBP51, it would also be of 
importance to analyse the antagonist of FKBP51, namely the FKBP52, which is 
essential for trafficking of the corticosteroid receptors into the nucleus. This would 
give further insight into the functionality of the receptors.  
Nevertheless, the decreased GR together with the increased FKBP51 expression 
and the result of the DST strongly supports the hypothesis of an increased GR 
sensitivity and/or functionality. This is also in accordance to the finding at the 
level of the hippocampus, supporting the concept that the receptor expression is 
not a prerequisite for its functionality. 
Another mechanism for compensating the decreased GR expression was shown 
in mice overexpressing MR in the hippocampus. Under stressful conditions, MR 
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was, thereby, able to partly reconstitute negative feedback despite GR deficiency 
(Harris et al., 2013). This might also be the case following CSC exposure, as MR 
protein expression in the pituitary was increased in CSC compared with SHC 
mice despite unchanged mRNA expression. The discrepancy between mRNA 
and protein expression would also be in line with the increased transcription rate 
described for the MR (Herman, 1993). However, to unravel the role of the 
increased MR expression, the DST has to be performed along with a MR and GR 
antagonist, to identify the role of each receptor in the negative feedback 
regulation at the level of the pituitary. 
 
2.3. Summary of the negative feedback analysis 
Overall, the analysis of the corticosteroid receptors revealed that the expression 
of GR as well as MR is differentially regulated in all four regions analysed. MR 
protein expression was up-regulated in the pituitary and PFC und unchanged in 
the hippocampus and PVN. GR protein expression was decreased in the pituitary 
and hippocampus, up-regulated in the PFC and unchanged in the PVN. These 
findings clearly indicate that the expression of both receptors is region-specific 
regulated. Moreover, I could show in my thesis that at least the GR expression in 
the hippocampus and pituitary itself is no criterion for its functionality. This is an 
important finding per se, suggesting that alterations of the receptor expression 
might dissemble an altered signalling. 
For getting more informations about MR and GR functionality, measurement of 
the translocation would help to get more information about their functionality as it 
was shown for the pituitary. Unfortunately, due to methological problems, 
measurement of GR in the nucleus is not possible in all three brain regions, as 
the nuclear extraction resulted in contamination of the nuclear fraction with the 
cytoplasmic marker ß-Tubulin. Another important factor constitutes the 
phosphorylation of the GR, which was found to play an important role, especially 
under conditions of low CORT levels (Adzic et al., 2009). In mice, 
phosphorylation at Ser220 of the GR gene enhances its transcriptional activity, 
given that the interaction of the GR with GRE on the promoter of different genes 
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is increased while phosphorylation at Ser212 decreases its binding to GRE 
(Galliher-Beckley and Cidlowski, 2009). Moreover, studies using MR and/or GR 
antagonist would help to unravel the influence of each receptor in regulating GC-
mediated effects, given the fact that an increased MR expression in the pituitary 
might probably rescue the reduced GR expression. Also measurement of the 
expression of GC-regulated genes, as performed in hippocampal cells, would 
give an insight into the transcriptional activity of the corticosteroid receptors.  
Taken together, given that negative feedback inhibition at the level of the might 
hippocampus and pituitary even denote a tendency towards an increase this 
overall indicates that the increased plasma ACTH concentrations in CSC 
compared with SHC mice are not due to an impaired negative feedback inhibition 
which is in contrast to the GC resistance found in the periphery. This further 
supports the hypothesis that the increased number of corticotroph cells is mainly 
responsible for the pituitary hyper-activity under basal and hyper-reactivity 
following exposure to a superimposed acute stressor exposure. 
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3 CSC and the influence of trait anxiety on the individual 
stress vulnerability 
In 1977, Zubin and Spring defined their model of “stress and vulnerability” in 
mental disorders. They outlined in detail that the ability to deal with stress, i.e. the 
vulnerability, varies within individuals. While people with low vulnerability need 
longer time or stressor intensity to become distressed, others with high 
vulnerability already suffer in response to low amounts of stress and develop 
serious mental disorders (Zubin and Spring, 1977). Therefore, it is of major 
importance to unravel the mechanisms underlying the vulnerability to stress and 
the development of stress-related disorders, whereby genetic as well as 
environmental factors, like the life history of an individual, are implicated (Kendler 
and Eaves, 1986).  
Polymorphisms, altering the individual vulnerability to acute or chronic stressor 
exposure have been previously described, e.g. for FKBP51, involved in the 
regulation of the GR sensitivity and translocation efficiency (Binder, 2009; 
Klengel et al., 2013) or for the GR itself (Wüst et al., 2004). Polymorphisms 
leading to over-expression of FKBP51 increased recovery period following an 
acute social stressor exposure in humans (Trier Social Stress Test) (Ising et al., 
2008), while chronic SD in FKBP51 knock-out mice produced a less stress 
vulnerable phenotype (Hartmann et al., 2012b). Also behavioural traits, like 
anxiety and temperament are associated with the development of stress-induced 
depression and enhanced GC reactivity (Sandi et al., 2008; Tyrka et al., 2008; 
Sandi and Richter-Levin, 2009). In high trait anxiety animals, the amygdaloid 
CRH system was more vulnerable following exposure to chronic unpredictable 
stress, indicating an increased vulnerability to develop psychiatric alterations 
associated with chronic stress (Sandi et al., 2008).  
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3.1 Effects of CSC on behavioural, physiological, neuroendocrine 
and immunological parameters 
To assess the influence of genetic differences, in this case the trait anxiety of an 
individual, to the effects of 19 days of CSC, I used the well characterized mouse 
line bred for high (mHAB) and low (mLAB) anxiety-related behaviour, and non-
seleceted normal CD1 (mNAB) mice. Thereby, all results obtained following CSC 
exposure were compared with results from previous studies conducted in 
C57BL/6 mice to validate the chronic stress procedure.  
 
Behavioural parameters  
On the EPM, breeding-line specific differences in innate anxiety between mNAB, 
mHAB and mLAB described in the literature (Krömer et al., 2005; Muigg et al., 
2009) were confirmed with mHAB mice exhibiting an increased anxiety-like 
behaviour compared with mLAB mice, while mNAB mice displayed an 
intermediate behaviour phenotype. The anxiogenic effect of CSC in C57BL/6 
mice (Reber et al., 2007; Slattery et al., 2012; Uschold-Schmidt et al., 2012) was 
confirmed in the mNAB, but neither in the mHAB nor in the mLAB group. At least 
in the mHAB group the lack of any detectable effect might be due to a ceiling 
effect given that already the mHAB SHC mice showed a high level of anxiety, 
e.g. displayed by spending only 6 % time on the open arm. To really confirm the 
ceiling effect, in future studies a different anxiety test, like light-dark box, should 
be used or the conditions of the EPM should be altered by making it less aversive 
for instance by changing the light conditions.  
Importantly, locomotion measured by the number of closed arm entries was not 
altered by the CSC procedure in any of the genotype. Only mLAB SHC mice 
generally moved less than respective mHAB mice, an effect already reported 
before (Krömer et al., 2005). This might be explained by the fact that mLAB mice 
in general spent more than 50% of their time on the open arm and, therefore, 
consequently showed fewer closed arm entries compared with mHAB mice. This 
finding supports the hypothesis that the number of closed arm entries does not 
simple reflect locomotor activity, but also reflects anxiety as well (File, 2001). 
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However, detecting no anxiogenic effect in mLAB mice indicates, and that is a 
very exciting finding, resilience to the effects of CSC with respect to the anxiety-
related behaviour. Thereby, one can also exclude that these mice are extremely 
robust and resistant to stressful life events or to any kind of manipulation, given 
that in rLAB rats it was shown that local application (via retrodialysis in the 
septum) of the anxiogenic neuropeptide AVP was able to increase anxiety-
related behaviour in this breeding line (Beiderbeck et al., 2007). 
 
Physiological parameters 
To validate the chronic psychosocial stress paradigm as well as to examine 
genotype specific differences, physiological parameters known to be altered in 
C57BL/6 mice following CSC or following chronic stressor exposure in general 
were assessed. 
Body weight gain was not affected in mNAB and mHAB mice, but was increased 
in mLAB CSC mice, compared with respective SHC mice. Nevertheless, as the 
chronic stress effect on this parameter was already shown to be inconsistent in 
C57BL/6 mice following CSC exposure, revealing a decrease (Reber et al., 2007; 
Veenema et al., 2008) but also no change (Slattery et al., 2012), as well as in 
other chronic stress paradigms (Bartolomucci et al., 2005; Schmidt et al., 2010a; 
Bartlang et al., 2012), this clearly indicates that body weight gain is no reliable 
indicator for chronic stress. Body weight gain is regulated by behavioural and 
neuroendocrine processes and is mainly determined by the input (food intake) 
and output (e.g. locomotion) (Bartolomucci et al., 2005). Therefore, analysis of 
the eating behaviour and/or locomotor activity would be necessary to unravel at 
least the mechanism underlying the increased body weight gain in CSC mLAB 
mice. However, the comparable body weight gain between mHAB and mNAB 
mice and the difference in the mLAB mice following CSC exposure again 
supports the concept of stress-resilience in the mLAB group. 
One of the most reliable physiological parameter with respect to chronic stress is 
adrenal hypertrophy, shown following chronic stressor exposure in general 
(Retana-Marquez et al., 2003; Schmidt et al., 2007) and, importantly, also 
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following CSC exposure in C57BL/6 mice (Reber et al., 2007; Uschold-Schmidt 
et al., 2012; Füchsl et al., 2013). mNAB as well as mHAB mice displayed an 
increased adrenal weight following CSC, confirming on the one hand the 
reliability of CSC as a chronic psychosocial stress model and on the other hand 
the determination of adrenal weight as an reliable parameter for chronic stress. 
As only mLAB mice of the CSC group showed no adrenal hypertrophy, this 
further demonstrates that mice with a low anxious phenotype are resilient to the 
chronic stress effects.  
Splenomegaly, reported in other chronic stress paradigms, like e.g. the social 
disruption paradigm in male mice (C57BL/6 and Balb/c) (Avitsur et al., 2003; 
Merlot et al., 2004) was found following CSC exposure in mNAB and at least by 
trend in mHAB mice, whereby this effect was not detected in mLAB mice, 
emphasizing again the reduced stress vulnerability in mLAB mice. Even though, 
spleen weight has never been assessed in C57BL/6 mice exposed to CSC, the 
studies mentioned above already indicate that splenomegaly is not mouse-line 
specific and, therefore, probably reflects a general consequence of 19 days of 
CSC. 
 
Neuroendocrine parameters 
Analysis of plasma CORT and ACTH levels is of major importance for analysis of 
basal HPA axis activity following chronic stressor exposure. In CSC mice of the 
mNAB and mLAB group, plasma ACTH concentrations in the morning were 
similar, while they were significantly increased in the mHAB group compared with 
respective SHC mice. An effect also found in C57BL/6 mice following CSC, 
where this is probably mediated by an increased number of corticotroph cells 
(see also Sec. 1.1). Nevertheless, future studies are needed to check if in mHAB 
CSC mice increased plasma ACTH levels are mediated by the same mechanism 
like in C57BL/6 mice, or if e.g. AVP plays a role in this process. In mHAB, mLAB 
and mNAB mice anxiety-related behaviour suggests to be positively correlated 
with the AVP expression (Landgraf et al., 2007). As under conditions of chronic 
stress AVP, in addition to CRH, is supposed to play a major role in stimulating 
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ACTH release from the pituitary (Ma et al., 1999), it is likely that following CSC in 
mHAB mice, the increased plasma ACTH release is driven by a stronger input of 
AVP due to their high anxiety level. Therefore, AVP has to be measured via IHC 
in all three breeding lines following CSC exposure. Similar basal ACTH 
concentrations in mHAB and mLAB SHC mice are at least in accordance to 
studies conducted in rats (Frank et al., 2006).  
Neither in the mHAB nor in the mLAB group plasma CORT concentrations were 
affected by CSC, but, interestingly, mNAB mice of the CSC group even showed 
hypocorticism in the morning compared with respective SHC mice. An effect only 
described for plasma morning CORT concentrations in C57BL/6 previously 
exposed to MS early in life (Veenema et al., 2008) and for plasma evening 
concentrations in C57BL/6 mice, while plasma morning concentrations were 
similar in SHC and CSC mice of this strain (Reber et al., 2007; Uschold-Schmidt 
et al., 2012). This finding clearly shows that the genetic background, as mNAB 
are CD1 mice, as well as early life events (Veenema et al., 2008) can increase 
the vulnerability to the consequences of chronic psychosocial stress, in this case 
increasing the negative effects on HPA axis functionality.  
Regarding line differences, mNAB SHC mice displayed significantly higher 
plasma morning CORT concentrations compared with respective mHAB and 
mLAB mice, which is most likely due to the higher adrenal weight this group 
shows. Similar basal CORT levels in mHAB and mLAB SHC mice are in 
accordance to other studies carried out in mice (Gonik et al., 2012) and rats 
(Liebsch et al., 1998; Frank et al., 2006) of this breeding line, even though 
adrenal weight of animals of the LAB line is higher in mice and lower in rats 
(Salome et al., 2006) compared with respective HAB animals. This might, at least 
in the rats, be due to a similar adrenal CORT content in the two lines (Salome et 
al., 2006). Nevertheless, this has to be further analysed in mice by measurement 
of the adrenal CORT content or of the capability to produce CORT. In vitro 
adrenal CORT secretion under basal conditions was similar in SHC mice of all 
three genotypes but is not in discrepancy to the above mentioned higher plasma 
CORT levels in mNAB mice, as in vitro data are expressed per mg of adrenal 
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tissue and adrenal weight is higher in mNAB SHC compared with mHAB and 
mLAB of the respective group.  
In vitro responsiveness of the adrenal gland in response to ACTH stimulation 
(100 nM) revealed a complete loss of the CORT secretion in mNAB and mHAB 
CSC compared with respective SHC mice. In contrast, C57BL/6 mice only 
showed a partially attenuated ACTH-stimulated CORT secretion following CSC 
exposure (Reber et al., 2007; Uschold-Schmidt et al., 2012). This further 
indicates an increased vulnerability of HPA axis functionality of mice of the CD1 
compared with the C57BL/6 strain.  
At the first glance, basal plasma CORT:ACTH ratios which were similar in SHC 
mice of all breeding lines are in contrast to the increased adrenal in vitro ACTH 
responsiveness found in mLAB SHC mice. Nevertheless, this result is in line with 
the increased CORT response reported in mLAB compared with mHAB mice 
following acute restraint stress (15 min) (Gonik et al., 2012). Thus, measurement 
of the response to an acute stressor is a more reliable parameter for 
interpretation of the in vitro results obtained by stimulation of adrenals with ACTH 
instead of the basal plasma CORT:ACTH ratio. 
The stimulation data together with the CORT:ACTH ratio strongly support a 
decreased ACTH responsiveness in CSC mice of the mNAB and mHAB line. This 
seems to be mediated by a reduced capability to produce CORT in the mNAB 
mice, given that plasma ACTH concentrations were unchanged and the adrenal 
weight was even increased. In the CSC mHAB group, the reduced in vitro ACTH 
responsiveness was paralleled by increased plasma ACTH concentrations 
together with an increased adrenal weight which did not result in enhanced 
plasma CORT concentrations. Nevertheless, it has to be determined in future 
studies if there is a real insufficiency of the adrenal glands or if this represents an 
adaptation to protect the organism from increased CORT levels, as the latter 
seems to be the case in C57BL/6 mice exposed to CSC (Uschold-Schmidt et al., 
2012). However, assumed that this constitutes a mechanism of adaptation, then 
in mNAB CSC mice this adaptation was too intense causing even hypocorticism. 
146  CHAPTER 4 - DISCUSSION 
 
 
However, mLAB CSC mice did not show any of these alterations at the level of 
the adrenal gland, supporting againg their stress resilience. 
 
Immunological parameters 
CSC has repeatedly been shown to represent an adequate and pre-clinically 
validated model for chronic psychosocial stress, as it, amongst others, promotes 
the development of somatic disorders, as for instance spontaneous colitis (Reber 
et al., 2007; Reber et al., 2011; Reber, 2012). Measurement of the IFN-γ 
secretion of anti-CD3 stimulated isolated mesLNC revealed an increased 
secretion of this pro-inflammatory cytokine in CSC mice of the mHAB and mNAB 
group, which is in accordance to C57BL/6 mice (Reber et al., 2007; Reber et al., 
2011), but not in the mLAB group. Nevertheless, regarding the histological 
damage score, which was increased in C57BL/6 mice following CSC (Reber et 
al., 2007; Reber et al., 2011), no alterations in any of the breeding lines were 
found, indicating that mice of the CD1 strain seem to be more resilient to the 
immunological, while they were shown to be more vulnerable to neuroendocrine 
alterations. Development of spontaneous colitis in C57BL/6 mice is influenced by 
various factors, like changes in immune competence, epithelial barrier function, 
and bacterial translocation during the initial phase of CSC exposure (Reber et al., 
2011), indicating that further studies are needed to unravel possible differences 
between the CD1 and C57BL6 mouse lines following CSC exposure.  
 
GR, MR and FKBP51 protein expression in the pituitary 
As already mentioned at the beginning of Sec. 2, polymorphisms in the GR or in 
FKBP51 are known to influence the individual vulnerability to chronic stressor 
exposure (Wüst et al., 2004; Binder, 2009). Therefore, and because of the fact 
that alterations in MR, GR and FKBP51 expression have been revealed in this 
study in C57BL/6 mice (see also Chapter 3, Sec. 3), I also analysed the 
expression of these three proteins in the pituitary of mHAB, mLAB and mNAB 
mice following CSC exposure. In contrast to what was found in C57BL/6 mice, no 
alterations of GR, MR and FKBP51 were found in the pituitary following CSC 
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exposure. One possibility for this discrepancy reagarding the results found in 
C57BL/6 mice might be the fact that only a low amount of mice (4 -5 per breeding 
line) were analysed, which is also reflected in the high standard deviation. The 
only difference that was found was a higher FKBP51 expression in CSC mice of 
the mNAB compared with the respective mHAB group. However, to really 
disentangle the significance of this result, future studies are needed examining a 
higher amount of animals. 
 
Conclusion 
Overall, the results of the behavioural, physiological, neuroendocrine and 
immunological parameters clearly indicate, that the individual genetic 
predisposition has a strong impact on the vulnerability to chronic psychosocial 
stressor exposure with mLAB mice being resilient to the maladaptive effects of 
CSC (see Table 2). Moreover, it became evident that the effects of CSC might be 
mouse strain-dependent.  
Mice of the low anxious phenotype showed no signs of somatic and affective 
maladaptations following CSC exposure. Therefore, the use of this breeding line 
enables the study of gene and environment interactions with respect to the 
development of stress-related disorders and makes it possible to analyse the 
mechanisms underlying the genetic predisposition of stress resilience. Against 
my expectation, mHAB showed no higher vulnerability to the effects of chronic 
stress compared with mNAB mice, although other studies demonstrated an 
increased chronic stress burden in high anxious mice (Sandi et al., 2008; 
Dhabhar et al., 2012). Nevertheless, this might be due to a kind of ceiling effect, 
as 19 days of CSC might constitute a too strong or intensive stressor. Thus, 
usage of a milder chronic psychosocial stress paradigm might enable the 
detection of possible differences between chronically stressed mNAB and mHAB 
mice. Moreover, as already mentioned before, it would be of interest to find out if 
mLAB mice are resilient to chronic stress per se or if they show signs of chronic 
stress-induced alterations when they are subjected to other chronic stress 
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paradigms, like chronic SD (Wagner et al., 2011) or exposure to an unstable 
social and hierarchical situation for several weeks (Schmidt et al., 2010a). 
 
CSC READOUT PARAMETER mHAB mNAB mLAB C57BL/6 
     
Body weight gain ↔ ↔ ↑ ↓ ↔ 
Absolute adrenal weight ↑ ↑ ↔ ↑ 
Absolute spleen weight (↑) ↑ ↔  
Basal plasma CORT 
(morning) 
↔ ↓ ↔ ↔ 
Basal plasma ACTH ↑ ↔ ↔ ↑ 
Plasma CORT:ACTH ratio (↓) ↓ ↔ ↓ 
In vitro adrenal ACTH 
responsiveness 
↓ ↓ ↔ ↓ 
Proinflammatory cytokine 
secretion from mesLNC 
↑ ↑ ↔ ↑ 
Histological damage score 
(colon) 
↔ ↔ ↔ ↑ 
Anxiety-like behaviour ↔ ↑ ↔ ↑ 
GR pituitary ↔ ↔ ↔ ↓ 
MR pituitary ↔ ↔ ↔ ↑ 
FKBP51 pituitary ↔ ↔ ↔ ↑ 
 
Table 2: Comparison of the effects of 19 days of CSC in mice selectively and 
bidirectionally bred for high (mHAB) and low (mLAB) anxiety-related behaviour, in non-
selected normal (mNAB) and in C57BL/6 mice on behavioural, physiological, 
neuroendocrine and immunological parameters. CSC exposure results either in an 
increase (↑) or decrease (↓) of the examined parameter or had no effect (↔). Arrows 
in parentheses indicate an increase or decrease by trend. [Data are taken from (Reber 
et al., 2007; Reber et al., 2011; Slattery et al., 2012; Uschold-Schmidt et al., 2012), 
Chapter 3, Sec. 4] 
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3.2 Why are mice of the low-anxious phenotype resilient to the 
consequences of CSC?  
One of the main questions arising from the study conducted in this breeding line 
is why mLAB mice are resilient to the consequences of chronic psychosocial 
stress. Thereby the SNP in the AVP gene - leading to a decreased synthesis and 
release of the anxiogenic neuropeptide - is mainly responsible for the low anxiety 
this breeding line shows (Bunck et al., 2009). But whether this is the only factor 
contributing to their stress resilience is still unknown, given that also other genes 
have been identified that seem to parallel the trait anxiety, including Glyoxylase-I 
(Krömer et al., 2005), enolase phosphatase (Ditzen et al., 2010) and TMEM123d 
(Erhardt et al., 2011). 
In brattleboro rats, the lack of AVP only partly prevented the consequences of 
chronic stressor exposure, e.g. the increased basal CORT levels, but had no 
influence on the development of depressive-like changes (Varga et al., 2011) or 
on physiological alterations, like adrenal hypertrophy or thymus involution 
(Zelena et al., 2004). These studies indicate that lack of AVP alone cannot 
protect against all chronic stress-induced effects and, therefore, also other 
factors, like the genes mentioned above must be involved.  
Nevertheless, to test if in mLAB mice, the SNP in the AVP gene is the main 
mediator of the stress resilience, one possibility would be to implant osmotic 
minipumps continuously delivering AVP in the brain during the CSC exposure 
and check for all parameters assessed before. Moreover, the reduced AVP 
expression might be compensated by increased CRH and/or OXT expression 
under basal as well as following chronic stressor exposure and has, therefore, to 
be analysed. At least under basal conditions, OXT mRNA expression in the PVN 
was shown to be similar in mHAB, mNAB and mLAB mice (Bunck et al., 2009). 
Not only the anxiety trait itself might explain their stress reactivity, but also other 
personality traits, like aggression, exploration or activity. Amongst AVP itself, their 
low anxious phenotype might impact their coping strategy, i.e. their behaviour in 
response to the resident during the CSC procedure, even though at the start of 
the CSC paradigm, mice of all three lines were in the subordinate position. One 
150  CHAPTER 4 - DISCUSSION 
 
 
recent study from Castro and colleagues (2012) investigated the influence of the 
combination of the traits anxiety and exploration on the effects of chronic 
unpredictable stressor exposure. Thereby, animals with low anxiety and low 
exploration seemed to be resistant to behavioural alterations while highly anxious 
animals showed more depressive-like alterations. In combination with low 
exploration, highly anxious animals showed also a higher stress vulnerability 
demonstrated by increased physiological (higher CORT levels in response to 
acute stress) and neurobiological responses (increased pERK1/2 activation in 
amygdala and hippocampus) following chronic stress (Castro et al., 2012). 
Thus, analysis of the behaviour of the experimental mice of the different breeding 
lines during CSC exposure would give further insight into the mechanisms of 
stress vulnerability. Proactive, i.e. more competitive rats have been shown to 
display higher autonomic stress responses, like increased blood pressure and 
increased catecholamine release compared with more reactive ones (Koolhaas 
et al., 1997). Rats displaying a more reactive and non-aggressive coping style 
showed higher basal plasma CORT levels as well as increased reactivity of 
plasma CORT and ACTH in response to an acute stressor (Veenema et al., 
2003; Veenema et al., 2004). Overall this indicates that proactive coping results 
in alterations of the SNS, while reactive coping implicates higher HPA axis 
activity and reactivity (Koolhaas et al., 1999; Koolhaas et al., 2007). At least in 
rats it was shown that during SD rHAB exhibit a more passive strategy, 
demonstrated by increased freezing, while rLAB showed a more active behaviour 
(Frank et al., 2006). Moreover, inter-male aggression was higher in rLAB 
compared with rNAB, while rHAB showed an intermediate aggressive behaviour 
(Veenema et al., 2007; Beiderbeck et al., 2011). Transferred to the mice this 
would confirm that in mLAB mice no alterations of HPA axis functionality have 
been observed following CSC exposure while mHAB mice showed e.g. increased 
plasma ACTH levels. Moreover, high aggressive individuals also displayed 
increased GC levels and/or responses (Gerra et al., 1997; van Bokhoven et al., 
2005), which would be in line with the increased adrenal ACTH responsiveness 
in vitro observed in mLAB mice.  
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Nevertheless, to really confirm these hypothesis, aggressive behaviour or 
behaviour in general during the CSC paradigm must be analysed in future 
studies. Moreover, not only parameters concerning HPA axis activation, but also 
parameters like catecholamine release, revealing alterations of the SNS, have to 
be assessed. According to the review of Koolhaas and colleagues (1999) and the 
aggression data obtained from the rHAB and rLAB rats, one would expect an 
increased activity of the SNS in mLAB mice following CSC exposure concomitant 
with no alterations in HPA axis activity as I already revealed in this study. 
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4. Summary and concluding remarks 
In the present thesis, I provided further evidence for the alterations of HPA axis 
functionality following chronic stressor exposure as well as for the individual 
variations concerning the vulnerability to the CSC-induced effects.  
I demonstrated that CSC increased plasma ACTH levels under basal conditions 
as well as in response to an acute heterotypic stressor, whereby this was mainly 
mediated by an increased number of pituitary corticotroph cells. As increased 
basal ACTH levels argue against an adaptation of the HPA axis in response to 
repeated stressor exposure, which was found at the level of the adrenal gland, 
this might constitute a kind of mal-adaptation at the level of the pituitary. 
Increased plasma ACTH levels in response to an acute heterotypic stressor are 
in line with the sensitization process described in the literature following chronic 
stressor exposure. Therefore, while pituitary mechanisms are not involved in the 
process of adaptation, I was able to demonstrate that the combination of pituitary 
and adrenal mechanisms is of importance to fulfill the sensitization process to a 
superimposed acute heterotypic stressor following CSC exposure.  
In addition, analysis of the negative feedback inhibition at different levels of the 
HPA axis revealed a site-specific regulation of the corticosteroid receptors 
following CSC exposure. Thereby, GR expression was decreased in the 
hippocampus and pituitary, unchanged in the PVN and increased in the PFC. MR 
expression was increased in the pituitary and PFC and unchanged in the 
hippocampus and PVN. At the level of the pituitary the DST revealed a 
completely functional or even increased negative feedback inhibition despite 
decreased GR expression. The same phenomenon, i.e. decreased receptor 
expression concomitant with increased functionality, was also shown in the 
hippocampus. These results clearly demonstrate the importance of measuring 
the signalling of the receptor, e.g. by analysis of the phosphorylation pattern or of 
the nuclear translocation. 
Both, the influence of life history of an individual, in detail the impact of early life 
stress analysed in the previous study (Veenema et al., 2008) and genetic factors, 
i.e. the trait anxiety of an individual analysed in the present study, extent the 
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knowledge of gene and environment interactions influencing the vulnerability to 
chronic psychosocial stress. I could clearly demonstrate that mice of the low 
anxious phenotype were resilient to the effects of 19 days of CSC regarding all 
parameters analysed. They neither showed behavioural, physiological, 
neuroendocrine nor immunological alterations, indicating that the chronic 
exposure to the resident had no effect in mLAB mice. Therefore, it is of major 
importance to unravel the underlying mechanism – it is very likely due to the low 
AVP expression – to find a treatment strategy for humans, protecting them from 
the negative consequences of chronic stress. Moreover the results clearly 
indicate that the analysis of chronic stress effects in a large cohort of animals 
should at least implicate the analysis of the trait anxiety of the animals and/or the 
stress coping, proactive or reactive, which might even differ in an inbred colony of 
mice. Selecting animals that differ extremely in their behaviour might give further 
insight into the individual variability in the vulnerability to the consequences of 
chronic stress. Importantly, these informations would help to promote the 
development of personalized medicine, given that the molecular mechanisms 
mediating the development of stress-related disorders probably varie between 
individuals. 
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Summary in German - Deutsche 
Zusammenfassung 
 
Der Begriff „Stress“ weckt meist nur negative Assoziationen, wobei oft in 
Vergessenheit gerät, dass die akute Stressantwort einen der fundamentalsten 
Überlebensmechanismen der Natur darstellt. Die Aktivierung des 
Kardiovaskulären-, des Bewegungs- und des Neuroendokrinensystems 
ermöglicht die sogenannte „Kampf oder Flucht“ Reaktion. Wenn es jedoch 
häufiger zu Stress kommt oder der Organismus die dauerhaften Belastungen und 
Anforderungen nicht mehr bewältigen kann, so spricht man von chronischem 
Stress. Chronischer Stress, beim Menschen vor allem ausgelöst durch 
psychosoziale Stressoren, verändert das physiologische Gleichgewicht, was 
unter bestimmten Umständen die Entwicklung von affektiven sowie auch 
körperlichen Erkrankungen begünstigen kann. Beispiele hierfür sind chronisch 
entzündliche Krankheiten des Verdauungstrakts, Erkrankungen des Herz-
Kreislaufsystems, sowie Angst- und Depressionserkrankungen. Um die 
Homöostase des Körpers nach Stresseinwirkung wiederherstellen zu können 
werden Stresshormone, Katecholamine und Glucocorticoide (GC) ausgeschüttet. 
Da die Ausschüttung von GC über einen längeren Zeitraum negative 
Auswirkungen auf den Organismus hat, ist es besonders wichtig, dass eine 
Adaptation auf den chronischen Stressor erfolgt. Darüberhinaus gibt es einen 
Prozess der Sensitivierung, der es einem chronisch gestressten Organismus 
ermöglicht, auf eine neue, möglicherweise noch schwerwiegendere, 
Herausforderung adäquat reagieren zu können. Die Mechanismen der 
Adaptation der Hypothalamus-Hypophysen-Nebennierenrinden (Hypothalamic-
pituitary-adrenal (HPA))-Achse sind vor allem auf Ebene der Hypophyse bekannt, 
wobei es bei chronischer Stressexposition zu einer Verringerung der Freisetzung 
des adrenocorticotropen Hormons (ACTH) kommt.  
Interessanterweise zeigen jedoch nicht alle Individuen die gleiche Vulnerabilität 
gegenüber den durch chronischen Stress verursachten Folgen. Während die 
einen stark anfällig für Stress sind, sind die anderen deutlich belastbarer oder 
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auch resistent gegenüber chronischem Stress. Eine wichtige Rolle spielen dabei 
sowohl die genetische Prädisposition als auch Umweltfaktoren (z.B. Ereignisse in 
der Kindheit und frühen Jugend). Ein wichtiges Ziel der heutigen Stressforschung 
ist daher die Untersuchung der Mechanismen, die dieser unterschiedlichen 
Stressvulnerabilität zu Grunde liegen, um die Pathologie von stressbedingten 
Krankheiten verstehen zu können. Ein geeigneter Ansatz, um die Mechanismen 
von stressbedingten Krankheiten im Allgemeinen und die Vulnerabilität im 
Speziellen zu untersuchen, ist die Verwendung geeigneter Tiermodelle. In der 
vorliegenden Arbeit wurde hierfür das Modell der chronisch-subordinierten 
Koloniehaltung (chronic subordinate colony housing (CSC), 19 Tage), ein 
etabliertes und präklinsch-validiertes Modell um chronisch psychosozialen Stress 
in männlichen Mäusen hervorzurufen, verwendet. Hierbei werden die 
Versuchsmäuse, vier männliche, gleichaltrige C57BL/6 Mäuse, zusammen mit 
einer älteren, schwereren und aggressiveren männlichen Maus, auch Resident 
genannt, für 19 aufeinanderfolgende Tage in einer Kolonie gehalten. In dieser 
CSC-Kolonie übernimmt der Resident die dominante Rolle, während die 
Versuchsmäuse die subordinierte Position einnehmen. In zahlreichen 
Publikationen konnte bereits gezeigt werden, dass CSC-Exposition sowohl 
affektive als auch körperliche Erkrankungen der Mäuse zur Folge hat. CSC 
Mäuse zeigten dabei eine erhöhte Ängstlichkeit auf der elevated plus-maze 
(EPM) im Vergleich zu den ungestressten Kontrolltieren (single-housed control 
(SHC)). Auch kam es zu immunologischen Veränderungen, die sich in einer 
Verkleinerung des Thymus, sowie einer spontanen Entzündung des Colons 
äußerten. Die zugrundeliegenden Mechanismen sind dabei noch nicht eindeutig 
verstanden, jedoch zeigten die Versuchstiere Veränderungen der HPA-Achsen 
Funktionalität. Plasma Corticosteron (CORT)-Konzentrationen am Morgen waren 
am Ende der CSC-Exposition im Vergleich zu den SHC Tieren unverändert, 
während die Werte am Abend in den CSC Tieren niedriger waren. Dies bedeutet 
Hypocortizismus in der aktiven Phase der CSC Mäuse. Da auch Nebennieren, 
deren Gewicht erhöht war, in vitro eine verringerte CORT-Freisetzung nach 
Stimulation mit ACTH aufwiesen, deutete dies auf eine Nebenniereninsuffizienz 
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in den CSC Tieren hin. Jedoch waren CSC Mäuse in der Lage auf auf einen 
akuten heterotypischen, also unbekannten, Stressor (5 min erhöhte Plattform 
Exposition), mit einer erhöhten CORT-Ausschüttung, trotz unveränderter ACTH 
Konzentrationen, reagieren zu können. Dieses Ergebnis und die Tatsache, dass 
die CORT Synthese in CSC Tieren nicht beeinträchtigt war, waren ein Beweis für 
die Funktionalität der Nebennieren. 
Die bisherigen Ergebnisse deuten daher darauf hin, dass auf Ebene der 
Nebenniere eine Adaptation stattfindet, welche die CSC Mäuse einerseits vor 
dauerhaft erhöhten Plasma CORT-Konzentrationen schützt. Andererseits 
ermöglicht ein Prozess der Sensitivierung eine erhöhte HPA-Achsenreaktivität 
auf einen akuten heterotypischen Stressor zeigen zu können. Diese 
Mechanismen der Adaptation und Sensitivierung wurden in anderen Studien 
hauptsächlich auf Ebene der Hypophyse gezeigt und nicht wie in den CSC 
Tieren auf Ebene der Nebenniere. Dennoch kann man vermuten, dass aufgrund 
des erhöhten Hypophysengewichts, welches 8 Tage nach Beendigung der CSC 
Exposition gefunden wurde und aufgrund der Tatsache, dass keine basalen 
ACTH Plasma Daten vorhanden sind, auch Hypophsenmechanismen an diesen 
Prozessen beteiligt sind.  
Der Fokus des ersten Teils der Arbeit lag daher auf der Untersuchung 
unterschiedlicher Parameter der HPA-Achse nach CSC Exposition, wobei ein 
besonderer Fokus auf Hypophyse und PVN gelegt wurde. Die Analyse der 
basalen Plasma ACTH Konzentrationen am Morgen zeigte eine erhöhte 
Freisetzung in CSC gegenüber SHC Tieren. Darüberhinaus kam es auch nach 
einer akuten heterotypischen Stressorexposition (6 min forced swim (FS)) zu 
einer erhöhten ACTH Freisetzung in CSC Tieren. Auf den ersten Blick ist dies 
gegensätzlich zum Ergebnis der Uschold-Schmidt Studie 2012 in der 
unveränderte ACTH Werte als Antwort auf einen akuten heterotypischen 
Stressor gezeigt wurden. Dies ist jedoch auf die Art des Stressors und auf 
Unterschiede im zeitlichen Ablauf zurückzuführen. Anhand der absoluten Plasma 
ACTH Werte ist ersichtlich, dass FS einen wesentlich stärkeren Stressor als 
Exposition auf einer erhöhten Plattform darstellt. Außerdem betrug die 
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Zeitspanne zwischen Beendigung des akuten Stressors und der Tötung der Tiere 
in der vorliegenden Studie 10 min und in der vorherigen Studie 5 min. Diese 
Ergebnisse zeigen, dass die erhöhte ACTH Antwort auf einen akuten 
heterotypischen Stressor eine bestimmte Zeit oder Stressorintensität benötigt, 
um sich zu entwickeln. Im Allgemeinen bedeutet dies, dass der Mechanismus der 
Adaptation hauptsächlich auf Ebene der Nebenniere vermittelt wird, während 
Nebennieren- und Hypophysenmechanismen kombiniert werden um die 
Sensitivierung auf den akuten heterotypischen Stressor zu realisieren. 
Als wahrscheinlichste Ursache für die Hypophysenhyperaktivität und –reaktivität 
in den CSC Tieren kommt das erhöhte Hypophysengewicht, das auch für Tag 20 
bestätigt werden konnte und die erhöhte Anzahl an corticotrophen, dass heißt 
ACTH-produzierenden, Zellen in der Hypopyhse, in Frage. Eine unveränderte 
relative mRNA- und Proteinexpression von Pro-Opiomelanocortin, dem Vorläufer 
von ACTH, zeigte darüberhinaus, dass die neu gebildeten Zellen funktionsfähig 
sind. Da jedoch nicht ausgeschlossen werden kann, dass auch noch andere 
Mechanismen für die erhöhte ACTH-Freisetzung verantwortlich sind, wurde 
zuerst die Expression der Rezeptoren für Corticotropin-releasing Hormon (CRH) 
und Arginin-Vasopressin (AVP), die massgeblichen Einfluss auf die ACTH 
Freisetzung haben, untersucht. Eine unveränderte CRH-R1 mRNA- aber 
erniedrigte Proteinexpression in den CSC Tieren bestätigten die Ergebnisse 
anderer Studien, wobei auch gezeigt werden konnte, dass eine erniedrigte CRH-
R1 nicht zu einer erniedrigten ACTH Freisetzung führte. Zusammen mit der 
unveränderten AVPR-1b mRNA- und Proteinexpression, deutet dies in den CSC 
Tieren darauf hin, dass beide Rezeptoren nicht an der erhöhten ACTH Sekretion 
beteiligt sind. Die erniedrigte CRH-R1 und die unveränderte AVPR-1b 
Expression lassen weiter vermuten, dass die neu gebildeten Hypophysenzellen 
sensitiver auf AVP als auf CRH reagieren. Dies muss jedoch unter anderem noch 
in Stimulationsversuchen gezeigt werden, wobei Hypophysen in vitro mit AVP, 
CRH und einer Kombination aus Beiden stimuliert und die ACTH Antwort 
gemessen werden soll.  
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Da zahlreiche Studien AVP eine wichtige Rolle in der Regulation der ACTH 
Freisetzung während chronischem oder länger anhaltenden Stress zuschreiben 
und aufgrund der Tatsache, dass momentan nur mRNA Daten vorhanden sind, 
wurde die Anzahl der parvo- und magnozellulären AVP-positiven Neurone im 
Nucleus paraventricularis (PVN) mittels immunohistochemischer Färbung 
gemessen, wobei jedoch kein Unterschied zwischen SHC und CSC Tieren 
gefunden wurde. Da nicht nur CRH und AVP die Freisetzung von ACTH 
stimulieren können, sondern beispielsweise auch Oxytocin (OXT), wurde auch 
die Anzahl der OXT-positiven Neurone im PVN von SHC und CSC Tieren 
gemessen, was wiederum keine Unterschiede lieferte. 
Alles in allem konnte im ersten Teil der Arbeit nachgewiesen werden, dass CSC 
Exposition zu einer Hypophysenhyperaktivität und –reaktivität führt. Dabei 
deutete eine erhöhte Anzahl an corticotrophen Hypophysenzellen, zusammen mit 
unveränderter AVPR-1b und erniedrigter CRH-R1 Proteinexpression darauf hin, 
dass dies durch die neu gebildeten corticotrophen Zellen, die vermutlich 
sensitiver gegenüber AVP als CRH sind, vermittelt wird. Darüberhinaus konnte 
gezeigt werden, dass Veränderungen der AVP und/oder OXT Expression keinen 
Einfluss auf die Reaktivität der Hypophse nach CSC Exposition haben.  
 
Der zweite Teil der Arbeit fokussierte sich auf die negative Feedbackinhibierung 
der HPA-Achse, hauptsächlich vermittelt durch Glucocorticoid- (GR) und 
Mineralocorticoidrezeptoren (MR), in der Hypophyse, im Hippocampus, im 
präfrontalen Cortex und im PVN. 
Im Hippocampus war die GR mRNA- und Proteinexpression reduziert, während 
die MR mRNA- und Proteinexpression als auch die Proteinexpression des 
FK506-bindenden Proteins 51 (FKBP51), das in der Regulation der Sensitivität 
und Funktionalität der Corticosteroidrezeptoren involviert ist, nach CSC 
Exposition unverändert waren. Jedoch konnte in vitro in isolierten hippocampalen 
Zellen gezeigt werden, dass die Funktionalität des GR nicht eingeschränkt, 
sondern gar erhöht war. Sowohl die CORT-induzierte hnRNA Expression des 
Period1 Gens in isolierten hippocampalen Zellen als auch die hippocampale 
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Zellviabilität in vitro nach 24 Stunden CORT-Stimulation war in CSC Tieren höher 
als in SHC Tieren.  
Im präfrontalen Cortex war die Proteinexpression von GR, MR und FKBP51 
erhöht, während im PVN keine Unterschiede zwischen SHC und CSC Tieren im 
Hinblick auf GR und MR Proteinexpression gefunden werden konnten. 
Auf Ebene der Hypophyse deutete eine reduzierte GR mRNA- und 
Proteinexpression auf eine verringerte negative Feedbackinhibierung hin. Jedoch 
zeigte das Ergebnis des Dexamethason (Dex) Unterdrückungstest eindeutig, 
dass das Feedback auf Ebene der Hypophyse unverändert, wenn nicht sogar 
erhöht war. Dabei wurden SHC und CSC Tiere am Morgen des Tag 20 ip mit Dex 
beziehungsweise Vehikel injiziert und 4 Stunden später einem akutem Stressor 
(6-min FS) ausgesetzt. 10 min nach Beendigung des Stressors wurden die Tiere 
getötet und Plasma ACTH Werte analysiert. Sowohl in SHC als auch in CSC 
Tieren war Dex in der Lage den stress-induzierten ACTH Anstieg zu blocken, 
was auch hier daraufhindeutet, dass der GR, trotz verringerter Expression, 
funktional ist. Dies wurde auch durch Messung der nukleären GR Expression 
nach akutem Stress und die erhöhte FKBP51 Expression, die wahrscheinlich auf 
eine erhöhte transkriptionelle Aktivität des GR vermittelt wird, bestätigt. 
Möglicherweise spielt dabei aber auch die erhöhte MR Proteinexpression und 
deren mögliche kompensatorische Wirkung eine wichtige Rolle, was in 
zukünftigen Studien noch genauer untersucht werden muss.  
Zusammenfassend lässt sich feststellen, dass MR und GR Expression in der 
Hypophyse und den verschiedenen Gehirnregionen unterschiedlich reguliert 
werden. Darüberhinaus konnte, sowohl in der Hypophyse als auch im 
Hippocampus gezeigt werden, dass eine reduzierte Anzahl an GR nicht 
unbedingt eine erniedrigte Funktionalität zur Folge hat. Dieses Ergebnis 
verdeutlicht, dass allein die Messung der Rezeptorexpression keine 
Rückschlüsse auf die Funktionalität zulässt und unterstreicht die Wichtigkeit der 
Analyse von Phosphorylierungen und/oder Expression von GC-regulierten 
Genen nach Stimulation mit CORT oder Dex.  
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Die Stressvulnerabilität gegenüber den negativen Konsequenzen von Stress 
variiert zwischen den Individuen, wobei negative Lebensereignisse zusammen 
mit genetischen Faktoren eine wichtige Rolle spielen. In Übereinstimmung damit 
konnte in einer vorherigen Studie bereits gezeigt werden, dass die 
Konsequenzen von CSC in adulten Mäusen verstärkt werden können, wenn 
diese in ihrer frühen Lebensphase wiederholter mütterlicher Trennung ausgesetzt 
wurden. Der dritte Teil der Thesis hatte daher zum Ziel, den Einfluss der 
genetischen Prädisposition, in diesem Fall die angeborene Ängstlichkeit, auf die 
Auswirkungen von chronisch psychosozialem Stress zu untersuchen. 
Dafür wurden CD1 Mäuse verwendet, die selektiv auf niedrige („low anxiety-
related behaviour“ = mLAB) beziehungsweise hohe („high anxiety-related 
behaviour“ = mHAB) Ängstlichkeit gezüchtet wurden und nicht-selektierte 
normale CD1 Mäuse („normal anxiety-related behaviour“ = mNAB). Auf der EPM 
und in der Licht-Dunkel Box zeigten mLAB ein niedriges, mHAB ein hohes und 
mNAB ein mittleres Angstverhalten. Nicht nur die angeborene Angst ist 
unterschiedlich zwischen mHAB und mLAB Mäusen, auch die Reaktion auf einen 
akuten Stressor war in mLAB höher als in mHAB Mäusen, obwohl die basalen 
CORT Werte in beiden Gruppen ähnlich waren. Da es jedoch noch keine Studien 
gibt, welche die Reaktion auf chronischen Stress in diesen Zuchtlinien untersucht 
haben, wurden in dieser Arbeit die verhaltensrelevanten, physiologischen, 
neuroendokrinen und immunologischen Folgen nach CSC Exposition im Hinblick 
auf die genetische Prädisposition untersucht. Die Hypothese dabei war, dass die 
geringere Ängstlichkeit der mLAB Mäuse einen protektiven Effekt auf die 
Konsequenzen von chronischen Stress im Vergleich zu mNAB Mäusen hat, da 
aus zahlreichen Studien bekannt ist, dass chronische Stressexposition zu einer 
erhöhten Ängstlichkeit führt. Folglich müssten mHAB Mäuse stärker von den 
CSC-induzierten Effekten betroffen sein. In Übereinstimmung mit den bekannten 
Effekten von CSC in C57BL/6 Mäusen zeigten sowohl mHAB als auch mNAB 
CSC Mäuse ein erhöhtes Nebennierengewicht, eine erniedrigte Sensitivität der 
Nebennieren gegenüber ACTH in vitro, eine niedrigeres Plasma CORT:ACTH 
Verhältnis und eine erhöhte IFN-γ Freisetzung von isolierten mesenterialen 
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Lymphknotenzellen als Antwort auf eine anti-CD3 Stimulation im Vergleich zu 
SHC Tieren der gleichen Linie. Nichtsdestotrotz war der CSC-induzierte 
anxiogene Effekt nur bei den mNAB Tieren jedoch nicht bei den mHAB Tieren 
sichtbar. Dies ist höchstwahrscheinlich darauf zurückzuführen, dass mHAB Tiere 
bereits vor CSC-Exposition eine sehr hohe Ängstlichkeit aufwiesen, z.B. 
verbrachten sie weniger als 6 % der Zeit auf dem offenen Arm der EPM, die 
durch CSC-Exposition nicht weiter gesteigert werden konnte. Das 
interessanteste Ergebnis dieser Studie ist aber die Tatsache, dass mLAB Mäuse 
resistent gegenüber chronischem Stress waren, da alle analysierten Parameter 
nach CSC unverändert waren. Auch konnte gezeigt werden, dass mHAB Mäuse 
nicht anfälliger gegenüber den CSC-induzieren Effekten als mNAB Mäuse sind, 
was eventuell an der Intensität des Stressors liegen könnte, die eine 
Unterscheidung zwischen beiden Gruppen nicht möglich machte.  
Zusammenfassend lässt sich feststellen, dass die genetische Prädisposition, in 
diesem Fall die angeborene Ängstlichkeit, die Vulnerabilität gegenüber chronisch 
psychosozialem Stress beeinflusst, wobei ein wenig ängstlicher Phänotyp 
Stressresistenz sowohl gegenüber affektiven als auch somatischen Folgen von 
CSC vermittelt. Die Kombination aus Mäusen mit angeborener extrem niedriger 
Ängstlichkeit und dem CSC Paradigma stellt daher ein wichtiges Werkzeug dar, 
um sowohl die molekularen Mechanismen die der Interaktion aus Genen und 
Umwelt zugrundeliegen als auch die Stressresistenz im Speziellen zu 
untersuchen. 
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Abbreviations 
ACTH Adrenocorticotropic Hormone 
ADX Adrenalectomy 
ANOVA Analysis of Variance 
ANXA1 Annexin 1 
AVP Arginine Vasopressin 
AVPR-1a Arginine Vasopressin Receptor 1a 
AVPR-1b Arginine Vasopressin Receptor 1b 
BNST Bed Nucleus of the Stria Terminalis 
BSA Bovine Serum Albumin 
Ca2+ Calcium 
cAMP cyclic Adenosine Monophosphate 
cDNA complementary Deoxyribonucleic Acid 
CBG Corticosteroid-binding Globulin 
CeA Central Amygdala 
CNS Central Nervous System 
CORT Corticosterone 
CRH Corticotropin Releasing Hormone 
CRH-BP Corticotropin Releasing Hormone Binding Protein 
CRH-R1 Corticotropin Releasing Hormone Receptor 1 
CRH-R2 Corticotropin Releasing Hormone Receptor 2 
CSC Chronic subordinate Colony housing 
DAG Diacylglycerol 
DBD DNA-binding domain 
Dex Dexamethasone 
DG Dentate Gyrus 
DMEM Dulbecco`s Modified Eagle Medium 
DNA  Deoxyribonucleic Acid 
DSS Dextran Sulfate Sodium 
DST Dexamethasone Suppression Test 
DTT Dithiothreitol 
EC Entorhinal Cortex 
EDTA Ethylendiamintetraacetic Acid 
ELISA Enzyme Linked Immunoabsorbent Assay 
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EPF Elevated Platform 
EPM Elevated Plus-Maze 
FKBP51 FK506-binding protein 51 
FKBP52 FK506-binding protein 52 
FS Forced Swim 
GABA gamma-aminobutyric acid 
GAPDH Glyceralaldehyd-3-Phosphatdehydrogenase 
GC Glucocorticoid 
Glu Glutamate 
GPCR G-Protein coupled Receptor 
GR Glucocorticoid Receptor 
GRE Glucocorticoid-responsive element 
h Hour 
HAB High Anxiety-related Behaviour 
HBSS Hank`s Balanced Salt Solution 
HPA Hypothalamic-Pituitary-Adrenal axis 
HSP Heatshock Protein 
IFN-γ Interferon γ 
IHC Immunohistochemical 
InL Infralimibic 
Ip Intraperitoneal 
IP3 Inositol 1,4,5-trisphosphate 
kd Dissociation constant 
kDa kilo Dalton 
LAB Low Anxiety-related Behaviour 
LC Locus Coeruleus 
MAPK Mitogen-activated Protein Kinase 
Mc Magnocellular 
Mc2r Melanocortin-2-receptor 
Mdr Multidrug resistance 
MeA Medial Amygdala 
mesLNC mesenteric Lymph Node Cells 
mEPSC miniature Excitatory Postsynaptic Current 
min Minute 
mM Millimolar 
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MP Milk Powder 
mRNA messenger Ribonucleic Acid 
MR Mineralocorticoid Receptor 
MS Maternal Separation 
Na3VO4 Sodium Orthovanadate 
NaF Sodium Fluoride 
NAB Normal Anxiety-related Behaviour; non-selected normal CD1 
NE Norephinephrine, Noradrenaline 
NGS Normal Goat Serum 
NLS Nuclear Localization Signal 
nM Nanomolar 
OA Open arm 
o/n Overnight 
OXT Oxytocin 
PBS Phosphate-Buffered Saline 
Pc Parvocellular 
Per1 Period 1 
PFC Prefrontal Cortex 
PIP2 Phosphatidylinositol 4,5-Bisphosphate 
qRT-PCR quantitative real-time Polymerase Chain Reaction 
PKA Proteinkinase A 
PKC Proteinkinase C 
PL Prelimbic 
PLC Phospholipase C 
POMC Pro-opiomelanocortin 
PTSD Posttraumatic Stress Disorder 
PVN Paraventricular Nucleus 
RNA Ribonucleic Acid 
RT Room Temperature 
SD Social Defeat 
SHC Single-housed Control 
S/N Supernatant 
SNP Single Nucleotide Polymorphism 
SNS Sympathetic Nervous System 
SON Supraoptic Nucleus 
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Sub Subiculum 
TBS Tris-buffered Saline 
TF Transcription Factor 
TPR Tetratricopeptide Repeat 
VDCC Voltage-dependent Calcium Channels 
11ß-HSD 11ß-Hydroxysteroid-Dehydrogenase 
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